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Lyngby, September 2009
Stig Bousgaard Mortensen
ii Preface
Abstract
This thesis deals with mathematical and statistical models with focus on appli-
cations in pharmacokinetic and pharmacodynamic (PK/PD) modelling. These
models are today an important aspect of the drug development in the pharma-
ceutical industry and continued research in statistical methodology within these
areas are thus important.
PK models are concerned with describing the concentration profile of a drug
in both humans and animals after drug intake whereas PD models are used to
describe the effect of a drug in relation to the drug concentration. PK models for
an individual are usually described as a deterministic mean value using ordinary
differential equations to which a random error is added. This thesis explores
methods based on stochastic differential equations (SDEs) to extend the models
to more adequately describe both true random biological variations and also
variations due to unknown or uncontrollable factors in an individual. Modelling
using SDEs also provides new tools for estimation of unknown inputs to a system
and is illustrated with an application to estimation of insulin secretion rates in
diabetic patients.
Models for the effect of a drug is a broader area since drugs may affect
the individual in almost any thinkable way. This project focuses on measuring
the effects on sleep in both humans and animals. The sleep process is usually
analyzed by categorizing small time segments into a number of sleep states and
this can be modelled using a Markov process. For this purpose new methods for
non-parametric estimation of Markov processes are proposed to give a detailed
description of the sleep process during the night.
Statistically the Markov models considered for sleep states are closely related
to the PK models based on SDEs as both models share the Markov property.
When the models are applied to clinical data there will often be a large variation
between individuals and this can be included in both types of models using
the mixed modelling approach. Estimation in these models is discussed with
emphasis on data with a more complex grouping structure.
iv Abstract
Resume´
(Abstract in Danish.)
Denne afhandling beskæftiger sig med matematiske og statistiske modeller med
fokus p˚a applikationer indenfor farmakokinetisk og farmakodynamisk (PK/PD)
modellering. Disse modeller udgør i dag et vigtigt aspekt af udvikling af lægemi-
dler i den farmaceutiske industri og fortsat forskning i statistiske metoder inden
for disse omr˚ader er derfor vigtig.
PK modeller beskriver koncentrationsprofilen af medicin i b˚ade mennesker
og dyr efter indtagelse af et lægemiddel hvorimod PD modeller bruges til at
beskrive virkningen af et lægemiddel i relation til koncentrationsprofilen. Of-
test bliver PK modeller for et individ beskrevet deterministisk ved brug af or-
dinære differentialligninger. Denne afhandling undersøger metoder baseret p˚a
stokastiske differentialligninger (SDEer) der gør det muligt udvide disse modeller
til at beskrive variation fra b˚ade tilfældige biologiske effekter og ogs˚a variationer
fra ukendte eller ukontrollerbare faktorer i et individ. Modellering ved hjælp af
SDEer giver ogs˚a nye metoder til estimering af ukendt input til et system, og
dette er illustreret her med en anvendelse til estimering af raten for insulinpro-
duktion i diabetespatienter.
Modeller for virkningen af lægemidler er et bredere omr˚ade da de kan p˚avirke
det enkelte individ p˚a et næsten ubegrænset antal m˚ader. Dette projekt fokuserer
p˚a at m˚ale effekten p˚a søvn i b˚ade mennesker og dyr. Søvnstrukturen bliver
normalt analyseret ved at kategorisere sm˚a tidssegmenter i et antal søvnstadier,
og dette kan modelleres ved brug af en Markov proces. Til dette form˚al er der
udviklet nye ikke-parametriske metoder til estimering af Markov processer for
at kunne give en detaljeret beskrivelse af søvnstrukturen i løbet af natten.
Statistisk er Markov modeller for søvnstadier tæt relateret til PK modeller
baseret p˚a SDEer da de begge deler Markov egenskaben. N˚ar disse modeller
anvendes til kliniske data, vil der ofte være en stor variation mellem enkeltper-
soner og denne kan beskrives i begge typer af modeller ved at anvende s˚akaldte
mixede modeller. Estimation i disse modeller bliver behandlet med vægt p˚a
data med en mere kompleks grupperingsstruktur.
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Chapter 1
Introduction
The drug development process in the pharmaceutical industry today generates
increasing amounts of data and this requires ongoing development and refine-
ment of the methods applied for the analysis. The present project explores
methods based on Markov and nonlinear mixed effects models with applications
mainly within pharmacokinetics and pharmacodynamics (PK/PD).
Nonlinear mixed models (NLMMs) are used as a standard tool today for
what is often referred to as population PK/PD modelling. Mixed models are
models with both fixed and random effects and can in many cases effectively
describe both the common structure of a response and the random variation
between e.g. a number of individuals in the data. This thesis extends the class
of models that can easily be fitted in this framework. For NLMMs the maximum
likelihood estimation involves an integral of dimension equal to the number of
random effects in the model. In cases where random effects only occur for one
level of grouping in the data (e.g. individuals) or if random effects are nested
(e.g. separate groups of individuals are observed at different study centers)
the dimensionality of the integration problem can be significantly reduced using
standard methods. This type of model structure has almost solely been the focus
of statistical software for estimation of NLMMs, which goes back to the first
software tool NONMEM (Beal and Sheiner, 2004) which was initially introduced
around 1980 (Beal and Sheiner, 1980). Situations with crossed random effects
where e.g. some individuals are observed at more than one study center requires
an evaluation of the full dimensional integral. In Chapter 2 it will be described
how this problem can be handled using the multivariate Laplace approximation.
2 Introduction
Pharmacokinetics and pharmacodynamics are in popular terms often de-
scribed as “what the body does to the drug” and “what the drug does to the
body”, respectively. Research in these disciplines has a long history and today
these disciplines constitute an important part of the drug development process.
A general introduction to PK/PD is given in paper B and a more thorough
description can be found in e.g. Rowland and Tozer (1997) or (Gabrielsson and
Weiner, 2006).
Pharmacodynamics is concerned with the effects of the drug. The effect of
a drug can e.g. be lowering of the blood pressure, in which case it is relatively
straight forward to measure, or it can be reducing pain, which is somewhat more
difficult to quantify. An example of a PD model for a pain reliever is illustrated
in paper B. Here the effect is measured on a visual analogue scale and this is
linked to a PK model to get a full PK/PD model for the drug.
A part of this project has been concerned with effect measures for sleep
and in particular a measure of sleep related to time. This study was initiated
by a new drug candidate Gaboxadol which has been under development by H.
Lundbeck. Studies have shown that Gaboxadol has sleep promoting effects that
differs from currently marketed sleep drugs.
Sleep is mainly studied using the electroencephalogram (EEG) which records
electrical signals from the neurons in the brains by placing a number of electrodes
on the scalp. The electrical signals are sampled at a high frequency of e.g.
100 Hz which results in a raw EEG recording. This recording is traditionally
transformed into sleep stages, where each segment of data of usually either 10 or
30 seconds (called the epoch length) is classified into sleep stages. For humans
there are six stages, namely wake, REM sleep and sleep stages 1 to 4. These
sleep stages were defined by Rechtschaffen and Kales (1968) and has been used
as a gold standard ever since. For rodents similar analysis can be performed,
but here it is usually only possible to classify 3 sleep stages, namely wake, delta
sleep and paradoxical sleep where the two latter are related to sleep stages 3-4
and REM sleep in humans, respectively.
Traditionally sleep has been evaluated by means of simple summaries like
time spent in each sleep stage, time to sleep onset and similar measures. In
order to study the dynamics of changes of the sleep process over night in more
detail it is chosen to model the sequence of sleep stages as an inhomogeneous
Markov process. Estimation of changes in parameters of the inhomogeneous
Markov model is discussed in Chapter 3 where a method based on local kernel
estimation is proposed for solving the estimation problem. It is further shown
how this can be used to estimate the pharmacodynamic effect of Gaboxadol.
Pharmacokinetics is the study of how a drug enters and circulates through
the body and in general it describes where the drug is in the body as a function
of time. The dynamical description of the body as a system is obtained using
a compartmental model structure, where each compartment represents an area
3of the body where the drug is contained and can be assumed to be evenly dis-
tributed. Examples of potential compartments are the bloodstream, muscles,
the stomach or peripheral tissue. The movement of the drug between the com-
partments is traditionally described using ordinary differential equations and
thus implicitly defines the body as a deterministic system without any random
biological variation. If such random biological variation is actually present or
if some parts of the system is not adequately described this may result in se-
rial correlation in the residuals between observations and model in a statistical
analysis.
To appropriately model these phenomena is has been proposed to introduce
stochastic differential equations (SDEs) for the modelling. By using SDEs it
is possible to include stochastic components in the model of a system to com-
pensate for true biological variation or structural misspecification of the model.
A part of this project has been concerned with the development of a software
tool for estimation of the embedded parameters of a general nonlinear mixed
model based on SDEs. This will be presented and discussed in more detail in
Chapter 4 and will also include applications of the modelling approach. Like
for the mixed model this work allows for using models that were previously too
complex to be used.
4 Introduction
Chapter 2
Mixed models
Mixed models make up a general class of models for the analysis of grouped
data. A mixed model handles dependence between observations within groups
by assuming the existence of one or more unobserved latent variables for each
group of data. The unobserved latent variables are assumed to be random and
hence referred to as random effects. A mixed model thereby consists of both
fixed model parameters θ and random effects b for modelling both the common
and group dependent structures in the data. Modelling using both fixed and
random effects has coined the term mixed-effects models or in short just mixed
models.
Random effects naturally enter the modelling when data is observed based on
a number of experimental units that are taken from a larger population. In such
cases it is often found that e.g. individuals from a population are very similar
but exhibit a certain amount of variation that is most appropriately modelled
as random. The distribution of the random effects thus represents the random
variation in the populations that cannot otherwise be reasonably explained by
fixed effects and covariates. In this way inference based on a mixed model
where the random effect distribution has been estimated along with the model
parameters will apply to the population as a whole and not only the individuals
selected for the study. From an inferential point of view this is the main benefit
achieved using a mixed modelling approach along with the possibility of judging
individual covariates such as sex, weight and height.
There are no constraints on the assumed distribution for the random effects,
but for a very wide range of applications they are assumed to have a Gaussian
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distribution with mean zero such that
b ∼ N(0,Ψ).
The random effect distribution is thus completely described by its covariance
matrix Ψ and this class of Gaussian mixed models will be the focus here.
2.1 Parameter estimation
Estimation in mixed models is based on maximum likelihood. The statistical
description of a mixed model is defined by a joint likelihood of the model pa-
rameters and the unobserved random effects based on the joint density of (y, b).
The joint likelihood is given as
L(θ,Ψ, b|y) = p(y, b|θ,Ψ) (2.1)
= p(y|b,θ,Ψ)p(b|θ,Ψ) (2.2)
= p1(y|b,θ)p2(b|Ψ) (2.3)
where (2.2) follows using Bayes’ theorem and (2.3) since p1(y|b) does not in-
volve Ψ and p2(b|Ψ) likewise does not involve θ. The part of the model defining
p1(y|b,θ) is sometimes referred to as the first stage model (with likelihood func-
tion L1(b,θ|y)) and p2(b|Ψ) as the second stage model. To obtain the likelihood
for the model parameters (θ,Ψ) the unobserved random effects are integrated
out based on the assumed (here Gaussian) distribution. The likelihood function
for estimating (θ,Ψ) is thus the marginal likelihood
LM (θ,Ψ|y) =
∫
Rq
L(θ,Ψ, b|y)db (2.4)
where q is the number of random effects and θ and Ψ are the parameters to
be estimated. The likelihood function in (2.4) gives a very broad definition of
mixed models: the only requirement for using mixed modeling is to define a
joint likelihood function for the model of interest. In this way mixed modelling
can be applied to any likelihood based statistical modelling. Examples of appli-
cations are linear mixed models (LMM) and nonlinear mixed models (NLMM)
(regression type models, see e.g. Bates and Watts (1988)), generalized linear
mixed models (McCulloch and Searle, 2001) but also models based on Markov
chains and SDEs as will be the focus of Chapter 3 and 4.
2.2 Evaluation of the marginal likelihood
For many classes of statistical models the integral in (2.4) is intractable with
no closed form solution available. An important exception to this is the widely
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used Gaussian linear mixed model where y = Xβ + Zb + ,  ∼ N(0,Σ), for
which the marginal distribution of the observation y is given explicitly as a
multivariate Gaussian distribution with mean Xβ and variance ZΨZT + Σ.
For Gaussian nonlinear mixed models
y = f(β, b) + ,  ∼ N(0,Σ), (2.5)
where the model function f is nonlinear, it is no longer generally possible to
derive an explicit marginal distribution. An exception to this is nonlinear mixed
models which are nonlinear only in β but not b. Such a model can be re-written
with a first-order Taylor expansion around b = 0 as f(β, b) = f(β,0) +f ′b(β)b
which is equivalent to a linear mixed model with Xβ = f(β,0) and Zb =
f ′b(β)b. For a given set of parameters β the likelihood function can thus be
evaluated based on the marginal multivariate Gaussian distribution as in the
linear mixed model. A clear distinction between nonlinear mixed models that
are either linear or nonlinear in the random effects is not always made, but is
important from a computational viewpoint.
2.2.1 Likelihood approximations
For mixed models where there is no closed form solution to (2.4) it is necessary
to invoke some form of numerical approximation to be able to estimate the
model parameters. The complexity of this problem is mainly dependent the
dimensionality of the integration problem which in turn is dependent on the
grouping structure in the data for the random effects. These structures include
a single grouping, nested grouping, partially crossed and crossed random effects.
For problems with only one level of grouping the marginal likelihood can be
simplified as
L(β,Ψ|y) =
M∏
i=1
∫
Rqi
p1(y|bi,θ)p2(bi|Ψ)dbi (2.6)
where qi is the number of random effects for each group and M is the number of
groups. Instead of having to solve an integral of dimension q it is only necessary
to solveM smaller integrals of dimension qi. In typical applications there is often
just one or only a few random effects for each group, and this thus greatly reduces
the complexity of the integration problem. If the data has a nested grouping
structure a reduction of the dimensionality of the integral similar to that shown
in (2.6) can be performed. An example of a nested grouping structure is data
collected from a number of schools, a number of classes within each school and
a number of students from each class. However, if some students changes school
during the study, the random effects structure is suddenly partially crossed and
the simplification relating to (2.6) no longer applies.
Estimation in models with a single level of grouping has received the main
focus of research within nonlinear mixed models and a number of approxima-
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tions have been proposed in the literature for the marginal likelihood function
in (2.6). Pinheiro and Bates (1995) compare the five most common methods,
namely the Lindstrom and Bates alternating method, a modified Laplacian ap-
proximation, importance sampling, Gaussian quadrature and adaptive Gaussian
quadrature. They conclude that the Lindstrom and Bates alternating method
performs well and is most computationally efficient. This method is however
only applicable for data with a single or nested grouping structure and further
requires individual parameters to be modelled as a linear function of the ran-
dom effects φij = Aijβ + Bijbi where Aij and Bij are design matrices for
the individual parameters and this constrains the individual parameters φij to
be normally distributed. This limits the alternating method from applications
such as pharmacokinetics, where log-normally distributed parameters are often
encountered.
Pinheiro and Bates further conclude that the Laplacian or adaptive Gaus-
sian approximations should be used when greater accuracy is required. The
Laplacian approximation is equivalent to adaptive Gaussian with one quadra-
ture point, and further points can thus be used in adaptive Gaussian to improve
the Laplacian approximation. However, increasing the number of points gave
only marginal improvement and did not seem necessary. Importance sampling
can be used to achieve similar accuracy, but was found to be less computa-
tionally efficient and also the stochastic element can give problems for gradient
based estimation procedures of the model parameters. Gaussian quadrature
were found to be too inefficient due to poor sampling of the integrand.
Both importance sampling, the Laplacian and adaptive Gaussian approxi-
mations are exact when the random effects are linear in the random effects. An
extension of this is a model where some random effects are linear and some are
nonlinear which is discussed in du Toit and Cudeck (2009). If there is only one
level of grouping they show that it is possible to separate these and only use
a numerical integration method for the integration over the nonlinear random
effects.
If the nonlinear mixed model is extended to include any structure of ran-
dom effects such as crossed or partially crossed random effects it is required to
evaluate the full multiple integral in (2.4) as mentioned earlier. This may sig-
nificantly increase computational demands due to the product rule. This states
that if an integral is sampled in m points per dimension to evaluate it, the total
number of samples needed is mq which rapidly becomes infeasible even for a
limited number of random effects. For this reason estimation in models with
crossed random effects is not supported by any of the standard software packages
for fitting NLMMs such as nlme (Pinheiro et al., 2008), SAS NLMIXED (SAS
Institute Inc., 2004) and NONMEM (Beal and Sheiner, 2004). However, esti-
mation in these model can efficiently be handled using the multivariate Laplace
approximation, which only samples the integrand in one point common to all
dimensions. Estimation based on the multivariate Laplace approximation is the
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main focus for paper E where it is shown how it can be implemented on a case
by case basis in R (R Development Core Team, 2008) with a limited amount of
coding required to make it possible to estimate NLMMs with any structure of
random effects.
2.3 Multivariate Laplace approximation
The Laplace approximation will be outlined in the following with application
to other than standard Gaussian nonlinear mixed models in mind. A thorough
description of the Laplace approximation in nonlinear mixed models is found
in Wolfinger and Lin (1997) and it is also presented in paper E. In short, the
Laplace approximation approximates the joint likelihood in (2.3) with a Gaus-
sian distribution centered at the modes of the random effects. This corresponds
to a 2nd order Taylor expansion (i.e. a quadratic approximation) of the joint
log-likelihood h given as
h(θ,Ψ, b|y) = logL(θ,Ψ, b|y) (2.7)
= log p1(y|b,θ) + log p2(b|Ψ) (2.8)
where the expansion of h is done around the mode of the random effects b˜ =
arg maxb L(θ,Ψ, b|y) for fixed θ and Ψ. Note that in paper E the parameter θ
includes Ψ, but here it is noted separately to distinguish the parameters used
only in the first stage model. The second-order Taylor expansion of the joint
log-likelihood h is given as
logL(θ,Ψ, b|y) = h(θ,Ψ, b|y) (2.9)
≈ h(θ,Ψ, b˜|y)− 1
2
(b− b˜)TH(b˜)(b− b˜) (2.10)
where the first-order term in the Taylor expansion disappears since the expan-
sion is done around the mode b˜ and H(b˜) = −h′′bb(θ,Ψ, b)|b=b˜ is the negative
Hessian of the joint log-likelihood evaluated at b˜ which will simply be referred
to as ’the Hessian’. Using the approximation in (2.10) in (2.4) the Laplace
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log-likelihood can be derived as
logLLA(θ,Ψ|y) = log
∫
Rq
exp
(
h(θ,Ψ, b˜|y)− 1
2
(b− b˜)TH(b˜)(b− b˜)
)
db
= h(·) + log
∫
Rq
exp
(
−1
2
(b− b˜)TH(b˜)(b− b˜)
)
db
= h(·) + log
∣∣∣∣ 2piH(b˜)
∣∣∣∣ 12 ∫
Rq
1
(2pi)
q
2 |H−1(b˜)| 12 exp
(
−1
2
(b− b˜)TH(b˜)(b− b˜)
)
db
= h(·) + log
∣∣∣∣ 2piH(b˜)
∣∣∣∣ 12
= h(θ,Ψ, b˜|y)− 1
2
log
∣∣∣∣∣H(b˜)2pi
∣∣∣∣∣ (2.11)
= log p1(y|b,θ)− 12 log |2piΨ| −
1
2
b˜
T
Ψ−1b˜− 1
2
log
∣∣∣∣∣H(b˜)2pi
∣∣∣∣∣
= log p1(y|b,θ)− 12 log |Ψ| −
1
2
b˜
T
Ψ−1b˜− 1
2
log |H(b˜)|
(2.12)
where the integral is eliminated by transforming it to an integration of a mul-
tivariate Gaussian density with mean b˜ and variance H−1(b˜). In the step in
(2.11) the fraction in the determinant is inverted to avoid a matrix inversion of
the Hessian. In (2.12) the log-likelihood function is written out further to show
the different components and it is slightly simplified by using that the constant
−q log 2pi from the determinant of the Hessian cancels out with q log 2pi from
the density function for the random effects.
The evaluation of the Laplace likelihood in (2.12) makes no assumptions on
the first stage model L1(b,θ|y) = p1(y|b,θ). As long as a likelihood function
of the random effects and model parameters can be defined it is possible to use
the Laplace likelihood for estimation in a mixed model framework. This will be
discussed further with the models used in Chapter 3 and 4.
The Laplace likelihood only approximates the marginal likelihood for mixed
models with nonlinear random effects and thus maximizing the Laplace likeli-
hood will result in some amount of error in the resulting estimates. However, in
Vonesh (1996) it is shown that the joint log-likelihood converges to a quadratic
function of the random effect for increasing number of observations per ran-
dom effect and thus that the Laplace approximation is asymptotically exact.
When choosing to use a Gaussian distribution for the random effects this can
be expected to give a faster rate of convergence compared to other distributions,
since the logarithm of the Gaussian distribution is in itself quadratic in the ran-
dom effects as seen in (2.12). In situations where individual random effects are
relatively well defined the Laplace approximation can thus be expected to per-
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form well and this holds independently of the first stage model. This makes the
Laplace approximation an attractive approach for many applications. However,
in practical applications the accuracy of the Laplace approximation may still be
of concern, but improved numerical approximation of the marginal likelihood
(such as Gaussian quadrature) may often easily be computationally infeasible
to perform. This concern is addressed in paper E where it is suggested to use
graphical methods to asses the accuracy of the approximation.
2.4 The nonlinear mixed model
As mentioned previously, the estimation scheme presented in paper E is based
on the multivariate Laplace approximation in (2.12) to give full flexibility in
random effects structure not otherwise found in standard software. The paper
focuses on the standard nonlinear mixed model with first stage model given by
(2.5) and the main point is to illustrate how an NLMM can be defined and
estimated in R with relative ease.
In the NLMM it is possible to apply a first order approximation of the
Hessian in (2.10) when using the Laplace approximation. This approximation
is equal to the expected Hessian (in both linear and nonlinear models) and is
referred to as the modified Laplace approximation by Pinheiro and Bates (1995)
and as the FOCE approximation in NONMEM (Wang, 2007). Further details
are found in paper E.
To illustrate the estimation scheme presented in paper E a data set with the
growth of 5 orange trees is used (Draper and Smith, 1981). The circumferences
of the trees are measured 7 times approximately every half year over a 4 year
period. The data has been used previously in the literature by Lindstrom and
Bates (1990) (see Figure 2.1) and Millar (2004) for illustration of NLMMs. The
former uses a single random effect for difference in asymptotic circumference and
the latter introduces an additional crossed random effect to handle difference
between sampling occasions.
In paper E it is shown that the apparently random effect of the sampling
occasion can in fact be explained by a deterministic effect of season and the fact
that some half year intervals are missed making the effect look ’random’. It is
also found that residuals within trees are strongly correlated in time which can
be modelled using a continuous auto-regressive (CAR) model given as
cov(ij , ik) = σ2 exp(−φ|tj′ − tj |) (2.13)
where tj is time in days for the jth observations of the ith tree. The resulting
model is similar to a model proposed for repeated measurements of growth of rats
suggested by Diggle (1988) which includes a random effect for variation between
rats and serial correlation. Although a continuous AR model is chosen here, a
similar model could be achieved using a discrete AR model where the correlation
12 Mixed models
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Figure 2.1: Plots of orange tree data together with the fit of a model by Lind-
strom and Bates (1990).
between measurements within a tree is φk, where k denotes the number of
half year periods between two observations and thereby correctly handling the
missed sampling occasions (Madsen, 2008). A more detailed interpretation of
the correlation structure and its relation with stochastic differential equations
will be discussed further in Chapter 4.
From an estimation perspective the model with crossed random effects (pos-
sibly in combination with the CAR model) is of particular interest, as these
cannot be estimated using standard software. In paper E it is shown how all
the models discussed are efficiently estimated using the suggested framework for
estimation in R.
2.4.1 Likelihood based inference
The estimation scheme for NLMMs in R gives the extra advantage of having
the marginal log-likelihood available in R. This can be used to directly create
profile likelihood for parameters in the model, which is not easily possible in
other standard software packages.
Profile likelihood plots are a key element in likelihood based inference since
it contains all information about to what extent different values of a parameter
are supported by the data. The profile likelihood can be used to make likelihood
based confidence intervals (CIs) instead of having to rely on the standard Wald
CI which is based on a quadratic approximation of the log-likelihood function.
The Wald CI is meaningful only if logL(θ) is at least approximately quadratic
and if this is not the case it is necessary to find a normalizing transform. The
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likelihood confidence interval is superior to the Wald approximation in the sense
that it automatically employs the best possible normalizing transform without
needing to know it. The likelihood CI is thus always as good as or better
than the Wald CI and will thus also better approximate the advertised coverage
probability (Pawitan, 2001).
These well established aspects of likelihood based inference touch upon an
important issue of how to make inference based on collected data in general.
This has been the focus of much debate and controversy through out the history
of statistics. It is still a highly relevant research area and thus deserves some
discussion.
Traditionally statistical results have been reported using either Fisher’s p-
value for measuring evidence against a null-hypothesis or using the Neyman-
Pearson hypothesis testing for choosing between a null and alternative hypoth-
esis using a decision rule that controls the long term error rates (Blume and
Peipert, 2003). Although the two approaches are fundamentally different in ob-
jective they are numerically closely related and this has led to some confusion.
If a researcher chooses a significance level α = 0.05 and finds p = 0.0003 after
conducting the study he can with confidence act as if the alternative hypoth-
esis is true with assurance given by the long term error rates. However, as a
researcher he might also at the same time argue that the small p-value provides
evidence against the null hypothesis in the particular study at hand (as argued
by Fisher). This is wrong however: a single number cannot both be seen from a
short and long run perspective. More detailed arguments for this can be found
in Goodman (1999).
A part from the confusion caused by the mix of the two methods, none of
them serve typical research purposes well. General research is not a matter
of making decisions and also the p-value is easily misleading since it does not
reveal any information about the range of effect sizes supported by data. This
has led to a greater focus on reporting results using confidence intervals, profile
likelihood and other likelihood based methods (Royall, 1997) as these methods
more adequately convey the statistical evidence available in the data. The
estimation framework presented in paper E supports these ideas by making
further analysis of the likelihood function in mixed models directly available.
2.4.2 Computational aspects
The computational complexity of using the mixed modelling framework will
always be somewhat greater than using the first stage model alone or by e.g.
estimating a set of common parameters across individuals simply using a pooled
likelihood. By pooled likelihood for data from M individuals y1, ...,yM is meant
the likelihood function L(θ) =
∏M
i=1 L(θ|yi). With estimation in a mixed model
using the Laplace approximation it is for every evaluation of the marginal like-
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lihood required to find the mode of the random effects b˜ and the Hessian for a
set of parameters θ and Ψ. This gives rise to a nested optimization structure
where the outer optimization of θ and Ψ involves repeated optimizations of the
random effects.
There is usually a number of finite difference approximations involved in the
Laplace likelihood, namely for the Hessian and the gradient of the joint and
marginal likelihoods used in the optimization of random effects and model pa-
rameters. These finite difference may be both time consuming and hinder fast
convergence if they are not sufficiently accurate. Recent work by Skaug and
Fournier (2006) points to a possible solution to this problem. They present a
software package in the C++ program language called ADMB-RE for mixed
models based on the Laplace approximation in (2.12). The package supports
estimation of mixed modelling for any programmable first stage model. Estima-
tion in the package uses a technique from computer science known as “automatic
differentiation” (AD) (Griewank, 2000). This is a technique that exploits the
chain rule of calculus to evaluate derivatives of functions defined in computer
programs to machine precision. This avoids the inaccuracies using finite dif-
ference approximations and also the limitations using symbolic differentiation
since any programmable function can be used as input. It can be shown that the
gradient of any function can be evaluated with so-called reverse mode automatic
differentiation in less than four times the cost of evaluating the function itself
independently of the number of model parameters. This is a strong result and
should be seen in contrast to finite difference approximations, where the cost is
proportional to the number of parameters.
There are some limitations of this approach however; model parameters are
not allowed to enter in if-statements in the model and the whole stack of oper-
ations needed to evaluate the function must be kept in memory. In particular,
the latter restricts models from using large systems of differential equations, as
the solution may easily involve too many computations to be kept in memory.
With these limitations in mind, the estimation in mixed models using AD offers
a number of benefits as both gradients of model parameters and random effects
and the Hessian can be evaluated to machine precision. Also recently the soft-
ware has been made freely available as open souce (ADMB Project, 2009). The
downside is that the use of the ADME-RE requires the first stage model to be
coded in C++ and in general requires a considerable coding experience to work
with. For these reasons it has still not gained widespread usage, but it may be
worth considering for complex estimation problems.
Chapter 3
Inhomogeneous Markov
processes
A Markov process is a stochastic process where all information on the past
relevant for predicting future states is given by the current state alone. The
process is thus independent of how the process arrived at the current state and
how long it has remained there. This property is called the Markov property
and is named after the Russian mathematician Andrey Markov (1856-1922) who
was the first to study such processes.
For a stochastic process it holds that information about the future state of
the process is described in probabilistic terms as conditional probabilities. The
state space for the stochastic process may be either continuous or discrete and
the process may evolve in either continuous or discrete time. Markov processes
in continuous time with continuous state space can for a certain class of these
models be described using stochastic differential equations and this will be the
topic of Chapter 4. This chapter will focus on Markov processes with a discrete
state space and both discrete and continuous time versions will be discussed.
When it is necessary to differentiate, the discrete state process in continuous
time is referred to as a Markov jump process and in discrete time simply as a
Markov chain.
Markov processes are divided into two further broad categories; it can be
either time homogeneous or time inhomogeneous. For a homogeneous Markov
chain the transition probabilities over a fixed time interval is independent of
time which is not required for an inhomogeneous Markov chain. In this chapter
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it will be shown how an inhomogeneous Markov jump process can be used
as a model for sleep stages and how time changes of parameters defining the
inhomogeneous model can be estimated efficiently using a method based on local
kernel estimation.
3.1 Sleep EEG
The motivational application for the project is the study of sleep EEG. An
electroencephalogram (EEG) records electrical activity of the brain’s surface
through electrodes placed on designated sites on the scalp. It can be used on
both humans and animals to study the activity of the brain and it can be used
both for wake and sleeping subjects, but the application here is focused only on
the sleep EEG. The frequency content of a recorded sleep EEG signal usually
varies from 1 to 30 Hz and the amplitude of the signal ranges from 20µV to
100µV (Forehand, 2003). The frequency and amplitude varies during the night
and based on the frequency range and amplitude of the wave they are denoted as
delta (0.5-4Hz), theta (4-7Hz), alpha (8-13Hz), and beta (13-30Hz) waves with
the highest amplitude for theta waves and the lowest for beta waves. When the
brain is active there is mainly high frequency content, whereas inactivity results
in a synchronized pattern of low frequency.
Based on the types of waves and other events in the sleep EEG the signal can
be classified into stages relating to ’the state of consciousness’ with is typically
done for epochs of 10 to 30 seconds. There are two general types of sleep states
called REM (rapid eye movement) sleep and NREM (Non REM) sleep. For
humans NREM sleep is further categorized into four sub-states denoted sleep
states I through IV. State I is a transitional state between wake and state II,
which is the first true sleep state. States III and IV are the deep sleep stages,
often collectively denoted slow wave sleep (SWS) where there is mainly delta
activity in the signal. REM sleep is distinctively different from NREM sleep
as the EEG signal shows high activity resembling wake. The body is relatively
paralyzed during REM sleep with low muscle tone except for the occurrence of
rapid eye movements. REM sleep is found in most mammals and is thought
to be important for learning and is also the time during which dreams occur
(Brodal, 2001). It is sometimes referred to as paradoxical sleep due the seeming
contradictions in its characteristics.
Human sleep cycles through the NREM sleep stages and back to REM sleep
about every 90 minutes whereas rats can go from wake to sleep and back within
minutes. This more fractured sleeping pattern for smaller animals is likely a
natural effects of the fact that they need to stay more alert during sleep. In
humans the sleep structure changes with age and also show individual differences
(Brodal, 2001).
The concept of dividing sleep into a number of states for a certain epoch
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length was first developed for humans and was standardized in Rechtschaffen
and Kales (1968) manual for scoring sleep. The time series data containing a
scored sleep stage for each epoch is called a hypnogram. Traditional analysis
of hypnograms to study sleep is done by using a range of standard summary
statistics such as total sleep time, latency to persistent sleep, wake after sleep
onset, number of awakenings etc. Such summary statistics may be sufficient to
show an effect of a drug by improving one or more of these measures, but they
do not give a detailed picture of changes in sleep structure during the night. In
the following it will be suggested to use new model based methods for describing
the time variations of the sleep structure.
3.1.1 Model assumptions and estimation
In order to study the dynamic changes of the sleep process during the night it
is chosen to model the sequence of sleep stages as an inhomogeneous Markov
process as has also been proposed earlier in the literature (Zung et al., 1965).
If isolated periods of time homogeneity is considered, the Markov assumption
implies that the time between state transitions (holding times) is exponentially
distributed since the probability of leaving the state is constant for every small
time step. This has been found to be a reasonable assumption, see e.g. Kemp
and Kamphuisen (1986).
Estimation of changes in parameters of the inhomogeneous Markov model
has previously been done by binning the data for small time intervals and using
standard maximum likelihood estimators for homogeneous Markov processes.
This is further developed in this chapter where a method based on local kernel
estimation is proposed for the estimation problem. This defines the estimation
problem in a well known statistical framework and it will be shown how it can be
used to efficiently extract information on the time course of pharmacodynamic
effects on sleep.
3.1.2 Data from sleep study on rats
The modelling approach for sleep using Markov processes will be illustrated
using a data set from a pre-clinical study on 6 rats weighing 275-300g and
housed singly under a 12:12h light:dark cycle with free access to food and water
(Anderson et al., 2006).
The study was performed to investigate the sleep effects of Gaboxadol, which
is a sleep promoting compound that has been under development by H. Lund-
beck (Wafford and Ebert, 2006). The drug has been found to have positive
effects on the sleep structure such as increasing the amount of slow wave sleep
during the night (Walsh et al., 2007). The clinical development of Gaboxadol
as a sleep drug was stopped in 2007 due to discoveries of significant negative
side effects.
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The 6 rats are each observed for two 23.5 hour periods. Three of the rats rats
are treated with placebo in the first period and an oral dose (PO) of 20µg/g
Gaboxadol at the beginning of the second period. The other three rats are
treated in the reverse order and thus all rats are observed for both a placebo
and treatment period. During the first 12 hours the light is kept on, and in the
remaining time the light is turned off. Rats are most active in the dark, and the
study design thereby resembles a human taking a sleep drug before bed time.
The sleep cycle of the rats is monitored using EEG. The EEG signal is mea-
sured with two electrodes implanted in the rat skull and the signal is transmitted
using a telemetry device so that the rats can move freely without any wires at-
tached. Based on the EEG three states are classified, namely wake (W), delta
sleep (DS) and paradoxical sleep (PS). The DS state corresponds to NREM
sleep in humans. These states are determined every 10 seconds giving 8,460
equidistantly spaced observations for each rat. An example of data from one
rat during the first 12 hours is shown in Figure 3.1 for both active drug and
placebo treatment. This figure corresponds to the hypnogram for the rat and
contains the time series of observed sleep states that will be modelled using a
Markov process.
The concentration PK profile of Gaboxadol in rats is also sampled in both
the brain and blood plasma. Due to the experimental complexity this cannot be
done on the same rats that are also used for the sleep EEG measurements and
thus only the mean profiles will be used. The mean PK profile data is shown
in Table 3.1. The data for concentration in plasma is based on 4 rats and the
data for concentration in the brain is based on 5 rats.
Plasma Brain
Time Conc. Time Conc.
Hours µg/ml Hours µg/ml
0.0 0.000 0.0 0.000
0.25 3.850 0.5 0.350
0.5 2.826 1.0 0.376
1.0 0.854 1.5 0.398
2.0 0.383 2.0 0.201
4.0 0.179 2.5 0.211
5.0 0.036 3.0 0.176
7.0 0.025 3.5 0.196
4.0 0.146
4.5 0.110
Table 3.1: PK data for a 20µg/g oral dose of Gaboxadol in rats.
The PK profiles will be used to compare with the pharmacodynamic effect of
Gaboxadol found using the Markov model for the sleep EEG data. In the follow-
ing a combined PK model for both the plasma and brain concentration profiles
is presented. The model is a two compartment model with blood plasma rep-
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Figure 3.1: Scored sleep states for a rat during the first 12 hours of the study.
Active and vehicle drug are shown above and below, respectively.
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resented by the central compartment and brain in the peripheral compartment.
The orally dosed drug is assumed to be absorbed in the plasma through a first
order process. The only route of elimination is through the central compart-
ment which gives the plasma concentration a double exponential decay profile.
The model is illustrated in Figure 3.2 and the corresponding model for the mass
transfer of Gaboxadol in the system is given as
dAs/dt = −kaAs
dAp/dt = kaAs − (ke + k12)Ap + k21Ab (3.1)
dAb/dt = k12Ap − k21Ab.
The unit for the compartments is [A] = µg/g which is understood as amount
of drug per gram rat since the dose is weight normalized and the units for the
rate constants are [k] = min−1.
Stomach
As
ka Plasma
Ap  Cp
Brain
Ab  Cb
k12
k21
ke
Figure 3.2: PK model for Gaboxadol concentration profiles.
The observations are assumed to be measured with a log-Gaussian distribu-
tion around the median response and, that is, the model residuals are additive
Gaussian on the log-scale. The number of parameters is limited by assum-
ing equal measurement variance for both plasma and brain concentrations (a
residual analysis of the final model fit indicates that this is a reasonable sim-
plification). The volume of distribution for the measurement compartments are
denoted Vp and Vb for plasma and brain respectively with a weight normal-
ized unit of [V ] = ml/g due to the weight normalized specification of the dose.
This gives the observations the correct unit of [C] = µg/ml. The measurement
equations are given as
Cp = Ap/Vp exp(p), (3.2)
Cb = Ab/Vb exp(b).
where [p b]T ∼ N(0, σ2I). An additive error model on the original scale for the
concentrations was also tried, but since the range of the concentration values is
relatively large (3.85 to 0.03 µg/ml) this was found to give too large standardized
residuals for the observations in the top of the range and the log-Gaussian model
was thus preferred.
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The model has a total of 7 parameters for the 16 observations excluding
the two zero observations as these cannot be included in the log-Gaussian error
model. The zero concentration observations at time zero are however implicitly
assumed by the model and it will thus not affect the fit. The model is estimated
by defining the likelihood function in R and maximizing it using R’s built in
optimizer nlminb. The parameter estimates are shown in Table 3.2. The blood
plasma volume Vp is estimated as 6.3% of the body mass and this corresponds
well to an approximate value of 7% that is a commonly used reference value
(Lee and Blaufox, 1985). The brain volume Vb is estimated to be much larger
than the blood volume and indicates that Gaboxadol is bound in the brain in a
form where it is not measured. The smallest rate constant is k21 and the release
from the brain is thus the rate limiting step.
The fit of the model is shown in Figure 3.3 and in Figure 3.4 the fit is shown
on log-scale. In particular from Figure 3.4 it can be noticed how the double
exponential decay in the plasma concentration seems to fit well to the observed
PK profile. Also, since the release from the brain is the rate limiting step the
terminal slopes in both compartments are identical (Gabrielsson and Weiner,
2006). This is illustrated in Figure 3.4 where the brain PK curve is inserted as
a dotted line together with the plasma PK curve.
ka 2.082 min−1
ke 80.132 min−1
k12 29.292 min−1
k21 0.624 min−1
Vp 0.063 ml/g
Vb 8.943 ml/g
σ 0.255 log µg/ml
Table 3.2: Parameter estimates for Gaboxadol PK model.
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Figure 3.3: PK model for Gaboxadol.
22 Inhomogeneous Markov processes
0 2 4 6 8
0.01
0.02
0.05
0.10
0.20
0.50
1.00
2.00
5.00
Hours
Pl
a
sm
a
 
(µg
m
l)
0 2 4 6 8
0.05
0.10
0.20
0.50
Hours
Br
a
in
 
(µg
m
l)
Figure 3.4: PK model for Gaboxadol shown on log-scale. The brain PK curve
(right) is inserted as a dotted line together with the plasma PK curve (left).
3.1.3 Discrete versus continuous time
As discussed at the beginning of this chapter the Markov process assumed to
generate the observed hypnograms can be modelled in either discrete or con-
tinuous time. In this thesis it is chosen to mainly work with the continuous
representation for reasons which is argued as follows:
It is not realistic to think that the real sleep process is separated into epochs
of an arbitrary length of either e.g. ten or thirty seconds. Sleep is a continuous
process and should thus also be modelled as such (Kemp and Kamphuisen,
1986). Of course the scoring of sleep into a number of states is in itself an
abstraction and interpretation of the data, but it is appealing to think of the
sleep states as a process describing the state of consciousness of the body which
may change at any time point and which it is simply chosen to sample at discrete
time points.
Moreover, the continuous representation makes the parameterization inde-
pendent of the sampling period which is not the case for a discrete time rep-
resentation. This is because the continuous process is parameterized by rate
related parameters related to the expected time until next state change whereas
the discrete process is defined in terms of probabilities directly related to the
sampling interval. For this reason the continuous time parameters may also be
easier to relate to without an in-depth understanding of Markov processes.
Finally if the actual process is evolving in continuous time and have con-
straints on the possible jumps so that not all jumps between all states are
allowed this can be directly included in the continuous time model representa-
tion. If the model is described in discrete time this may not be the case, since
the process may change to any state in a series of jumps and thus such physical
restrictions are more difficult or impossible to make use of in a discrete model
of the process.
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3.2 Model definition
A general description of the continuous time Markov process is given in the
following. Let {x(t) ∈ S; t ∈ T} be a continuous time process with a finite state
space S = {1, ...,m} and T = [0,∞[. The process is defined by a family of
stochastic matrices of transition probabilities P (t, u) = {pij(t, u)}, u > t, given
as
pij(t, u) = Pr(x(u) = j|x(t) = i). (3.3)
Since the transition probabilities are only dependent on the previous state of
the process it is by definition a Markov process. To simplify the notation in the
following the Markov process is assumed to be homogeneous such that pij(t) =
Pr(x(t+ u) = j|x(u) = i). The functions pij(t) must satisfy
0 ≤ pij(t) ≤ 1, (3.4)∑
j pij(t) = 1, (3.5)
pik(t) =
∑
j pij(v)pik(t− v), t > v. (3.6)
A process fulfilling (3.5) is called an honest process since it almost surely (i.e.
with probability 1) will stay in the state space S. The equation in (3.6) is
known as the Chapman-Kolmogorov equation for time homogeneous Markov
processes which follows directly from the law of total probability, Pr(A) =∑
j Pr(Bj) Pr(A|Bj), and the Markov property (Cox and Miller, 1965). The
Chapman-Kolmogorov equation in (3.6) makes it possible to build up condi-
tional probabilities over longer time intervals (0, t) from the smaller intervals
(0, v) and (v, t). This makes it convenient to define the continuous time Markov
process by the transition rates over short time intervals ∆t → 0. This is done
using a first order Taylor expansion of transition probabilities given as
pij(∆t) = qji∆t+ o(∆t), i 6= j,
pii(∆t) = 1 + qii∆t+ o(∆t).
(3.7)
since pii(0) = 1 and pij(0) = 0 and where o(∆t) represents a quantity that goes
to zero faster than ∆t. In this way the time homogeneous continuous Markov
process can be defined solely in terms of the matrix of transition rates Q = {qij}
also simply know as the Q-matrix. Based on (3.7) it is seen that for (3.5) to
hold it follows that
qii +
∑
j 6=i
qij = 0. (3.8)
meaning that the row sum of Q must be 0 and in combination with (3.4) it
is also seen that Q has diagonal elements qii ≤ 0 and off-diagonal elements
qij ≥ 0, i 6= j. It also holds that wij = −qij/qii is the probability of going to
state j when a jump from state i occurs. This can be used to give a different
parameterization of Q based on qii and wij .
24 Inhomogeneous Markov processes
Using (3.7) it is possible to find transition probabilities for very small time
steps ∆t. To extend this to arbitrary time steps it is necessary to define the
forward equations. Suppose that the process starts at state i, x(0) = i, and that
pij(t) = Pr(x(t) = j|x(0) = i). Using (3.6) for ∆t > 0 this gives
pik(t+ ∆t) = pik(t)(1 + qkk∆t) +
∑
j 6=k
pik(t)qjk∆t+ o(∆t), (3.9)
where the first term is the probability of going directly from i to k and staying
there and the last term is the probability of going from i to j and then to k.
Letting ∆t→ 0 in (3.9) results in p′ik(t) =
∑
j pij(t)qjk and in matrix notation
this is written as
P ′(t) = P (t)Q (3.10)
with initial condition P (0) = I. If a time inhomogeneous Markov process is
considered the equation generalizes to
∂
∂u
P (t, u) = P (t, u)Q(u), (3.11)
which is known as the Kolmogorov forward differential equation. For a given
Q(t) the conditional probabilities governing the process is thus completely de-
scribed using (3.11). It can be shown that if Q(t) is time invariant then time
between jumps (holding times) are exponentially distributed and that the diag-
onal elements qii(t) of Q(t) contains the negative rate for leaving a state. This
follows from (3.7) since the probability of staying in the same state in any in-
terval ∆t is 1 + qii∆t which gives a geometric distribution of holding times for
∆t > 0 and an exponential distribution for ∆t→ 0.
3.2.1 Likelihood estimation
The process x(t) is observed at N discrete time points that are chosen indepen-
dent of the observed process. The model dynamics are assumed to be slowly
varying relative to the time between observations. The observation sequence is
denoted {xk} and contains the state at time tk where k = 1, ..., N .
The likelihood function is formed as a product of conditional densities that
can be found using (3.11) and is given as
L(Q(t)) =
∏N−1
k=1 Lk(Q(t)) (3.12)
=
∏N−1
k=1 p(xk+1|xk) (3.13)
This likelihood function is called a conditional likelihood function since it is
defined conditional on the first observation.
As noted above, the model dynamics are assumed to be slowly varying rel-
ative to the time between observations. This has the implication that Q(t)
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for tk ≤ t ≤ tk+1 can be assumed constant between two observations so that
Qk = Q(tk). With this approximation the transition probabilities in (3.13) can
be found using the forward equations in (3.10) as
P (tk, tk+1) = exp(∆tkQk) (3.14)
where ∆tk = tk+1− tk and exp(·) denotes the matrix exponential. The approxi-
mation avoids solving the partial differential equations in (3.11). If ∆tk is larger
relative to the time variations of Q(t) one can also choose to use a first or higher
order expansion of Q(t) which also has an explicit solution for the transition
probabilities.
3.2.2 The imbedding problem for Markov chains
For estimation problems where it is assumed that the Markov process evolves in
continuous time it could seem tempting to estimate the transition probabilities
directly instead of estimating parameters in the continuous time representation
where the matrix exponential is involved. However, this leads to problems since
the matrix exponential is not a one-to-one transformation and this is related to
the imbedding problem for Markov chains.
The imbedding problem for Markov chains is the question about whether a
given discrete time Markov chain can be obtained by discrete time sampling of
a continuous time Markov jump process. The imbedding problem has received
much attention within theoretical analysis of Markov processes going back to
Elfving (1937) and later e.g. Kingman (1962) and the problem is also relevant
in the present context of estimating parameters using maximum likelihood.
To clarify the problem it is illustrated for a time homogeneous process which
is observed with a constant sampling interval ∆t (Bladt and Sørensen, 2005). If
it is assumed that the observations come from a Markov process in continuous
time the parameters Q are estimated using the likelihood function in (3.13).
The transition probabilities are constant due to a constant Q and ∆t and are
estimated as exp(∆tQˆ) where Qˆ is the MLE of Q. If it is instead assumed
that the observed sequence of states comes from a Markov process in discrete
time, the parameters to be estimated are directly the transition probabilities
P d, which define a discrete time Markov process. It can be shown that the
maximum likelihood estimate is given as Pˆ d = {nij/ni.} where nij denotes the
number of jumps from i to j and ni. the total number of jumps from i.
If there exist a Q fulfilling the criteria for an intensity matrix and such
that Pˆ d = exp(∆tQ) then this Q is the MLE Qˆ. However, the equation will
not always have a solution, in which case the estimated Pˆ d does not represent
transition probabilities that can be obtained from a continuous time Markov
chain. Exactly defining the set matrices Pˆ d where the equation can be solved
given the constraints on Q is a difficult problem, but a simple and sufficient
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criterion is that all diagonal elements of Pˆ d are ≥ 1/2 (Cuthbert, 1973). This
indicates that the problem is related to the sampling frequency, since a faster
sampling will result in higher diagonal probabilities.
This discussion emphasizes the necessity of estimating parameters in the
continuous time representation if this is the model that should be used for
inference and in particular if the actual process is known to evolve in continuous
time. The continuous time representation involves the extra complexity of using
the matrix exponential to evaluate the likelihood function but insures that the
estimated parameters will in fact represent a continuous time Markov process.
3.3 Non-parametric estimation
Until now estimation of the time varying Q(t) matrix has been referred to with-
out a specific parameterization in mind. The problem of finding a suitable
parameterization is in some sense comparable to the problem of finding a suit-
able regression function in non-linear least squares regression based on a set of
observations. The problem here is that it is not possible to get a visual impres-
sion of the time variations of Q(t) by plotting the observed data (see e.g. Figure
3.1) since the rate related parameters of Q(t) cannot be directly related to the
individual observations.
To overcome this problem the data can be separated in small time segments
where the parameters of the intensity matrix can be estimated by assuming a
locally time homogeneous process. This approach is used in Kemp and Kam-
phuisen (1986) for clinical hypnogram data and in Madsen et al. (1985) for
observations of cloud cover and results in rough estimates of the time varia-
tions.
In paper D an improved method for estimation of the time variations of Q(t)
is presented. The method is based on a locally weighted likelihood function to-
gether with a polynomial approximation of the parameters defining Q(t). The
method is generally applicable for local estimation in continuous time Markov
processes and has a number of advantages in comparison to more simple ap-
proaches as the one described above. It is possible to use any choice of kernel
for weighing the data and the use of higher order polynomials makes the method
more capable of capturing rapid changes in the Q(t) matrix. A typical problem
when doing local estimation using e.g. a zero or first order polynomial is that
estimates of peaks will be negatively biased since this shape is not well approx-
imated by these lower order polynomials. To avoid this problem it is necessary
to use a relatively smaller bandwidth which on the other hand results in a larger
variation in the estimates. A second order polynomial is naturally a much bet-
ter approximation around peaks also for larger bandwidths, which gives more
robust estimates since it is possible to use a larger bandwidth without increasing
the bias in same way as for the low order polynomial approximations. In paper
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D there is a comparison of the results of estimation using 0th, 1st, and 2nd
order polynomials where it is seen how the 2nd order approximation is much
more sensitive to peaks in the parameters.
The method for local estimation method in paper D uses a set of parameters
β which defines the local polynomials used to describe the time variations Q(t)
around a time point of interest tc. As in ordinary local estimation methods the
idea is to find a local estimate of Q(tc) by estimating the parameters β using
locally weighted data. To get a complete picture of the time variations in Q(t)
the method is repeated for a series of suitably close values of tc ∈ T .
The local estimation method for inhomogeneous Markov processes will be
outlined in the following in order to provide the basis for discussing extensions
of the methods for choosing bandwidth presented in paper D.
3.3.1 Choice of bandwidth
The likelihood function for the local estimation method at a given time point
of interest tc is defined as
logL(β, tc) =
N−1∑
k=1
w(xk, tc) logLk(β) (3.15)
where Lk is the likelihood of a single observed transition defined in (3.13). The
weights for the observed transitions are w(xk, tc) and are found as
w(xk, tc) = Kh(xk)(tk − tc). (3.16)
The kernel function K is a symmetric probability function and h(xk) is a state
dependent bandwidth. The bandwidth defines the size of the local neighborhood
by scaling the kernel function as Kh(t) = K(t/h)/h (Fan and Gijbels, 1996).
The definition of the weights in (3.16) as state dependent is an extension
to the definition in paper D, where the weights are simply defined as wk(tc) =
Kh(tk − tc) independently of the observed state.
The reason for introducing the state dependent bandwidth is that informa-
tion about the ith row in Q(t) is mainly contained in the observed transitions
from state i. If there are no observations of transitions from state i it is not
possible to estimate any parameters for state i related to holding times or prob-
abilities of jumping to other states. Conversely, if many observations of tran-
sitions from state i are available in the data the ith row in Q(t) will be well
defined. By using a state dependent bandwidth it is possible to define local
bandwidths that include a more even amount of information about the individ-
ual states and thereby making the method more equally local for all parameters
to be estimated.
Two methods for state dependent bandwidth are considered. The bandwidth
for a state i can be chosen such that the interval tc ± h(i) contains either
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1. a total of M observations of state i, or,
2. a fixed proportion α of the observations of state i (denoted nearest neigh-
bor (NN) bandwidth).
With Method 1 it may happen that M is larger than the observed number of
jumps from a state, that is M > ni. for some i ∈ S. To handle this smoothly
the bandwidth is increased for these states by a factor M/ni. of the bandwidth
covering all observations. In this way the kernel weights given in (3.16) will even
out and approach a constant within the observation window for h → ∞. The
approximation of parameters with only very limited information will thus tend
toward a global polynomial representation.
Methods 1 and 2 differ in that the first method aims at using an equal
amount of information to estimate parameters for each state, whereas the second
method will use a fixed proportion of the information available for each state.
The preferred method will depend on the application at hand.
In paper D an example of a non-parametric estimation of the Q matrix for
the EEG hypnogram data from the study of Gaboxadol in rats is illustrated. The
estimation is performed by pooling all data from the six rats to give estimates
of the mean effects in the data. Only the treatment data is used giving a total
of 8, 460×6 = 50, 760 observations. The parameterization of Q is given in terms
of q1(t) for the rate for leaving state i and wi for the probability of jumping
to i − 1 when a transition occurs. The parameter w1 = 0 since physiologically
jumps from W to PS should not occur and this can be implemented directly in
the continuous time representation. The model is thus defined as
f : θ(t) → Q(t) :
Q(t) =
 −q1(t) q1(t) 0w2(t)q2(t) −q2(t) (1− w2(t))q2(t)
(1− w3(t))q3(t) w3(t)q3(t) −q3(t)

qi(t) = exp[θi(t)], i = 1, 2, 3
wi(t) = logit−1[θi+2(t)], i = 2, 3 ,
(3.17)
where the parameters θ(t) = [θ1(t), ..., θ5(t)] are estimated locally using 2nd
order polynomials defined by the parameters in β. With 5 parameters in the
model and using 2nd order polynomials this gives a total of 15 parameters in β
that is estimated for every time point tc. When defining the parameterization of
the model it is necessary to make the model unbounded in the θ(t) parameters
which is done here using the exponential and logit transform for the rate and
probability parameters respectively. If the model is not unbounded in θ(t)
the polynomial representation of these parameters may easily give values of
the parameters where the model cannot be evaluated to find the transition
probabilities.
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In paper D the parameters [θ1(t), ..., θ5(t)] are estimated locally using 2nd
order polynomials and a state independent NN bandwidth of α = 0.40 of the
total number of observations. The result is seen in Figure 3.5. For comparison,
the result of estimation using the state dependent bandwidth in Method 1 with
M = 6000 and using 2nd order polynomials is shown in Figure 3.6 with the
bandwidth for the individual states shown in the last row. For both figures a
tricube kernel function has been used. For the NN method using α = 0.40
the bandwidth is constantly 0.40× 23.5 h. = 9.4 hours since the sampling times
are equidistant For the state dependent bandwidth the bandwidth varies since
the frequency of visits to the three states differ throughout the time period. In
particular it is seen that the bandwidth is as low as 3-4 hours for the DS state
during the initial 12 hours and using the 2nd order polynomial this gives a much
more apparent effect peak in expected time in the DS state with a maximum of
more than 12 minutes compared to 6 minutes for NN method.
For the PS state there is only a total of 1343 observations ( M) giving a
constant bandwidth of 23.5 h × 6000/1343 = 105 hours. This results in tricube
weights between 1 and 0.9955 for a 24 hour range which again results in almost
global polynomial approximations for the two parameters related to the PS
state. The global estimates for the two parameters q3 and w3 for the PS state
are thus similar to 2nd order polynomials that has been either log or inverse-
logit transformed but deviations are still seen since the estimates are correlated
with the other more locally estimated parameters.
3.3.1.1 Relation of effect to the PK-profile
To compare the effect of Gaboxadol on the non-parametric estimates of the sleep
parameters the analysis has been carried out on both placebo and treatment
data. The results are shown in Figure 3.7 using M = 6000, the same as used for
Figure 3.6. It is seen that the most apparent effect of Gaboxadol is found in the
estimates of the expected time in the DS state. The significant peak between 0
and 6 hours is only found in the treatment data, whereas the placebo data seems
to be rather constant during this period. The effect on the expected time in
the DS state can thus be attributed to Gaboxadol, and it is thereforeinteresting
to see how the estimated effect relates to the mean PK concentration profile of
Gaboxadol in the brain which is modelled in Section 3.1.2.
In Figure 3.8 the expected time in the sleep state DS is compared with the
PK profile of Gaboxadol in the brain. The figure indicates that there is a direct
relation between the PK profile and the expected time in the DS state with a
delay of approximately one hour. The indication of this relation directly benefits
from the high temporal resolution and sensitivity of the estimate of the expected
time in DS found using the non-parametric local estimation method.
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Figure 3.5: Estimate of the Q(t) matrix as a function of time using 2nd order
local polynomials and a NN bandwidth α = 0.40. The surrounding lines are
Wald 95% pointwise confidence intervals.
M
in
ut
es
0
1
2
3
4
0 6 12 18 24
E(W) = 1/q1
M
in
ut
es
0
5
10
15
0 6 12 18 24
E(DS) = 1/q2
M
in
ut
es
0.0
0.1
0.2
0.3
0.4
0 6 12 18 24
E(PS) = 1/q3
pr
ob
ab
ilit
y
0.0
0.2
0.4
0.6
0.8
1.0
0 6 12 18 24
w1: W −> PS
pr
ob
ab
ilit
y
0.0
0.2
0.4
0.6
0.8
1.0
0 6 12 18 24
w2: DS −> W
pr
ob
ab
ilit
y
0.0
0.2
0.4
0.6
0.8
1.0
0 6 12 18 24
w3: PS  −> DS
H
ou
rs
0 6 12 18 24
0
5
10
15
Kernel span
No. obs W :   GBX 14570
H
ou
rs
0 6 12 18 24
0
1
2
3
4
5
6
Kernel span
No. obs DS :   GBX 34846
H
ou
rs
0 6 12 18 24
0
40
80
12
0
Kernel span
No. obs PS :   GBX 1343
Figure 3.6: Estimate of the Q(t) matrix as a function of time using 2nd order
local polynomials and a state dependent bandwidth M = 6000. Plots in the 3rd
row show bandwidths for (and number of jumps from) the individual states.
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Figure 3.7: Estimate of the Q(t) as in Figure 3.6. The Gaboxadol treatment is
shown in a solid line and placebo in a dashed line.
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Figure 3.8: Expected time in DS state versus brain PK-profile.
3.3.2 Numerical issues
Depending on the application and amount of data, the numerical implementa-
tion of the local estimation method for Markov processes requires some consider-
ation to give reasonable estimation times. In the example using the sleep states
from rats there are 8,460 observations for each rat and treatment. It is necessary
to solve the Kolmogorov forward differential equation for each observation to
find the probability of the transition given β. Since the sampling period is only
10 seconds, which is very short relative to the time variations of the parameters,
this is done using the matrix exponential by assuming constant parameters over
the sample intervals, see (3.14). When estimating using the pooled data the
matrix of transitions probabilities for all possible jumps for a single time point
can be reused for all six rats, but this still means that the matrix exponential
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is evaluated 8,460 times for each evaluation of the likelihood function.
The implementation of the local estimation method has been done mainly
in R. The default R installation does not have a matrix exponential function so
the initial work was done using the Matrix package that uses a method by Ward
(1977) based on a Pade’ approximation with three preconditioning steps which
has originally been implemented for Octave (Eaton, 2002).
A small side result from this initial work with the Matrix package was the
discovery of an error in the code which resulted in erroneous evaluations of the
matrix exponential that was evident for certain matrices. This was pointed out
to Martin Maechler, a member of the R Development Core Team, who was able
to locate the bug which turned out to come from the original Octave code.
The final implementation of the estimation method is partly based on R with
the evaluation of the likelihood function (3.15) including the matrix exponential
being done in Fortran. The matrix exponential is evaluated using DGPADM from
Expokit (Sidje, 1998) which uses a Pade approximation to the exponential
function combined with scaling-and-squaring (Moler and Van Loan, 1978). By
keeping the likelihood function solely in Fortran gives a significant speedup.
The optimization of the parameters in the likelihood function is done by calling
general optimizers from R. This was found as a good compromise between coding
complexity and flexibility.
The optimization problem is in itself relatively complex. As mentioned there
are a total of 15 parameters in β in the model for the rat EEG data that is
estimated for every time point tc and these parameters are all dependent on each
other. The optimization problem at each tc benefit from the fact that they are
serially related such that the final estimate of β at tc is a good initial value at the
next tc + ∆t. The estimation of β has been done with a standard quasi-Newton
method with BFGS updating of the Hessian for finding the search direction and
using soft line search for finding the next iterate (Nocedal and Wright, 2006).
This method generally performs well for optimization of likelihood functions and
is available in optim in the stats package in R. The method initializes the Hessian
as the identity matrix which is also most commonly done. However, this can be
improved in the serial optimization structure by using the final Hessian estimate
from the previous tc as the initial estimate in the next optimization. This feature
is available for the ucminf method (Nielsen, 2000) and was implemented in R
for this purpose (Nielsen and Mortensen, 2008). The method works well but it
is not found that the improved initial estimate of the Hessian gives a notable
reduction in estimation times. The ucminf method were afterwards also used
for the estimation problems with mixed models in paper E and here it is in fact
able to outperform optim and nlminb both from the stats package in R.
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3.4 Parametric estimation
The non-parametric estimates of the time variations of the Markov process can
be used to identify a possibly more simple parametric description of these time
variations. This can be used for modelling the main structures in the parameters
by testing for model reduction using a standard likelihood ratio test (Madsen,
2008). Also in a parametric model individual variations can be described using a
mixed model with random effects and the drug effect can be included as function
of the PK concentration profile, which gives the possibility of statistically testing
different relations with PK profile for the parameters in the Markov process.
It is noted that the mixed modelling approach modifies the Markov assump-
tion to be conditional on the random effects. When the random effects are
integrated out, the process is nolonger of the Markov type. One can see this
as a more flexible class of processes, which can still be interpreded in a Markov
framework.
Karlsson et al. (2000) use the parametric approach to describe the sleep
structure in a study of 21 patients that are treated with both placebo and
the sleep drug Temazepam. The modelling is not done in continuous time but
instead in discrete time where each transition probability is modelled separately.
This means that for modelling jumps e.g. from state 1 to 2 all data with jumps
from state 1 is extracted and it is noted if a jump to state 2 occurs or not.
The data for a particular transition from i to j is thus binary yk ∈ {0, 1},
k = 1, ..., ni., and the modelling of each transition probability as a function of
time is similar to a logistic regression problem. The main focus of the modelling
is to incorporate the drug effect in the model and also to include the individual
variation using Gaussianly distributed random effects. Both the drug effect
and random effects are included additively on the logit scale of the transition
probability which ensures that probabilities are always in the interval [0; 1]. The
model is fitted using NONMEM to handle the estimation of the mixed model.
NONMEM has the possibility of directly specifying the log-likelihood for the first
stage model which is given as logL1(b,θ) = ykp∗ij(b,θ, t)+(1−yk)(1−p∗ij(b,θ, t))
where p∗ij(b,θ, t) denotes the transition probability as a function of the random
effects b and parameters θ in the model. The model is fitted using the ’Laplace’
option in NONMEM which uses the likelihood in (2.12).
The approach in Karlsson et al. (2000) has also been applied to the rat EEG
data to investigate the individual difference between the rats. The transition
from DS to W is considered and rough estimates of the individual transition
probabilities are shown in Figure 3.9. The estimates are found by counting the
number of transitions from DS to W in two hour intervals and dividing by the
number of observations of DS in this interval.
The transition probability is modelled with a simple model with two levels
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Figure 3.9: Individual probabilities of going from DS to W.
of the transition probability θ1 and θ2 given as
f(t,θ) =
exp(t− θ3)θ4(θ2 − θ1)
(1 + exp(t− θ3)θ4) + θ1 (3.18)
where t is the point in time, θ3 is the time of the change from θ1 to θ2 and θ4
defines the smoothness of this change such that for θ4 =∞ the model is a step
function with two levels θ1 and θ2. Similarly to Karlsson et al. (2000) the drug
and individual random effect is included as
logit p∗ij(tk) = logit[f(t,θ)] + θ5c(tk) + bi′ (3.19)
where c(t) is the concentration of Gaboxadol in the brain at time t (c(t) = 0
when the rat receives placebo) and bi′ ∼ N(0, σ2) is the random effect for rat i′.
The model for the transition probability is shown in Figure 3.10 for a number
of draws of random effect to illustrate how they affect the model. The model
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Figure 3.10: Model for transition probability from DS to W.
is fitted using NONMEM. To focus on the individual differences two random
effects are estimated for each rat for the placebo and Gaboxadol treatment. The
estimates of the random effects are shown in Figure 3.11 where the two random
effects for each rat is plotted against each other together with a y = x line. From
Figure 3.11 it is seen that the estimates of the random effects are almost identical
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Figure 3.11: Model for transition probability from DS to W.
between the two nights. This is interesting since it indicates that there is an
inherent sleep pattern for each rat which does not vary between the two nights
where they are observed. Some rats simply seem to have a higher tendency to
go from DS to W than others. This results in a more rapidly oscillating sleep
pattern in the hypnogram which is found to correspond well to estimates of the
random effects for each rat.
The parametric description of the sleep structure can also be done in contin-
uous time by defining the Q(t) matrix as a function of a set of parameters θ that
are estimated using (3.12). Similarly to the discrete time parametric estimation
it is also possible to include random effects in such a model to account for in-
dividual differences by using the Laplace likelihood for mixed models given in
(2.12). However, since the entire matrix Q(t) must be modelled and estimated
in a single model, such a model very easily becomes very complex if it should
adequately describe the time variations in all parameters that are found using
non-parametric estimates. For this reason a parametric description of Q(t) for
the rat EEG data has not been pursued any further.
Given a parameterization of Q(t) for a continuous time model that involves
both fixed and random effects, the maximum likelihood estimation of such a
model is a challenge in itself as it involves both solving the Kolmogorov forward
differential equation and using the Laplace likelihood. If such a model were to
be applied it is necessary perform the estimation in a computationally efficient
frame work to give reasonable estimation times, and it will thus be outlined how
the estimation can be done in NONMEM.
NONMEM does not include a matrix exponential function, but instead it
is very efficient for solving differential equations as these are used in compart-
mental PK modelling. This can be used to find the conditional probabilities of
the observations by solving the forward equation (3.10) directly with the initial
condition given by the previous observation. In a system with three states there
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are three differential equations to solve for pi = [pi1 pi2 pi3] given as
d
dt
pi = pi
 q1 q12 q13q21 q2 q23
q31 q32 q3
 (3.20)
but since the conditional probabilities must sum to 1, it is only necessary to solve
two of the differential equations to find the probabilities pi1 and pi2. Depending
on the previously observed state the initial condition for [pi1 pi2] will be either
[1 0], [0 1] or [0 0] for state 1, 2, and 3, respectively. The forward differential
equations for pi1 and pi2 becomes
d
dt
[
pi1
pi2
]
=
[
q1 − q31 q21 − q31
q12 − q32 q2 − q32
] [
pi1
pi2
]
+
[
q31
q32
]
(3.21)
and they can be derived in a similar way for a system of any size. This system
can be solved in NONMEM by considering pi1 and pi2 as two pseudo compart-
ments which are reset before each observation to [0 0] using a reset event in the
data file and possibly updated to [1 0] or [0 1] with an additional dose event
if the previous observation is either 1 or 2, respectively. When the differential
equations are solved for each observation to give the conditional probabilities
of the observation, the first stage likelihood can be formed in NONMEM in
the same way as it is done for the discrete time Markov models as discussed
previously. This approach has been implemented in NONMEM and was found
to estimate the parameters in the Q(t) matrix correctly by testing using simple
parametric models. The estimation method in NONMEM opens up for exper-
imentation with the parametric approach for continuous Markov processes in
combination with mixed effects modelling, but as mentioned previously this has
not been pursued further here.
3.5 Discussion
Although local estimation of parameters in an inhomogeneous Markov process
is a promising way of extracting information about the sleep process, it should
still be kept in mind that any results and interpretations are limited by the
model used for scoring sleep stages.
For human sleep staging the guidelines by Rechtschaffen and Kales has been
strongly debated over the past many years (Himanen and Hasan, 2000). The
guidelines were developed for healthy adults with undisturbed sleep and the
scoring may thus be ambiguous for patients with sleep disturbances. The guide-
line in general leaves some room for interpretation and this results in inter-rater
agreements around 90% when raters are compared. This observation suggests
using a hidden Markov model by assuming that stages are observed with mea-
surement error.
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Such a model of observing states with ’noise’ (misclassification) is equivalent
to the model with SDEs observed with measurement error as presented in Chap-
ter 4. The process defined by SDEs is also Markov but evolves in a continuous
space where as the sleep process only evolves in a small discrete set of sleep
stages.
A number of replacements to the Rechtschaffen and Kales guidelines has been
suggested such as Himanen et al. (1999) and Grube et al. (2002). However, none
of these have gained wide spread usage and the original guidelines are thus still
used as the gold standard. The most likely reason for this is that although new
methods may deal with some of the shortcomings in the original guidelines it
is still necessary to use them to be able to compare with past results in sleep
studies. For this reason it is very relevant to consider improved analysis of the
original sleep stages by using new methods such as the non-parametric approach
presented here. This will help increase the understanding of the underlying sleep
process while still being kept in a framework that can be related to other results
in the area.
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Chapter 4
Stochastic differential
equations
Stochastic differential equations (SDEs) represent an extensively studied math-
ematical theory that has found a wide range of practical applications. SDEs
provide the tool for building dynamical models based on differential equations
where it is possible to include some amount of randomness or noise into the
model. A very simple example of such a model is an exponential population
growth model where the growth rate is only approximately known and thus
loosely given by r(t)+”noise”. The model for the population growth can there-
fore be written as da(t)/dt = (r(t) + ”noise”)a(t).
To explain this in popular terms, consider a constant growth rate model,
say with a growth of 3%/year. An ordinary differential equation model will
convert this to an exponential formula for the population. If, for some reason,
the growth is higher in one year the model implies a reduced growth growth the
following year so the population returns to the originally projected curve. An
SDE model will instead accept the higher growth rate in that year and use the
actual population as the base for future growth, applying and expected growth
of 3%/year.
In order to understand how this can be described mathematically it is nec-
essary to look more closely at the theory defining SDEs.
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4.1 Brownian motion
Brownian motion is fundamental to the interpretation of stochastic differential
equations as it shows up as the continuous time version of a discrete random
walk. The random walk process is given as
xn = z1 + z2 + ...+ zn (4.1)
where Pr(zi = −1) = Pr(zi = 1) = 1/2. The process in (4.1) is a discrete time
process on the integer number line which will move one up or down at each step.
Based on zi define a continuous time process
yt =
√
∆t(z1 + z2 + ...+ z[t/∆t]) (4.2)
where [t/∆t] is the integer part of t/∆t, then for ∆t→ 0 it holds that E[yt] = 0
and V[yt] =
√
∆t
2
[t/∆t]V[zi] → t. The central limit theorem implies that
yt → βt where βt is Gaussian N(0, t).
It can be shown that the limiting process βt is in fact standard Brownian
motion (Gard, 1988), which is a special form of the more general Wiener process
which does not necessarily have mean zero. As can be seen from above it
holds for Brownian motion that Pr(β0 = 0) = 1 and that it has stationary
and independent increments. This means that for any t > s and h > 0 the
distribution of βt+h − βs+h is the same as the distribution of βt − βs (namely
N(0, t−s)) and for non-overlapping time intervals [t1, t2] and [t3, t4], the random
variables βt2 − βt1 and βt4 − βt3 are independent. It can also be shown that βt
is continuous with probability one (Øksendal, 2007), and it will be assumed in
the following that βt is one such version.
4.2 Itoˆ integrals
In a more general form a dynamical model based on differential equations in-
cluding noise as discussed in the beginning may be written as
dxt
dt
= b(t, xt) + σ(t, xt)wt (4.3)
where xt is a stochastic process defined as {x(t, ω) ∈ R |ω ∈ Ω, t ∈ T} where
usually T = [0,∞[ and Ω is the ensemble of the process with all possible out-
comes (Madsen, 2008). For fixed t, x(t, ·) is a random variable and for fixed
ω, x(·, ω) is a realization of the process. The first term in (4.3) is called the
drift and the second term the diffusion term. The noise in the system in (4.3)
is represented by the stochastic process wt which drives the process. It is not
directly clear how the differential equation in (4.3) defines the stochastic process
xt or which process is the most appropriate to use for wt. From an application
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point of view the process wt should at least approximately have the following
properties (Øksendal, 2007)
1. t1 6= t2 =⇒ wt1 and wt2 are independent,
2. wt is stationary,
3. E[wt] = 0 for all t.
These properties describe a continuous white noise process. However, true con-
tinuous white noise is a mathematical abstraction since such a process would
have a constant power spectral density function for all frequencies (Jazwin-
ski, 1970). This requires the process to have infinite power and it is thus not
physically realizable. Hence there is no “reasonable” stochastic process with a
continuous sample path satisfying both 1 and 2. If instead a discrete version of
(4.3) is considered this will look like
xk+1 − xk = b(tk, xk)∆tk + σ(tk, xk)wk∆tk. (4.4)
If wk∆tk is replaced by ∆Vk = Vtk+1 − Vtk then it is seen based on 1 to 3
above that Vt should have stationary and independent increments with mean
zero. It turns out that the only process with a continuous path fulfilling this is
the Brownian motion. By setting wk∆tk = ∆βk in (4.4) gives a corresponding
stochastic differential equation of the form
dxt = b(t, xt)dt+ σ(t, xt)dβt. (4.5)
The white noise process is thus replaced by the infinitesimal increments of Brow-
nian motion. Although Brownian motion is nowhere differentiable (with prob-
ability 1) it can be shown that white noise is the formal derivative of Brownian
motion wt ∼ dβt/dt (Jazwinski, 1970), which is another argument for choosing
the construction in (4.5). If standard integration notation is used to solve (4.5)
it results in the equation
xt = x0 +
∫ t
0
b(s, xs)ds+ “
∫ t
0
σ(s, xs)dβs”. (4.6)
This gives a definition of the stochastic process xt in (4.5) as a process that
satisfies (4.6). What is left is to look more closely at how the stochastic integral
“
∫ t
0
σ(s, xs)dβs” (4.7)
should be interpreted. In ordinary calculus the integral is defined as the limit
of an infinite sum, which in the Riemann-Stieltjes form is given as∫ t
0
f(t)dg(t) = lim
n→∞
∞∑
j=1
f(τj)(g(tj+1)− g(tj)) (4.8)
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where τj is in the interval [tj , tj+1]. For a deterministic function g under certain
regularity conditions this limit converges to a unique value independent of how τj
is chosen in the interval [tj , tj+1]. The stochastic integral in (4.7) can be defined
in the same way by replacing g(t) with the sample path of Brownian motion
βt. Unfortunately the sample path βt is not sufficiently smooth to define it in
the Riemann-Stieltjes sense since βt has independent increments and therefore
is almost nowhere differentiable and has unbounded variance (Øksendal, 2007).
Instead, it turns out that the expectation of the stochastic integral in (4.8) with
g(t) = βt depends on how τj is chosen in the interval [tj , tj+1]. The following
choices have proven to be the two most useful
• τj = tj which defines the Itoˆ integral, or,
• τj = (tj + tj+1)/2 which defines the Stratonovich integral.
The choice of which interpretation is used depends on the particular application
of the model, but it is important to note that the stochastic process xt defined as
an SDE as in (4.5) can only be understood through the choice of interpretation
of the stochastic integral. In biological systems the noise process dβt is often
thought to represent discrete pulses with finite separation to which the system
responds and for this the Itoˆ interpretation is the most appropriate (Turelli,
1977). In these type of applications the Itoˆ interpretation has thus been the
most widely applied and it is also the interpretation that will be used in the
following.
When the Itoˆ interpretation is chosen it can be shown that the resulting
process xt is a Markov process: the future development of the process from
time t depends only on xt and not on any previous history of the process. This
can be shown by considering (4.5) based on small time increments δt
xt+δt − xt = b(t, xt)δt+ σ(t, xt)(βt+δt − βt) (4.9)
where b and σ are evaluated at xt due to the Itoˆ interpretation (Jazwinski,
1970). For a given xt then xt+δt will only depend on the Brownian motion
increment βt+δt − βt which is independent and specifically independent of xt.
Therefore the distribution of xt+δt depends only on xt and the process is thus
a Markov process. The stochastic process defined with the Itoˆ interpretation is
thereby a generalization of a continuous time Markov process in discrete state
space discussed in Chapter 3 to a Markov process with a continuous state space.
4.3 Filtering problem
Modelling using SDEs makes it possible to define dynamical models that includes
randomness in the system. However, in most practical applications it is not
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xk−1 xk xk+1
ykyk−1 yk+1
Figure 4.1: Hidden Markov model with states xk and observations yk.
possible to observe the state of the system directly without error and this results
in a hidden Markov model as illustrated in Figure 4.1.
Estimation of the outcome of a stochastic process defined by an SDE model
based on noisy observations is called the filtering problem. The problem will
be discussed here for both a univariate stochastic process and measurement but
may readily be generalized to higher dimensions for both.
The stochastic process is given as in (4.5) and defines the evolution of the
system and is therefore denoted the system equation where xt is the state of
the system. The system is observed at discrete time points tk with observations
given as
yk = h(xk, tk) + ek (4.10)
which is denoted the measurement equation where ek ∼ N(0, S) and ek is serially
independent and independent of βt. If the set of observations until time tk is
defined as Yk = {y1, y2, ..., yk} the filtering problem is more precisely defined
as finding the probability distribution of the state at time t given Yk, that is
finding
p(x, t|Yk)
for t ≥ tk. Since the process xt is a Markov process the evolution of the prob-
ability distribution can be described as the conditional distribution given an
initial condition p(x, t|Yk) where
∂p(x, t|Yk)
∂t
= −∂p(x, t|Yk)b(x, t)
∂x
+
1
2
∂2[p(x, t|Yk)σ2(x, t)]
∂x2
(4.11)
which is known as the Kolmogorov forward equation or the Fokker-Planck equa-
tion (Jazwinski, 1970).
What remains to be shown is how to update the probability distribution
p(x, tk|Yk−1) to p(x, tk|Yk) when a new observation yk is obtained. By noting
that p(x, tk|Yk) = p(x, tk|yk,Yk−1) and using Bayes’ theorem gives
p(x, tk|Yk) = p(yk|xk,Yk−1)p(x, tk|Yk−1)
p(yk|Yk−1) . (4.12)
Since residuals are independent p(yk|xk,Yk−1) = p(yk|xk) = p(ek|xk) which is
directly given by the Gaussian probability density function. The term p(x, tk|Yk−1)
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can be found using (4.11) and also it holds that
p(yk,Yk−1) =
∫
p(yk|x)p(x, tk|Yk−1)dx.
Using (4.11) and (4.12) together gives an iterative filter with a prediction
equation to find p(x, tk|Yk−1) and an updating equation to find p(x, tk|Yk). This
filter can be used iteratively to find the conditional distribution of the state given
the available observations.
4.3.1 Conditional moments
Although the filter described above fundamentally solves the filtering problem,
the partial differential equation in (4.11) is not easy to work with. Instead it
is a common approach in filtering theory to describe conditional distributions
only by their means and covariances which is known as a second order filter. If
x denotes a multi-dimensional state, then p(x, tk|Yk−1) can be described by
xˆt|tk−1 = E[xt|Yk−1] (4.13)
Pˆ t|tk−1 = E[(xt − xˆt|k−1)(xt − xˆt|k−1)T |Yk−1] (4.14)
The two moments of the conditional distribution of the state given Yk−1 at time
tk is thus denoted as xˆk|k−1 and Pˆ k|k−1. Similarly using the Bayes’ theorem
for updating leads to xˆk|k and Pˆ k|k given Yk.
Estimating the two moments forward in time will give a Gaussian approx-
imation to the conditional distributions, which in the general case is only an
approximation. A special case arises for the linear model when the three func-
tions b, σ, and h defining the system and observation equations in (4.5) and
(4.10) are linear in the state and the σ function is further independent of xt.
For this case it can be shown that if the initial distribution p(x, t1) is Gaussian
then all following conditional distributions are also Gaussian and thus com-
pletely described by their mean and variance (Jazwinski, 1970). In this case
it is possible to derive explicit solutions for the conditional moments xˆk|k−1,
Pˆ k|k−1, xˆk|k and Pˆ k|k and the resulting filter is known as the Kalman filter
(KF) (Kalman, 1960). The Kalman filter is described in algorithmic form in
paper C.
Since the conditional distributions are described completely by their mean
and covariance in the linear case the filter state is said to be 2 dimensional
(Jazwinski, 1970). For non-linear models on the other hand the filter state is in-
finite dimensional as it cannot be described by any finite number of parameters;
it is represented exactly only through the complete density p(x, t|Yk). How-
ever, if it is assumed that the sampling interval is ’small’ relative to the degree
of non-linearities in the system it is reasonable to assume that the conditional
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probabilities are approximately Gaussian and thus well approximated by their
two first moments. This is due to the fact that both the Brownian motion
increments are Gaussian and also the measurement error is Gaussian. These
assumptions leads to the Extended Kalman filter (EKF) which handles non-
linear models by repeatedly linearizing the model and estimating the two first
moments of the conditional densities. For a description of the EKF used for
estimation of embedded parameters in an SDE based model see Kristensen and
Madsen (2003).
4.4 Likelihood estimation
In statistical applications of models based on SDEs it is necessary to be able to
estimate a set of parameters θ which describes the model. With a slight change
of notation from the previous the model can be written as
dxt = f(xt, t,θ)dt+ σω(t,θ)dωt (4.15)
yk = h(xk, tk,θ) + ek (4.16)
where ωt is standard Brownian motion, ek ∼ N(0,S) is white noise and ek and
ωt are independent and both the state xt and observations yk are allowed to be
multi-dimensional. The combination of (4.15) and (4.16) is called a (stochastic)
state space model. If the system was observed directly (i.e. without noise in
the measurement equation (4.16)) the likelihood function could be formed as a
product of the conditional probabilities of the observed states in the same way
as it is done in Chapter 3 in (3.13) for the Markov model with a discrete state
space. However, the model here is a hidden Markov model where the states are
not observed directly so instead the likelihood function is formed as a product
of conditional densities of the observations yk based on their one-step predic-
tions. Given the second order moment representation for the state as xˆk|k−1
and Pˆ k|k−1 then the moment representation of the conditional distribution of
the next observation p(yk|Yk−1) is found as
yˆk|k−1 = E[yk|Yk−1] = h(xˆk|k−1, tk,θ) (4.17)
Rˆk|k−1 = CPˆ k|k−1C
T + S (4.18)
where Rk|k−1 is found using the law of error propagation with
C =
∂h
∂xt
∣∣∣
x=xˆk|k−1,t=tk,θ
. (4.19)
This approximation is good when the measurement function is approximately
linear in the close neighborhood of xˆk|k−1 and this is usually the case. Using
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(4.17) and (4.18) the likelihood function for θ is found as
L(θ|YN ) = p(y1|θ)
N∏
k=2
p(yk|Yk−1,θ). (4.20)
The probability of the first observation in found given an initial Gaussian dis-
tribution of the state which may fixed or estimated by including it as a part of
the likelihood function for θ.
4.5 Mixed models with SDEs
Modelling using stochastic differential equations is a strong tool for biologi-
cal systems such as those encountered in PK/PD modelling. PK/PD models
are usually based on ordinary differential equations (ODEs) which assumes an
entirely deterministic model for the biological system. SDEs are a natural exten-
sion to this since they are designed to model partly unpredictable fluctuations
in a system. Although indeed actual random fluctuations will often exist and
have an important influence a biological system, the fluctuations modelled by
SDEs do not necessarily have to be truely random but can also be thought of
as an effect of other aspects of the biological system which are unknown or not
possible to include in the model and may thus affect the system in a partly
unpredictable way.
If a deterministic model based on ODEs is used to model such a system,
these different sources of random or uncontrollable error can lead to significant
systematic deviations in the model predictions which will result in correlated
residuals with an ODE based model. This could be modelled using some form
of auto-regressive process for the residuals, but only modelling this with SDEs
will allow to identify in which parts of the model the randomness is occuring.
The differences between ODE and SDE based models are further discussed in
paper A.
Dynamic models based on SDEs can be incorporated in a mixed effects
framework to handle larger overall differences between e.g. individuals, study
centers, batches, and other structures in the data. The estimation of mixed
models with SDEs is handled using the likelihood function in (4.20) in combi-
nation with the Laplace approximation.
As discussed there are strong arguments for modelling using SDEs in biolog-
ical systems, but until recently there has not been software available designed
for mixed models based on SDEs. It has been shown in Tornøe et al. (2005)
that it is possible to perform the estimation in NONMEM with a model specific
implementation of the extended Kalman filter by modifying the NONMEM data
file and control stream. This approach is mainly aimed at experimentation with
simple models as it somewhat complex to setup. This has led to the development
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of the package PSM (Population Stochastic Modelling) for R which is able to
estimate models in this general framework. The package is described in paper C.
The package is developed with an extension of NONMEM in mind, and is thus
like NONMEM designed only for data with a single level of grouping using the
likelihood function in (2.6). The first stage model is thus given as p1(Yini |bi,θ)
where Yini denotes the ni observations and bi the random effects for individual
i. As mentioned, for an SDE based model this first stage likelihood function is
evaluated using (4.20) where bi and θ together make up the parameters defining
the individual SDE model.
Given that PSM is designed for one level of grouping it is not possible to
handle crossed random effects that may arise from individuals being treated at
different study centers or receiving treatment with drugs from different batches.
Although the dynamical model based on SDEs will typically be set up for
modelling single individuals this may still be combined with a model with the
crossed random effects by letting each individual joint likelihood depend on the
full vector of random effects. In this case the first stage model is defined as
p1(Y|b,θ) =
∏
i p(Yini |b,θ) where Y denotes all observations and p(Yini |b,θ) is
again found using (4.20). The marginal likelihood requires an integration over
the complete vector of random effects b as given in (2.4) which is evaluated using
the multivariate Laplace approximation in (2.12). This application again em-
phasizes the great flexibility using the full multivariate Laplace approximation
for mixed modelling.
4.6 Applications of SDE based models
The SDE based mixed modelling approach has been applied to a problem of
estimating the insulin secretion rate and the extraction rate of insulin in the
liver for patients with type II diabetes. This form of diabetes is caused by a
reduced production of insulin together with a decreased sensitivity of the cell in
the body to use insulin and both the insulin secretion rate and liver extraction
rate are thus important to measure.
The data used for the analysis has been obtained from 12 type II diabetic
patients (Degn et al., 2004). The patients were served three standardized meals
over a 24 hour period and 35 samples of both insulin and C-peptide concentra-
tions were taken during this period. C-peptide is a peptide that is made when
pro-insulin is split into C-peptide and insulin and is thus produced in equimolar
amounts. C-peptide is not extracted by the liver as insulin is and thus measur-
ing the concentration of C-peptide in the blood is a more direct indication of
insulin secretion since liver extraction does not have to be taken into account.
The concentration of C-peptide in the blood is known to be well described by a
two compartment model with rate constants given in Cauter et al. (1992). With
this model given together with measurement of the C-peptide concentration it
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is thereby possible to estimate the insulin secretion rate.
In paper A a method is suggested where the insulin secretion rate is mod-
elled as a continuous random walk process represented as Brownian motion.
This gives a relatively model free description of the secretion rate which can be
estimated based on the data using the filtering approach for SDE models de-
scribed above. The model includes mixed effects to handle individual differences
and is estimated using an early prototype of PSM. Also a model for estimation
of the liver extraction rate is presented using the combined measurements of
insulin and C-peptide. The liver extraction is often modelled as a constant
but with the SDE based approach it is possible to track time changes of this
parameter in the model.
In paper C the model for the insulin secretion is extended to depend on
meal times and estimated in the final version of PSM. A main benefit from
estimating the secretion rate in the SDE based framework is that it seperates
the measurement error from the estimate of the secretion rate and also that
the probabilistic description makes it possible to provide confidence limits to
estimates of the secretion.
Although not directly stated, SDE models also appear indirectly in other
more common applications. The continuous auto-regressive (CAR) model in
(2.13) used for the residuals of the orange tree data discussed in Section 2.4 im-
plicitly states that the model residuals are generated by an Ornstein-Uhlenbeck
(OU) process with mean 0. The OU-process is the solution to the stochastic
differential equation
dt = −φt dt+ σ dωt (4.21)
which has Gaussian conditional densities
E[t|s] = s exp(−φ(t− s)) (4.22)
V[t|s] = σ
2(1− exp(−2φ(t− s)))
2φ
(4.23)
for s < t which can be derived using the Fokker-Planck equation (Iacus, 2008).
The unconditional distribution is seen to be t ∼ N(0, σ2/(2φ)) by letting t→∞
and the auto-covariance is given as cov(s, t) = σ2/(2φ) exp(−φ|t− s|) as also
shown in (2.13) in a slightly different parametrization. The OU-process is called
a mean reverting process due to (4.22) or sometimes colored noise due to the
exponentially decreasing auto-correlation as opposed to a zero auto-correlation
for the idealized white noise process.
This relation of the CAR residual correlation structure with the OU-process
shows how it should be interpreted. The residuals for each tree can be seen as
sampled directly from a realization of an OU-process where the process describes
the difference between model prediction and the actual tree height. There is
thus no independent measurement error in the model. This could be included
by introducing a measurement equation as ek = tk + zk where zk ∼ N(0, σ2z).
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The effect is that measurements taken at (almost) coinciding time points will
not have a correlation of 1 but instead only σ2/(σ2 + σ2z). This is also called a
nugget-effect (Matheron, 1962) and can easily be included directly in the residual
correlation structure in the NLMM by adding σ2z to the diagonal in Σ in (2.5).
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Chapter 5
Conclusion
A central part of the statistical methods used in this thesis are based on the
Markov property. Pharmacodynamic models can be described as hidden Markov
processes in continuous state space by using stochastic differential equations to
model random biological variations and fluctuations from unknown factors in
the system. Sleep processes based on a classification of sleep states can similarly
be modelled as a Markov process which instead evolves in a discrete state space.
Although the response types in these two applications are fundamentally differ-
ent the statistical models based on the Markov property show up as a strong
method in both cases.
The work with pharmacodynamic models including SDEs in this project il-
lustrates some of the benefits using this approach in comparisons to using models
solely based on ODEs. In particular an application is presented which uses the
SDE approach to estimate both insulin secretion and the liver extraction rates
of insulin for patients with type II diabetes. This is a powerful method made
available by SDEs that is generally applicable to estimation of unknown inputs
or tracking of time varying parameters in both linear and nonlinear models.
Today investigation of models based on SDEs within this area is mainly done
for research purposes, and this may to a large part be due to the lack of software
supporting estimation of SDE based models. This has been addressed during
this project with the development of a software package (PSM) for this purpose,
and the hope is that this will open up for an increased application of the SDE
based approach in the future within pharmacodynamic modelling.
Within sleep modelling a Markov based model has been used to model the
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sleep hypnogram, which is the time series observations of sleep states. The
present work has focused on a continuous time representation which is argued
to give the most appropriate representation of the process, as sleep is known to
evolve in continuous time. The main contribution within this area has been the
development of a non-parametric estimation method which is able to give both
a more robust and accurate estimate of the time variations of the parameters
in the model compared to other more simple approaches. Being based on non-
parametric methods makes it entirely data driven and it can thus be used to give
valuable detailed insight into the time dependence of the sleep process. This
can be used to establish a direct relation with sleep effect to the concentration
profile of a drug, and thereby give an early indication of how the drug interacts
with the body. This approach has been illustrated based on a sleep study in rats
where both the PK profile and sleep effects have been considered in combination.
Both the Markov models for sleep and for pharmacodynamic models based
on SDEs can be used in a mixed modelling approach to handle variation be-
tween groups in the data. If data has a crossed grouping structure (such as for
individuals belonging to different study centers) this poses a difficult estimation
problem which cannot easily be handled by standard software. It is proposed
and demonstrated how such models instead can be estimated by a direct imple-
mentation of the marginal likelihood function, which avoids these restrictions
on the grouping structure for mixed modelling.
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Introduction
The non-linear mixed-effects (NLME) model based on ordinary differential equations
(ODEs) is a widely used method for modelling pharmacokinetic/pharmacodynamic
(PK/PD) data [1], since the model enables the variation to be split into inter- and intra-
individual variation. It is, however, a well known problem that this model class has a
too restricted residual error structure, as it assumes that the residuals are uncorrelated
white noise. This assumption applies well to the expected distribution of assay error,
but it is unfortunately a crude simplification to assume that the assumption also applies
to the remaining sources of error [2]. Other important sources of error may arise from
structural model mis-specification or unpredictable random behavior of the underly-
ing process, which both result in serially correlated residual errors. Previous work
with simulation of more complex error structures has shown that ignoring the serial
correlation may lead to biased estimates of the variance components of the model or
all population parameter estimates depending on the error structure [3].
A powerful way to deal with these problems is to introduce stochastic differential
equations (SDEs) in the model setup. SDEs are an extension to ODEs and facilitate
the ability to split the intra-individual error into two fundamentally different types:
(1) serially uncorrelated measurement error, which is typically mainly caused by
assay error and (2) system error, which may be caused by model mis-specifications,
simplifications or true random behavior of the system.
Apart from providing a statistically more adequate model setup, the SDEs also
allow new tools for the modeller. The SDE approach results in a quantitative estimate
of the amount of system and measurement noise, and it can therefore also be used as
a tool for model validation. If no significant system noise is found to be present, this
indicates that the proposed model structure gives a suitable description of the data.
However, if significant system noise is found, it can be estimated and may be used to
identify a possible remaining model structure, since aspects which are not explicitly
modelled will give rise to system noise. It is important to emphasize that this rela-
tion does not hold the other way around, since system noise may also arise from true
unmodellable random behavior of the system, and estimated system noise may thus
not be seen as evidence of an insufficient model structure. A detailed iterative scheme
for model development based on SDEs has been described in [4]. Another important
advantage of the SDE approach is the inherent confidence intervals for system states.
This is facilitated by the estimation of system noise, and thus follows as a natural part
of the model specification.
Several programs exist for modelling based on SDEs. The first implementations
focused on single subject modelling, such as Continuous Time Stochastic Modelling
(CTSM) [5]. CTSM is in fact also able to use multiple individuals for estimation of
structural parameters, but this is done using a naive pooled likelihood function where
no inter-individual variance components are estimated. Later research has also made
it possible to include SDEs in population modelling by using an approximation algo-
rithm of the likelihood function with SDEs for the widely used NLME model. This
algorithm is described in [6] and is based on the use of the Extended Kalman Filter
to estimate conditional densities of each observation to form the individual likeli-
hood function. The population likelihood function is then approximated based on the
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first-order conditional estimation (FOCE) method. It has been shown in [7] how this
algorithm for estimation of SDEs can be used in NONMEM [8], but this is by no
means a trivial programming task to set up for a given model. It requires a modified
data file and an implementation of the Kalman filter within the NONMEM control
stream. Moreover, the NONMEM implementation cannot be used to form Kalman
smoothing estimates, which is an important feature of the SDE approach, where all
data is used to give optimal estimates at each sampling point.
This paper will present the first prototype implementation of a general software
tool for estimation of NLME models based on SDEs. The implementation has been
made in Matlab and it makes experimentation with the new modelling approach read-
ily available. The flexibility of the modelling approach will be demonstrated by two
examples of applications. In the first example the model is used for stochastic decon-
volution to estimate insulin secretion rates in 12 type II diabetic patients and in the
second example the model is used to estimate/track the time variant behavior of the
liver extraction rate for the same individuals.
Theory
This section contains an overview of the theory for population modelling using NLME
models based on SDEs. It will present the state space model for individual modelling
and how this can be extended to incorporate SDEs. The parameters of the population
model are estimated with a maximum likelihood (ML) approach by first defining an
individual likelihood function, which forms the basis for the population likelihood
function. The individual likelihood function is evaluated on the basis of the Extended
Kalman Filter (EKF), and this will also be outlined. A more detailed description of the
estimation algorithm can be found in [6]. To ease notation, all vectors and matrices
are written using a bold font.
A mixed-effects model is used to describe data with the following general structure
yi j , i = 1, . . . , N , j = 1, . . . , ni (1)
where yi j is a vector of measurements at time ti j for individual i , N is the number
of individuals and ni is the number of measurements for individual i . Note that the
number of measurements for each individual may vary. In a mixed-effects model the
variation is split into intra-individual variation and inter-individual variation, which
is modelled by a first and second stage model.
First stage model
The first stage model for an NLME model with ODEs can be written in the form of a
state space model. A state space model consists of two parts, namely a set of continuous
state equations defining the dynamics of the system and a set of discrete measurement
equations, which defines a functional relationship between the states of the system and
the measurements obtained. In the general form the state space equations are written
as
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dxt = f (xt , ut , t,φi )dt (2)
yi j = h(xi j , ui j , ti j ,φi ) + ei j (3)
where t is the continuous time variable and the states of the model and the optional
inputs at time t are denoted xt and ut respectively. The input ui j is typically frequently
sampled covariates such as body temperature etc. which may affect the system, or a
variable indicating an interaction with the system such as an intravenous infusion. Both
the state, measurement and input can be multi-dimensional, and are in such cases thus
represented by a vector at time ti j . The individual model parameters are denoted φi
and finally f (·) and h(·) are the two possibly non-linear functions defining the model.
Measurements are assumed observed with an uncorrelated Gaussian measurement
error. The variance of the error may depend on both state, input, time and individual
parameters, that is ei j ∈ N (0,(xi j , ui j , ti j ,φi )).
It is important to draw attention to the concept of states, as this is essential to the
understanding of the model setup. States are generally not directly observable or at
best only observable through measurement noise. The actual relation between mea-
surements and states is defined in the measurement equation by the function h(·). A
state can represent many different aspects of the system of interest, e.g. concentra-
tions or amounts in compartments, a volume, a parameter with unknown time varying
behavior, or an input to the system that we wish to estimate. The state space formula-
tion is thus a very flexible form of model specification, and the use of the state space
model will be illustrated with the applications presented later on in this paper.
Extending the first stage model with SDEs
In the ordinary state space model, noise is only allowed to enter through the measure-
ment equation, see Eq. 3. The result is that error due to model mis-specification or
true random fluctuations of the states is absorbed into the measurement error term and
hence may give rise to correlated residuals. To allow for error to originate from the
system specification, a stochastic term is added to the system equation. This results in
a stochastic state space equation defined as follows
dxt = f (xt , ut , t,φi )dt + σω(ut , t,φi )dωt (4)
yi j = h(xi j , ui j , ti j ,φi ) + ei j (5)
where ωt is a standard Wiener process defined by ωt2 − ωt1 ∈ N (0, |t2 − t1|I). The
entire part σω(ut , t,φi )dωt is called the diffusion term and describes the stochastic
part of the system and f (xt , ut , t,φi )dt is called the drift term and describes the deter-
ministic part. Together the drift and diffusion terms define the stochastic dynamics of
the system.
By looking at the formulation of the extended first stage model, it is seen that
noise is now allowed to enter in two places, namely as system noise via the diffusion
term and as measurement noise. It is noted that if no system noise is present, the
model will reduce into the standard ODE case, and this also ensures that physiological
interpretation of structural parameters is preserved with the use of an SDE model.
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Second stage model
The second stage model for the individual parameters describes the variation of the
individual parameters φi between individuals and can be defined in a number of ways,
each with different properties. In the present work it has been chosen to use
φi = g(θ, Zi ) · exp(ηi ) (6)
where ηi is the multivariate random effect parameter for the i th individual, which is
assumed Gaussian distributed with mean zero and covariance  :ηi ∈ N (0,). The
fixed effect parameter of the NLME model is θ , which is also sometimes referred to
as the structural parameter or population parameter. The second stage model in Eq. 6
includes an optional covariate Zi . This can be used to include individually measurable
covariates such as height, weight etc. that could affect φi . The chosen formulation of
the 2nd stage model restricts variations in ηi from changing the sign of g(θ, Zi ) which
is typically an advantage as φi may be used as parameter for a variance or other sign-
sensitive parameters. Moreover the resulting distribution of the individual parameters
is log-Gaussian, as is often the case when dealing with PK/PD models. The second
stage model in Eq. 6 may easily be replaced if other model structures are needed,
and this can be done without yielding any changes to the final population likelihood
function as long as ηi is still assumed to have a Gaussian distribution.
Maximum likelihood estimation of the NLME model with SDEs
The full set of parameters to be estimated for the final NLME model with SDEs are the
matrices , σω,  and the fixed effect parameters in the vector θ . The three matrices
are usually fixed to some degree so that only the diagonals or other partial structure
remains to be estimated.
The estimation of model parameters is based on a first stage likelihood function,
which is formed as a product of probabilities for each measurement. Due to the assump-
tion of correlated residuals with the inclusion of the Wiener process, it is necessary to
condition on the previous measurements to define the probability density of each mea-
surement. In the approach chosen here, this is done by assuming that the conditional
densities for the states are Gaussian and thus fully described by the state-prediction
and the state prediction variance for each observation. These can be found using the
Extended Kalman filter, which gives the unbiased minimum variance estimate of the
evolution of the model states [9]. This will hold exactly for the linear case but only as an
approximation in the non-linear case. The assumptions for the EKF can be examined
by testing for a Gaussian distribution of the residuals and by testing for correctness of
the estimated SDEs [10]. The prediction from the EKF is defined by
yˆi( j | j−1) = E( yi j |φi ,, σω, ui ,Yi( j−1)) (7)
Ri( j | j−1) = V ( yi j |φi ,, σω, ui ,Yi( j−1)) (8)
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where Yi j = [ yi1, . . . , yi j ] and this gives the conditional distribution of the one-step
prediction error
i j = yi j − yˆi( j | j−1) ∈ N (0, Ri( j | j−1)) (9)
The first stage likelihood function is calculated as the simultaneous density function
for the i th individual
p1(Yini |φi ,, σω, ui ) =
⎛⎝ ni∏
j=2
p(yi j |Yi( j−1), ·)
⎞⎠ p(yi1|·) (10)
≈
ni∏
j=1
exp
(
− 12Ti j R−1i( j | j−1)i j
)
√|2π Ri( j | j−1)| (11)
where conditioning on φi , , σω and ui is denoted “·”.
Based on the first and second stage model density functions, the full NLME like-
lihood function can now be defined. The second stage distribution is simply a mul-
tivariate Gaussian density denoted p2(ηi |), and combining this with the first stage
distribution results in the population likelihood function
L(θ ,, σω,) =
N∏
i=1
∫
p1(Yini |ηi , θ ,, σω, ui )p2(ηi |)dηi (12)
=
N∏
i=1
∫
exp(li )dηi (13)
where li is the a posteriori log-likelihood function for the random effects of the i th
individual given by
li = −12
ni∑
j=1
(
Ti j R
−1
i( j | j−1)i j + log |2π Ri( j | j−1)|
)
− 1
2
ηTi 
−1ηi −
1
2
log |2π|
(14)
The population likelihood function in Eq. 13 cannot be evaluated analytically, and
therefore li is approximated by a second-order Taylor expansion, where the expansion
is made around the value ηˆi that maximizes li . At this optimum the first derivative
∇li
∣∣
ηˆi
= 0 and the population likelihood function therefore reduces to
L(θ ,, σω,) ≈
N∏
i=1
∣∣∣∣−	li2π
∣∣∣∣− 12 exp(li )∣∣∣ηˆi (15)
as shown in Appendix. The approximation of the 2nd derivative 	li is done using the
FOCE method, as it is also normally done in the NLME model based on ODEs. The
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objective function for parameter estimation is chosen as the negative log-likelihood
function given as
− log L(θ ,, σω,) ≈
N∑
i=1
(
1
2
log
∣∣∣∣−	li2π
∣∣∣∣ − li) (16)
Kalman filtering
The Extended Kalman Filter plays a central role for working with the NLME model
with SDEs as seen from the previous section. Therefore a brief introduction to the EKF
will be given here, as well as to the three new types of state estimates made available.
For a detailed description of the EKF algorithm please refer to [5,6,11,12].
For linear state-estimation problems the Kalman Filter will give an unbiased mini-
mum variance state estimate. The solution can be derived explicitly using simple linear
algebra, and hence the algorithm runs efficiently in a computer implementation. For
non-linear problems it is necessary to use another method for state-estimation like
that obtained by the Extended Kalman Filter, which has been used here. The Extended
Kalman Filter is for the main part identical to the Kalman Filter, except for the state
prediction which requires a solution to the non-linear differential system equations.
This solution is obtained by a point-wise first-order approximation and therefore, for
non-linear systems, the EKF will only provide an approximate minimum variance esti-
mate of the states. The EKF also runs slower due to the need for a numerical algorithm
to solve the non-linear differential equations.
The Kalman Filter is a two-part algorithm consisting of prediction and updating,
which iterates through all observations. In the prediction part the current estimated
states and covariances are used to create predictions of the two first moments of the state
and observation to a time point ti j given the information at time ti( j−1). These predic-
tions are denoted xˆi( j | j−1), Pˆ i( j | j−1), yˆi( j | j−1) and Rˆi( j | j−1), respectively. Updating
is performed at measurement time points, where the states and covariances are updated
accordingly.
The updating is based on a compromise between the observation and current model
state. In a situation where the model is good but the observations are dominated by
measurement error, the state estimate should rely more on the model as opposed to
fitting the observations. On the other hand, if the model is incomplete the states should
rely more on the observations than the model. This trust in model versus observations
is balanced by the Kalman gain, which is dependent on the magnitude of system noise
σω and observation noise .
The initial conditions of the state and state covariance (xˆi(1|0) and Pˆ i(1|0)) need to
be specified for the Kalman filtering algorithm. The initial state can either be fixed or
included in the likelihood function, whereas Pˆ i(1|0) for this implementation has been
chosen to be estimated as the integral of the Wiener process and system dynamics over
the first sample interval in accordance with the method used in [11].
A key feature of the SDE approach to population modelling is the ability to give
improved estimates of the system states given the individual parameters and also to
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provide confidence bands for the states. Confidence bands at a timepoint t are directly
given by the estimated state covariance matrix Pˆ i(t |...) from the EKF, where t can be
both at or between measurements. There are four types of state and state covariance
estimates available when using the EKF, each of which differs in the way data is used.
The four types are:
• Simulation estimate: xˆi( j |0), Pˆ i( j |0)
Provides an estimate of the state evolution for a repeated experiment, without
updating based on measurements. This is an ODE-like estimate, but it also yields
a confidence band for the state evolution.
• Prediction estimate: xˆi( j | j−1), Pˆ i( j | j−1)
The prediction is used here to give the conditional density for the next observation
at time ti j given the observations up to ti( j | j−1).
• Filtering estimate: xˆi( j | j), Pˆ i( j | j)
Best estimate at time ti j given the observations up to time ti j .
• Smoothing estimate: xˆi( j |N ), Pˆ i( j |N )
Optimal estimate at time ti j utilizing all observations both prior to and after time
ti j .
For a conventional ODE model the state is found by the simulation estimate, which
is entirely given by the (possibly ML-estimated) initial state of the system. The covari-
ance matrix for the states is 0 since no system noise is estimated. In other words the
ODE model assumes that a new experiment will yield an identical outcome of the
underlying system apart from observed measurement noise. By moving to SDEs, sys-
tem noise is separated from measurement noise, thereby enabling the model to provide
confidence bands for the realization of the states in a new experiment. By improving
the model, the confidence bands for the states will become narrower and theoretically
be zero if the true model is used and no random fluctuations in system states are
present.
With SDEs three new types of estimates, apart from the simulation estimate, also
become available. In the present setup the prediction estimate is used to give con-
ditional Gaussian densities to form the likelihood function. The filter estimate is the
best obtainable state estimate during the experiment, where the subsequent observa-
tions are not present. The third type of state estimate is the smoothed estimate. This
provides the optimal state and state covariance estimate (xˆi( j |N ) and Pˆ i( j |N )) based
on all obtained observations, both prior and subsequent to the time of interest. The
smoothed estimate is therefore often the natural estimate of choice when studying the
behavior of the system in post hoc analysis.
Software implementation
The estimation algorithm outlined in the previous section has been implemented in a
Matlab framework called population stochastic modelling (PSM). It is intended that
this should work as a software prototype, in order to make further experimentation
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with the model setup easily available. The program may be obtained by addressing an
email to the corresponding author.
Features
The implementation is designed to handle any non-linear mixed effects models using
SDEs based on the general model definition in the previous section. The model spec-
ification is achieved through a set of Matlab functions written in m-files. A complete
model specification consists of state dynamics f and diffusion term magnitude σω,
output function h and uncertainty , derivatives of state d f /dt and output dh/dt ,
initial state x0, second stage model g and finally a variance function  for the random
effects. Each function is prepared to use all input arguments as specified by the model
definition.
The implementation has been made in two versions. The first is able to handle the
general non-linear case, and is thus based on the use of an algorithm for solving the
differential equations in the EKF. It has been chosen to useode15s, which is a Matlab
built-in ODE solver. The second version is only able to solve linear systems, which
will run significantly faster since it is based on an explicit solution of the differential
equations.
The population parameters are estimated by maximizing of the population likeli-
hood function given in Eq. 15. Maximization is performed using a publicly available
Matlab implementation ucminf of a gradient search BFGS method with soft-line
search and trust-region type monitoring of step length [13]. For additional perfor-
mance it is possible to guide the optimization by providing an initial guess and bound-
aries for the parameters. The implementation is also able to assess parameter variance
and correlation based on a numerical approximation of the Hessian of the likelihood
functions [14].
Implementation details
In the evaluation of the population likelihood function it is necessary to evaluate the
individual a posteriori log-likelihood function for each individual at its optimum,
since a Taylor expansion is made around this point. Hence for one evaluation of the
population likelihood function an optimization must be performed on each individual
likelihood function. These optimizations only share the given population parameters
and are therefore evaluated independently. This observation can be used to employ
the use of parallel computing, where the individual optimizations are distributed to a
number of CPUs.
Matlab does not have the option for parallel computing by default1, but this can be
made possible using external software. MatlabMPI2 is a package developed at MIT
and it enables parallel computing in Matlab by creating a set of scripts that is executed
1 A distributed toolbox for Matlab is under development by The MathWorks.
2 J. Kepner, Parallel Programming with MatlabMPI, http://www.ll.mit.edu/MatlabMPI/, 2006.
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Table 1 Computation times using parallel computing
CPUs Time (s) Reduced to (%) CPU-time per individual (s) Overhead per CPU (%)
1 serial 241.8 100.0 12.1 −−
1 242.4 100.2 12.1 0.2
2 128.3 53.0 12.8 5.8
3 101.7 42.0 15.3 20.7
4 72.0 29.7 14.4 16.0
5 66.0 27.3 16.5 26.7
10 50.0 20.6 25.0 51.6
in separate processes. MatlabMPI uses message passing but it was found faster to pass
all data and parameters through files. The individual calculation extracts its unique
part of data by using its identifier number. The individual log-likelihood result is
passed back into the leader thread by proper message passing to avoid deadlocks or
race conditions. A shared memory environment is beneficial as message passing is
implemented through shared files.
In order to illustrate the effect of parallel computation for population modelling,
a model was setup and estimated on the basis of simulated data for 20 subjects. The
resulting computation time is found in Table 1 and it can be seen that the computation
time is reduced to a little less than one-fifth of the original using five CPUs. For this
example overhead begins to dominate when using more than five CPUs, however for
more computationally intensive models, the benefit of adding more CPUs is expected
to be less affected by overhead.
For non-linear models a significant part of the computation time is spent in the
prediction part of the Extended Kalman Filter when solving the differential system
equations. The prediction includes both state and state covariance, and these differen-
tial equations are coupled and must therefore be solved simultaneously. To account for
this coupling, the two prediction equations have been collected into one system with a
combined input vector Z which stores both the states and the covariance matrix. The
symmetry in the covariance matrix is exploited so only the upper part is transferred,
i.e.
Z =
(
Z1
Z2
)
=
(
xˆt |k
U (P t |k)
)
(17)
where U () is a column vector containing the upper matrix. Conversion to the vector
Z is then used in conjunction with ode15s and the output is converted back into a
state vector and covariance matrix. The use of a single vector Z complies with the
Matlab standard conventions for ODE solving algorithms, and the chosen algorithm
ode15smay thus easily be substituted to suit the dynamic properties of a given model.
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Validation of implementation
The implementation of PSM has been validated with CTSM and NONMEM. The com-
parison with CTSM has been used to verify correct implementation of the Kalman
Filter and Extended Kalman Filter by comparison with CTSM’s individual likelihood
function. The comparison was based on a model using SDEs and showed identical
outcomes from the two programs.
The comparison with NONMEM was done with a model based on ODEs in order to
verify the population likelihood function. The comparison showed that PSM produces
identical population parameter estimates and also identical estimates of the individual
random effects parameters for four simulated data sets containing 2, 4, 10 and 20
subjects.
A final validation with NONMEM was done on the objective function value. The
NONMEM objective function (lN M ) is advertised as −2 log L but in fact it lacks a con-
stant equal to the likelihood of the data. The PSM objective function (lPSM) is − log L
as seen in Eq. 16 and the relation thereby becomes lN M = 2·lPSM−log(2π)·∑ ni . This
relation between the two objective functions was found to hold for all the estimated
models on the four simulated data sets, and this demonstrates that the formulations of
the objective functions are equivalent.
Applications
The general approach of including SDEs in the NLME model as implemented in PSM
has a potential of improving model development and performance for a wide range
of PK/PD modelling situations, as has been discussed previously. The applications to
illustrate the functionality of PSM in the present paper have been chosen to focus on
a feature inherent to the new approach. The SDEs enable a simple way to estimate
unknown inputs and time-varying parameters by modelling these as a random walk.
The technique works for both linear and non-linear problems, and this will be illus-
trated in the following by two models to estimate the insulin secretion rate and liver
extraction rate.
Data
The data originates from a double-blind, placebo-controlled, randomized crossover
study with a duration of 24 h starting at 8 a.m. in the morning. Thirteen patients (5
women and 8 men) with type II diabetes were examined. Their age given as mean±1
standard deviation was 56.4 ± 9.2 years, BMI was 31.2 ± 3.6 kg/m2 and the duration
of diabetes was 3.0 ± 2.6 years (range 5 months to 8 years) [15].
C-peptide and insulin measurements will be used for analysis in this paper, and only
the placebo data is used. This is done to focus the presented analysis on two types of
application of the NLME model which are only possible by extending it with SDEs,
namely stochastic deconvolution of an unknown input and continuous tracking of the
behavior of a parameter.
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One of the patients was discarded since the measurement times were delayed com-
pared to the rest. The data used thus consists of 24-h C-peptide and insulin profiles
for 12 individuals, see Fig. 1.
The subjects were sampled 35 times during the 24 h at varying time intervals, mainly
concentrated after meal times. A total of 3 standard meals were given at 8 a.m., noon
and 6 p.m., each to be finished within 20 min. These times correspond to 0, 240 and
600 min after the study was initiated, see Fig. 2.
Deconvolution
The first example of application will illustrate how the model setup can be used for
deconvolution of the insulin secretion rate (ISR) based on a standard two-compartment
linear model for C-peptide measurements [16]. It is known that C-peptide and insulin
are secreted in equi-molar amounts, and this fact is used to construct the model. The
basic idea is to model the secretion rate into the central compartment as a pure random
walk (Wiener process) and then estimate ISR as the realization of this random walk
using the EKF to provide a smoothed estimate.
The modelling of the ISR as a random walk actually means that no model is given
for the ISR, and therefore it is instead estimated entirely based on the data. For a
linear system this technique resembles a deconvolution, but it will provide a more
smooth estimate compared to an ordinary deconvolution. This is because the EKF sep-
arates system noise from measurement noise, where the system noise for this model
is assumed to be the ISR of interest. The extent of smoothing is determined by the
maximum likelihood estimated σISR, the magnitude parameter for the random walk
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Fig. 4 Smoothed estimate of ISR for individual 1 and 2
for ISR, which influences the Kalman gain on increments of the random walk. A larger
magnitude leads to a more fluctuating random walk with larger increments and vice
versa for a smaller magnitude. The resulting estimate of the random walk and thereby
the ISR is thus optimal in a likelihood sense, since the EKF as mentioned earlier has
been shown to yield the minimum variance state estimate for a linear system.
The deconvolution setup requires three states, namely a central compartment state
C1 modelling the measured C-peptide concentration, a peripheral compartment state
C2, and a state ISR for the random walk. This gives the state vector x = [ C1 C2 ISR ]T .
The C-peptide kinetic parameters k1, k2, ke are set equal to the Van Cauter estimates
found in [17].
The C-peptide measurement error is assumed to be additive Gaussian white noise
with variance . The model states are constrained to steady state at t = 0 given an
initial individually estimated concentration Ci in C1, that is x0 =
[
Ci k1k2 Ci keCi
]T
and Ci = C01 exp η, η ∈ N (0,C1). The state equation for the model is shown in
Eq. 18
dx =
⎡⎣−(k1 + ke) k2 1k1 −k2 0
0 0 0
⎤⎦ x dt + diag
⎡⎣ 00
σISR
⎤⎦ dω (18)
and the measurement equation is simply y = C1 + , where  ∈ N (0, ). The
ML estimated population parameters are C01 , , σISR and C01 and based on these an
optimal estimate of ISR can be found by using the Kalman smoothing algorithm.
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Fig. 5 Dynamics of the combined model for estimation of insulin secretion rate and liver extraction rate
Figure 4 shows the smoothed estimate of ISR for the first two individuals together
with a ±1 standard deviation band. The assumption of steady state in the beginning
defines the initial level of ISR based on C01 and this appears appropriate.
State-estimation
The second example of application goes to illustrate how the model setup may be used
for state-estimation in non-linear systems. The method is also sometimes referred to
as parameter tracking, when the state represents a parameter, which is suspected of
having some time-varying behavior. Although non-linear state-estimation is funda-
mentally different from deconvolution, which only applies to linear systems, it can be
performed with SDEs in basically the same way as the approach for deconvolution
presented in the first example of application.
The aim is to estimate the dynamic liver extraction rate, which represents the frac-
tion of insulin that is absorbed by the liver. This fraction is often modelled as a constant
to simplify statistical models, although it is known to be time-varying. As previously
done the insulin secretion rate is estimated based on the information in the C-peptide
measurements and then used as input into a one-compartment insulin model. The state
I models the measured insulin concentration in the compartment and the insulin elim-
ination is set to ke,I = 0.355 min−1. This value has been reported for a similar study,
also on type II diabetic patients [18]. By having a fixed elimination rate and ISR given
from the C-peptide part of the data, the information in the insulin measurement can
be used to estimate the liver extraction. The fraction which passes through the liver
is modelled by a state F , and the input into the insulin compartment is thus F · ISR
making the model non-linear in the states. The final layout of the model is shown in
Fig. 5. The layout is identical to the layout first proposed in [19], where it is shown
that by assuming a constant liver extraction rate it is possible to estimate the kinetic
parameters and a piecewise constant ISR.
In an initial model F was modelled directly as a random walk in the same way as ISR.
The estimation of the model returned a very low estimate of the insulin measurement
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standard deviation at only 0.01 pmol/l. This is an unrealistically small value and indi-
cates a problem with separation of noise components, since virtually all the variation
in the insulin measurements thereby is assumed to originate from the fluctuations of
the liver extraction.
This problem can be solved by imposing further smoothing to the state-estimation
by choosing to model the derivative of F as a random walk instead of directly F as
before. This is achieved by introducing a new state named X as shown in Eq. 19 and
20
d F
dt
= X (19)
d X = σX dω (20)
where ω is a Wiener process. The change in the model for F causes the increments of
the derivative of F to be penalized by the Wiener noise gain σ instead of the incre-
ments of F directly. The result is a less flexible model for F where fluctuations are
further constrained, and the modification is easily implemented using the flexibility
made available by the stochastic state space approach. In total the model contains six
states, namely x = [C1 C2 I ISR F X ]T , which are all estimated simultaneously by
the Extended Kalman Filter using the two-dimensional measurements with C-peptide
and insulin. The system equations are shown in Eq. 21.
dx =
⎡⎢⎢⎢⎢⎢⎢⎣
−(k1 + ke)C1 + k2C2 + I S R
k1C1 − k2C2
−ke,I I + F · I S R
0
X
0
⎤⎥⎥⎥⎥⎥⎥⎦ dt + diag
⎡⎢⎢⎢⎢⎢⎢⎣
0
0
0
σISR
0
σX
⎤⎥⎥⎥⎥⎥⎥⎦ dω (21)
The estimation of the population parameters in the new model with a constrained
model for F results in a better separation of noise. The standard deviation for the
insulin secretion rate is estimated at a satisfactory level of 19.8pmol/l.
As could be expected, the model finds an ISR which is almost identical to the one
found using just a C-peptide deconvolution model, since the information in the added
insulin measurements is used to estimate the liver extraction. The smoothed estimate
of the fraction of insulin passing the liver F is shown in Fig. 6 for individual 1 and 2.
The plots illustrate that the proportion sent through the liver, F , is below one for the
entire time interval as it naturally should be. This also holds for 8 out of the remaining
10 individuals. For the two last individuals F varies between 0.5 and 1.8. This is
however not of great concern, because F and ke,I are correlated and it is thus probably
just indicating that ke,I for this particular individual is set too high.
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Fig. 6 Smoothed fraction of insulin passing the liver ±1 SD for individual 1 and 2
Discussion
By the presented software implementation PSM, we have shown that it is possible to
develop a general purpose PK/PD population modelling tool that is able to handle the
extra functionality made available by using SDEs in NLME models. The implemen-
tation opens up for the possibility to easily make further experiments with the model
setup to allow for accumulation of more knowledge about the modelling approach.
It is important to emphasize that the software implementation is to be considered
a prototype, which should only be used on research level. A necessary step to make it
more widely usable is to move to another programming language. This implementation
has been done in Matlab, which is ideal for numerical implementations, but it lacks
in speed and parallel computing options. The standard within scientific programming
today is Fortran, and this is also an obvious choice here due to its efficient handling
of numerical computations and linear algebra calculations. Another advantage of For-
tran is the accessibility of modules already available, such as algorithms for numerical
optimization and ODE solvers.
The optimal platform for a future implementation is a shared memory system.
Shared memory parallelism can be implemented easily in Fortran using the OpenMP3
application program interface. OpenMP supports multi-platform shared-memory par-
allel programming in Fortran on all architectures, including Unix and Windows plat-
forms. OpenMP is a scalable model that gives a flexible interface for developing a
parallel application for platforms ranging from the desktop to the supercomputer and
it supports parallelism through meta tags that will make portability to single CPU,
multi-core CPU, and shared-memory multiprocessor (SMP) units simple. Some com-
pilers are also able to create parallel calculations by automatically analyzing the code,
but the largest improvements are achieved using manual parallelization.
3 Further details may be found at www.openmp.org.
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The present paper has illustrated how parallelization introduced at the individual
minimizations of the population likelihood function has a strong potential of reducing
the estimation time for a future final software program when dealing with data con-
taining a large number of individuals. It can also be argued to introduce parallelism at
an even higher level in the gradient calculation of the population likelihood function.
This would generally be advantageous for models where the number of population
parameters exceeds the number of individuals in data.
The first example of application in this paper demonstrated how the NLME model
can be used for deconvolution of ISR by introducing SDEs. Although the estimation
of ISR using SDEs is loosely denoted deconvolution, it is in fact not strictly speaking
deconvolution but instead a probabilistic description of an unknown input, which is
modelled as the realization of a stochastic process. Pure deterministic deconvolution
using ODEs for the model shown in Fig. 3 will estimate ISR at each measurement to
be equal to the rate giving the ‘missing’ amount in the central C-peptide compartment
C1. With the SDE approach the measurement noise on C-peptide is taken into account
by the Kalman filter, which yields a minimal variance estimate of the states resulting
in a more smooth estimate of ISR where the effect of noise is reduced.
Deconvolution based on noisy data is generally an ill-posed problem, meaning that
even small perturbations in data lead to significant changes in the estimated solution
[20]. The problem has been addressed by existing software by applying various kinds
of regularization techniques to constrain the solution. An example is WinNonlin [21],
which is a standard PK/PD software solution that can also be used for deconvolution.
The program addresses the problem of deconvolution by introducing a smoothness
factor and as a consequence it is simply left up to personal choice and preference of
the user to specify the level of smoothing. An improved solution can be found using
WinStoDec presented by [22], which is based on stochastic deconvolution and can
be used for linear time-invariant systems [23]. It has been shown by [24] that the
stochastic deconvolution approach is equivalent to the SDE approach presented here,
which is furthermore by nature also able to handle non-linear time-varying systems,
as has been demonstrated with the state-estimation approach in the second example
of application presented here.
In conclusion, a fully functional prototype tool named PSM for estimation of NLME
models based on SDEs has been implemented in Matlab and validated. The use of par-
allelization in the implementation has demonstrated a strong potential of reducing com-
putation times in future implementations in a faster programming language. Finally
two examples of application concerning insulin modelling demonstrated the possibil-
ity for deconvolution and non-linear parameter tracking facilitated by the extension
of the NLME model to use SDEs.
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Appendix: Approximation of population likelihood function
The population likelihood function for the NLME model with SDE’s is defined in Eq.
13 as
L(θ ,, σω,) =
N∏
i=1
∫
exp(li )dηi (22)
where li is the individual a posteriori log-likelihood function. In most cases the integral
cannot be evaluated analytically. For a general evaluation the individual a posteriori
likelihood function can be approximated by a second order Taylor series expansion of
li around the value ηˆi of the individual random effects parameter which maximizes li .
It follows that
li ≈ li + ∇T li (ηi − ηˆi ) +
1
2
(ηi − ηˆi )T 	li (ηi − ηˆi ) (23)
≈ li + 12 (ηi − ηˆi )
T 	li (ηi − ηˆi ) (24)
since ∇li = 0 at ηˆi . Based on the approximation in Eq. 24 the integral in Eq. 22 can
now be evaluated by moving constants such that the integral is over a multi-variate
Gaussian density with mean ηˆi and variance (−	li )−1. This integral is equal to one
and the result is
∫
Li dηi ≈
∫
Li · exp
(
−1
2
(ηi − ηˆi )T (−	li )(ηi − ηˆi )
)
dηi (25)
≈ Li
∣∣∣∣ 2π−	li
∣∣∣∣ 12 ∫ ∣∣∣∣ 2π−	li
∣∣∣∣− 12 exp (−12 (ηi − ηˆi )T (−	li )(ηi − ηˆi )
)
dηi
(26)
≈ Li
∣∣∣∣ 2π−	li
∣∣∣∣ 12 · 1 (27)
≈ Li
∣∣∣∣−	li2π
∣∣∣∣− 12 (28)
where Li = exp(li ). The step in Eq. 28 is done to avoid a matrix inversion of the
Hessian. By combining Eq. 22 Eq. 28 the population log-likelihood function can now
be approximated by
L(θ ,, σω,) ≈
N∏
i=1
∣∣∣∣−	li2π
∣∣∣∣− 12 exp(li )∣∣∣ηˆi . (29)
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1 Introduction
The development of new medical drugs is driven by progress in many areas.
These include medicine, biotechnology, new production equipment and not least,
as will be the focus here, the area of mathematical and statistical modelling.
Before a new drug can move from a simple molecule in the laboratory to
become a new product in the local pharmacy, there are many questions which
must first be answered: Is it safe, also for patients, elderly people, pregnant
women, etc.? Does the drug work? In which way should it be given to the
patient? Are there any unwanted side-effects? The answer to all these questions
require a long series of trials, which must be carefully planned to discover all
facets of a new drug candidate.
New drug candidates are in the early development phase initially tested with
animals. These tests aim to show if the drug seems to work and also to check for
unwanted side effects. The next step is to move to clinical trials with humans.
These trials have traditionally been separated into 4 phases. In Phase 1 the drug
is given to healthy young male persons mainly to see if it is safe for humans
but the sponsor (the drug company) will of course also look for indications of a
positive effect. In Phase 2 the drug is given to the target patient group again
mainly to show that it is still safe, but also to give indications of a positive
effect. When safety has been established and the sponsor believes in the drugs
potential, it will be moved to Phase 3, which generally involve the largest and
most costly trials. These trials focus on proving the positive effect of the drug
to the health authorities. If all goes well, the drug is approved and marketed.
In some cases this will be followed by new trials, which is known as Phase 4
studies.
The series of clinical trials is not only very costly but also time consuming.
The drug may easily take 10 years to get approved and marketed to the patients.
Due to this both health authorities and drug companies are looking of ways to
accelerate this project, while still keeping it as safe as possible. The primary
target is to insure that no harmful drugs get approved, but at the same time
that the good drug are not delayed unnecessarily from reaching the patients,
who will benefit from them. It is in this connection that mathematical and
statistical modelling has become an important tool, since it may help to give
improved understanding of the outcome of clinical trials.
The scientific disciplines concerning mathematical modelling in drug devel-
opment are called pharmacokinetics and pharmacodynamics, or in brief just
PK/PD. In popular terms PK is often described as “what the body does to
the drug” and PD as “what the drug does to the body”. More specifically
PK focuses on modelling how the drug passes through the body, normally by
modelling concentrations in various areas of the body as a function of time, see
Figure 1(a). PD aims at linking these modelled drug concentration to certain
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measure of effect through a PD-model. An example of a PD-model is shown
in Figure 1(b). With a combined PK/PD model it is thus possible to give a
picture of the expected effect for a given dose as a function of time as illustrated
in Figure 1(c).
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(c) Combined PK/PD model
Figure 1: Illustration of PK/PD modelling.
For more thorough reading on pharmacokinetics and pharmacodynamics the
books Gabrielsson and Weiner (1997) and Rowland and Tozer (1997) are sug-
gested.
2 The ADME Model
A complicated process is initiated as soon as a drug enters the body. This
process can be divided into four phases, absorption, distribution, metabolism
and elimination and hence the acronym ADME.
The absorption phase describes how the drug enters the body, or more pre-
cisely how the drug enters the bloodstream. When using intravenous (iv) ad-
ministration, no absorption phase is present since the drug is injected directly
into the bloodstream. The whole dose can be given in one rapid injection, called
a bolus dose, or by using a constant rate infusion over a certain period of time.
All other dosing methods, that is when the drug is not injected directly into
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the bloodstream, are called extravascular dosing. Examples of such methods
are injections into a muscle or fat tissue and oral dosing. Those methods have
one thing in common, they require an absorption phase since the drug needs
to cross some boundaries in the body before it reaches the bloodstream. As an
example when administrating a pill (oral dosing), the pill needs to dissolve and
cross the gut wall before it reaches the bloodstream.
The distribution phase describes how the drug spreads through the body,
into its fluids and tissues, after it has reached the bloodstream. It is in the
distribution phase the drug is brought to the place of action trough the blood-
stream. The time it takes for the drug to get to the place of action is very
dependent on if it is easily accessible by the bloodstream. The heart is, as an
example, easily accessible by the bloodstream while the bone marrow is not.
The third phase, metabolism, describes a process where the initial (parent)
compound is broken into another compounds, called metabolites. The metabo-
lites can either be inactive, therefore reducing the drugs effect on the body, or
they can be active, sometimes more active than the parent compound. The liver
plays a leading role in metabolism since it produces many of the enzymes used
by metabolism.
The last phase, the elimination phase, describes how the compounds and
their metabolites are removed from the body via excretion. Most drugs are
eliminated via the kidneys with urine.
The four phases of the ADME model can be summarized as:
Absorption Drug entering the body
Distribution Drug is spreading to different areas of the body
Metabolism Drug is being changed to new chemical compounds
Elimination Drug is removed from the body
3 Fundamental concepts
Concentration is defined as amount per volume and is the most central concept
in PK/PD modelling. The reason is that concentration of a drug is relatively
easy to measure from a blood sample and at the same time concentration is a
key factor when modelling both positive and negative effects of a drug. Con-
centration is calculated as
C =
A
V
(1)
4
where A is amount of drug and V is the volume of distribution. The amount
of drug is either measured as mass (mg) or in number of molecules (mol). The
volume of distribution is defined as the volume which the drug has to distribute
evenly into in order to reach the measured concentration in the blood, C. If the
the drug only distributes into the blood then the volume of distribution will be
equal to the volume of the blood. However, often the volume of distribution will
be larger than the volume of the blood. This can happen if the drug distributes
into other parts of the body or if the drug is chemically bound in a way where it
cannot be measured. The amount of drug is unchanged, but only a smaller part
can be measured in the blood. This will result in a larger volume of distribution
to reflect the lower measured concentration of the drug.
Another central issue is the timecourse of the elimination of the drug. In the
most simple model one assumes that the elimination rate is proportional to the
remaining amount of drug, A. The proportionality constant is CL/V , where
CL is called clearance and measures the volume of blood which is cleared for
drug per time. The rate of clearance is thus CL/V ·A. CL and V are sometimes
referred to as micro constants and are sometimes replaced by
K =
CL
V
, (2)
where K, the elimination rate constant, is a so called a macro constant. The
choice of parameterization will be decided by the identifiability of the parameters
based on the given data. In some situations it is possible to estimate both CL
and V but some times they cannot be separated and it is thus only possible to
estimate K.
A basic measure of the exposure of the drug is called AUC, which stands for
area under the curve. AUC measures the area under the curve of concentration
vs. time. An important feature of AUC is that it can be evaluated for most
types of models and it can even be determined graphically based of a series of
concentration measurements.
4 Compartment models
The purpose of PK modelling is mainly to describe how a drug passes through
the body by modelling concentrations of the drug in different areas of the body.
To measure the concentration of a drug a blood sample is usually taken and the
concentration measured. Since the heart is pumping blood constantly it can be
assumed that the concentration of the drug is the same within the bloodstream
at a given time. This means that as soon as the drug has reached the blood-
stream the concentration of the drug is the same throughout the bloodstream.
However, it might not be the case that the drug spreads instantly to other parts
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of the body. Therefore, in order to build mathematical models to describe how
the concentration changes with time the body can conveniently be divided into
parts, called compartments, where the drug can be assumed to behave in the
same manner. This type of modelling is called compartment modelling. The
compartment where the concentration is measured, usually the bloodstream, is
of special interest and is called the central compartment.
The most basic model found is the one describing a one compartment system,
which only includes the central compartment and a possible absorption compart-
ment. This model is appropriate to use if the drug distributes to accessible areas
of the body instantly. If the drug is given directly into the bloodstream (iv) the
system only includes a central compartment while in the case of extravascular
dosing the system should have an absorption compartment in addition to the
central compartment. As an example, if the drug is administrated orally the
system should include a gut compartment.
In some cases the one compartment model is not suitable for describing the
system and in these cases a multi compartment model may need to be applied
(see Sec. 4.2). However, in the remaining part of this report the focus will
mainly be on the one compartment model (with an additional compartment if
the drug is not administrated directly into the bloodstream) since many systems
can be described using that model.
A compartment system can easily be visualized by drawing the compart-
ments as circles and the connections between them with arrows indicating the
direction of the flow between the compartments. A figure showing the one com-
partment system in case of intravenous bolus dose is shown in Figure 2(a) and
in the case of oral dosing in Figure 2(b).
Central
K
(a) 1-compartment
system
Gut Central
Ka
K
(b) 1-compartment system with additional
gut compartment
Figure 2: Illustration of compartment models.
The transfer rate of a drug from one compartment to another can usually
be described using first order kinetics, meaning that the rate of change is pro-
portional to the amount of the drug in the source compartment.
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4.1 One-compartment models
The relationship between the rate of elimination and the amount of a drug in a
one compartment model with first order kinetics when drug is administrated as
a bolus dose (the system shown in Figure 2(a)) can be written mathematically
as:
dA
dt
= −K ·A (3)
where A is the amount of the drug and K is the first order elimination rate
constant. K is always positive and its size controls the speed of the elimination.
The differential equation can be solved resulting in a function describing the
amount of the drug in the central compartment at a given time
Abolus(t) = A0 exp(−K · t) (4)
where A0 is the amount of the drug at time t = 0, that is the size of the given
dose.
In the case of extravascular dosing other compartments needs to be added
to the model. E.g. for oral dosing a extra gut compartment is often sufficient
to model the absorption phase (the system shown in Figure 2(b)). Usually the
rate of change in the gut compartment can be described with first order kinetics
resulting in the following differential equation
dAgut
dt
= −Ka ·Agut (5)
where Agut is the amount of the drug in the gut and Ka is the first order
absorption constant. It is usually the case that Ka > K meaning the absorp-
tion of the drug from the gut into the central compartment is faster than the
elimination process. However, in some cases Ka < K which is known as the flip-
flop situation. The flip-flop situation is discussed further in Section 4.1.2. The
change in amount in the central compartment can now be found by combining
(3) describing the elimination, and (5) describing the absorption from the gut
resulting in
dA
dt
=
from gut︷ ︸︸ ︷
F ·Ka ·Agut−
elimination︷ ︸︸ ︷
K ·A (6)
where F denotes the bioavailability which is the fraction of the dose that reaches
the central compartment. The differential equation can be solved resulting in
an expression for the amount of drug in the central compartment for a given
time which is a function of both the absorption and the elimination:
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Aoral(t) =
KaFA0
Ka −K (exp(−K · t)− exp(−Ka · t)) (7)
Equations (4) and (7) can now be used to describe the amount of drug in
the central compartment for a one compartment system in the case of a bolus
dose and oral dosing, respectively. Usually it is more interesting to model the
concentration (C) in stead of the amount since it is the concentration of the
drug in the blood that is measured. According to (1) the concentration is found
by dividing the amount by the volume of distribution resulting in
Cbolus(t) =
Abolus(t)
V
=
A0
V
· exp(−K · t) (8)
in the case of a bolus dose, and
Coral(t) =
Aoral(t)
V
=
KaFA0
V (Ka −K) (exp(−K · t)− exp(−Ka · t)) (9)
in the case of oral dosing.
4.1.1 Case study: pain reliever
To illustrate the use of compartment modelling the drug paracetamol will be
used as a case study. Paracetamol is the active substrate in a large number of
pain relieving drugs on the market although its mechanism of action is still a
source of debate. At correct dosages it works well against head ache and fever
but at very high dosages it can cause lasting damages on the liver. For adults
it is recommended to take doses of 1000mg at most 3-4 times a day and never
more than 4g per day.
Paracetamol has been tested in a number of trails and it has been shown
that the pharmacokinetics can be adequately described by a multi-compartment
model structure, which will be introduced in Section 4.2 in further detail (see also
Rawlins et al. (1977)). As a good approximation however, it can be modelled
using a one-compartment model with a 1st order elimination from the blood
and likewise a 1st order absorption from the stomach. Paracetamol can thus
be modelled with the systems shown in Figure 2 for intravenous bolus and oral
dosing. Based on Rawlins et al. (1977) the elimination rate constant can be
found to K = 0.28h−1 and the volume of distribution is 0.60L/kg giving V =
42L for an average 70kg adult. The absorption is controlled by an absorption
rate constant of Ka = 1.80h−1 and the bioavailability is found to F = 0.89.
Note that Ka > K holds here, meaning that paracetamol is absorbed faster
than it is eliminated.
Based on the information found for paracetamol it is possible to draw the
concentration as a function of time based on (8) and (9). This is called a
8
concentration profile and is shown for both intravenous bolus and oral dosing
in Figure 3.
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Figure 3: Concentration profiles for dosing of 1000mg paracetamol.
Concentration profiles are also commonly shown with concentration on a
log-scale as seen in Figure 4. This makes it possible to directly read off the
elimination rate constant K as the slope of the line for intravenous bolus dos-
ing. For oral dosing K is found as the slope of the last part of the profile
(terminal slope) where it follows a straight line. This holds since Ka > K and
the absorption from the gut thus has finished so the drug is only contained in
the blood as for intravenous bolus dosing.
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Figure 4: Concentration profile on log-scale for dosing of 1000mg paracetamol.
In this case looking at Figure 4(b) we find approximately
K = −∆(logC)
∆t
= − log 3− log 7.5
7h− 4h ≈ 0.305h
−1 (10)
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which compares well to the true value of K = 0.28h−1.
4.1.2 Flip-flop situation
Cases where the absorption rate constant is larger than the elimination rate
constant (Ka < K) is called a flip-flop situation. In these situations the absorp-
tion will be the so-called rate limiting step in the final phase of the elimination
for oral dosing (Gabrielsson and Weiner 1997) and thus the terminal slope for
oral dosing will be −Ka instead of −K as shown in Figure 4(b). For intravenous
dosing the slope is −K independent of Ka.
In order to be able to decide if it is a flip-flop situation it is necessary to
perform both an intravenous bolus dosing study and an oral dosing study. If
the terminal slope of the oral dosing concentration profile is parallel to the
intravenous bolus concentration profile it is a normal situation, since the final
elimination rates are equal. This can be known since the intravenous bolus
concentration profile consists only of an elimination phase without an absorption
phase.
On the other hand, if it is observed that the terminal slope for oral dosing
is less steep than the intravenous bolus profile slope then the final phase must
be absorption. The two situations are illustrated in Figure 5.
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(a) Terminal phase for oral dosing is elimi-
nation
Time
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(b) Terminal phase for oral dosing is absorp-
tion
Figure 5: Situations with both elimination (normal) and absorption (flip-flop)
as terminal phase seen as parallel and non-parallel terminal slopes respectively.
It is possible to determine the remaining rate constant (eitherKa in a normal
situation and K in a flip-flop situation) using the method of residuals. This is
explained in detail in Gabrielsson and Weiner (1997).
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4.1.3 Maximum concentration
It is often of importance to know the maximum concentration, Cmax, of a drug in
the blood and the time it takes to reach this maximum, tmax. For an intravenous
bolus dose the maximum concentration is obtained just after the drug is injected
into the the bloodstream, that is tmax = 0 and the maximum concentration can
be calculated as
Cmax,iv =
A0
V
(11)
where A0 is the size of the dose and V is the volume of distribution.
In the case of extravascular administration, the concentration will not peak
until after a while because of the absorption step. In general, the time it takes
to reach the maximum can be found by differentiating the expression for C(t)
for the system, with respect to t, set the derivative equal to zero and finally
solve for tmax. In the case of oral dosing in a one compartment system following
first order absorption and elimination the expression for C(t) is given in (9).
Differentiating this expression, setting the derivative to zero and solving for
tmax gives
tmax =
1
Ka −K ln
(
Ka
K
)
(12)
The resulting maximum concentration at tmax then becomes
Cmax,oral =
KaFA0
V (Ka −K) (exp(−K · tmax)− exp(−Ka · tmax)) (13)
which can be simplified to
Cmax,oral =
FA0
V
exp(−K · tmax) (14)
4.1.4 Half-life of drug
An important property of a drug is its biological half-life, t1/2. The half-life is
the time it takes for reducing the amount of drug left in the body by 50%. In
the case of a bolus dose, in a one-compartment system, the amount of the drug
in the body at t = t1/2 is
A(t1/2) = A0 exp(−K · t1/2) (15)
according to (4). By definition, half of the given amount (A0) should be left at
in the body at t = t1/2 or
1
2
A0 = A0 exp(−K · t1/2) (16)
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which can be simplified to
t1/2 =
ln 2
K
(17)
4.1.5 Constant rate infusion and multiple dosing
It is often the case that it is not enough for a patient to have effect of a drug
during the time span where a single pill or intravenous bolus dose is active in
the body. In some cases the solution is simply to give a higher dose, but since
this may cause unwanted side effects, this is not always the best way to go.
Another possibility to prolong the effect of a drug is to give it as a constant
rate infusion into the vein. This is the best way to control the drug flow into
the body and it is easily modelled for a constant rate Rin by
dC
dt
=
Rin
V
− CL
V
· C (18)
assuming a one-compartment model with first order elimination. The solution
is given as
C(t) =
Rin
CL
[
1− exp
(
−CL
V
t
)]
. (19)
In some cases it is more practical to approximate the constant rate infusion
by taking pills with a constant time interval. This is known as multiple dosing
and is related to a constant rate infusion by the equation
Rin =
F ·A0
τ
(20)
where A0 is the dose in each pill, F is the bioavailability (the fraction that
reaches the blood) and τ is the time interval between dosing. The concentration
profile for multiple dosing is a sum of single oral dosing profiles which can be
written as
CMD(t) =
N−1∑
n=0
Coral(t− nτ) (21)
where N is the number of doses and Coral is given in (9).
The system is in steady state when the elimination rate equals the infusion
rate, that is when
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Rin
V
=
CL
V
CSS (22)
which gives a steady state concentration
CSS =
Rin
CL
. (23)
It can be shown by using (19) that 90% of CSS is reached after 3.32 half-
lives. This result is independent of the rate of infusion which gives rise to the
general rule of thumb that 90% of steady state concentration is reached after
3-4 half-lives (Gabrielsson and Weiner 1997).
Two examples of constant rate infusion and multiple dosing concentration
profiles for paracetamol are shown in Figure 6.
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Figure 6: Multiple dosing of 4g paracetamol with 4 oral doses of 1g shown as a
thick line. The dotted line is a constant rate infusion at a corresponding rate.
4.2 Multi-compartment models
It may be the case that the one-compartment model is not sufficient to describe
the distribution and elimination of a drug. More complicated models where
additional compartments are added to the central compartment, resulting in
a multi-compartment system, should then be applied. As a consequence, the
system consists of a central compartment, representing the bloodstream and
rapidly equilibrated organs, one or more peripheral compartments, represent-
ing more slowly equilibrating tissues, and finally in the case of extravascular
administration, an absorption compartment.
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The expression for C(t) for a one compartment system (intravenous dosing)
only includes a singe exponential term (Equation (4)). The best way to reveal
how many compartments are needed to best describe the time course of the
concentration is to plot the concentration on a semi-logarithmic scale. For
a multi-compartment system this will most likely look like a piecewise linear
function. As a general rule of thumb one compartment is needed for each linear
part that is identified. As an example a two compartment system in the case of
a bolus dose and the corresponding concentration profile are shown in Figure
7. It can be seen by looking at the figure that the concentration profile consists
of two linear phases, a rapid initial and a slow terminal phase, which is the
”fingerprint” of two-compartment systems.
Central
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K12
K21
K
(a) Two-compartment system
Time
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(b) Concentration profile for a two-
compartment system
Figure 7: Illustration of two-compartment models.
The system shown in Figure 7(a) can be described mathematically using
two differential equations, where C1 and C2 represents the concentration in the
central compartment and the peripheral compartment respectively.
dC1
dt
= K21 · C2 −K12 · C1 −K · C1 (24)
dC2
dt
= K12 · C1 −K21 · C2 (25)
A solution of the differential equations, that is an expression for the concentra-
tion in the central compartment, can be written as
C = A · exp(−αt) +B · exp(−βt) (26)
Expressions for A,B, α, β given by K12, K21 and K can be found in Gabrielsson
and Weiner (1997). The half-lives of the two phases can finally be calculated as
t1/2,α =
log(2)
α
(27)
and
t1/2,β =
log(2)
β
. (28)
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4.2.1 Case study: pain reliever continued
To illustrate the use of compartment modelling, the intake of paracetamol was
modelled using a one compartment model in Section 4.1.1. It has however been
shown that paracetamol concentration, after intravenous bolus dosis, follows a
bi-exponential decline indicating that a two compartment model should be used
to describe the system. Based on Rawlins et al. (1977), the time course of the
concentration following an intravenous bolus dose of 1000mg is given by
C(t) = 13.8 · exp(−2.55t) + 13.0 · exp(−0.28t) (29)
The resulting concentration profile is shown in Figure 8.
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Figure 8: Concentration profile for paracetamol (1000mg intravenous bolus).
5 PD modelling
This section contains a brief introduction to pharmacodynamics (PD). In phar-
macodynamics the dependent variable is not always straight forward to define.
The dependent variable in pharmacokinetics is amounts or concentrations of
the drug but for pharmacodynamics the dependent variable is not so obvious.
How is the effect of a drug measured? Drugs against high blood pressure or
fewer can be measured on the actual drop in pressure or temperature. Within
epilepsy the desired effect of a drug should lower the number of seizures making
the PD measurement a count. Within pain relieve the measurement can be a
scale where the subject grades the pain and here the response variable will be
an ordinal variable.
This wide variety of possible outcomes of a pharmacodynamic trial makes it
hard to present a single methodology to handle all cases of PD modelling. This
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section will focus on the most simple models and only with continuous response
variables.
5.1 Receptor Theory
This section includes a quick introduction into receptor theory and how it helps
in the understanding of the pharmacodynamic response. The presentation of
the receptor theory is highly inspired by Gabrielsson and Weiner (1997).
Before a drug molecule can give rise to a pharmacodynamic effect it needs
to interact with the cells. The cell membrane is covered in different receptors
each with a specific structure. The structure defines which molecules that can
attach to the receptor. In engineering terms a receptor can best be described
as a docking station. The drug binding to the receptor initiates a change in the
structure of the receptor and thereby changing the cell membrane.
Drugs are divided into two classes according to their function on the receptor.
Agonists initiates a structural change in the receptor thereby changing the cell
resulting in a response. Antagonists have a different role by simply binding to
the receptor but not inducing any response. By occupying the receptor it blocks
the receptor for other molecules. This is also why antagonists are sometimes
referred to as blockers.
The set of unoccupied receptors [R] placed on the target cells that potentially
can bind with drug molecules [D] and their relation to the bound drug/receptor
complex [DR] can be stated as
[D] + [R]
k1

k−1
[DR] (30)
where D denotes the drug, R the receptors and DR the bound drug/receptor
complex.
The equation is based on a reversible receptor that can release the drug and
be occupied by a new drug molecule. The constant k1 indicates the rate of
change from unbound to bounded and k−1 the other way. The binding property
between the drug and the receptor determines the proportion of bound drug at
equilibrium. The term affinity, which is often used to describe how good a drug
binds to the receptor, is defined as
Affinity =
k1
k−1
=
1
Kd
. (31)
The inverse of the affinity is denoted the disassociation constantKd as shown
above and is also often used.
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The properties of association and disassociation determines the proportions
in each state at equilibrium. It is clear that both the willingness to associa-
tion/bind and the ability to stay associated/connected affects the proportions
in equilibrium. One easy way to affect the amount of bound drug is simply to
add more drug.
The link from the drug/receptor complex to the pharmacodynamic response
can be thought of as a direct link between the receptor occupancy and the re-
sponse. However often an extra state is included although hard to measure. The
extra state extends the occupied state by introducing an occupied and activated
state. It splits the assumption that an occupied receptor is automatically active.
Inactive︷ ︸︸ ︷
[D] + [R]  [DR] 
Active complex︷ ︸︸ ︷
[DR∗] (32)
Equation (32) should be interpreted using the concepts of binding and acti-
vation. Now a drug can be specified as both having a property for binding and
activation of the receptor. This ability to activate the receptor is denoted in-
trinsic activity and is more difficult to measure (Gabrielsson and Weiner 1997).
5.1.1 Michaelis-Menten model
It is possible to derive a model for the relation between drug concentration and
effect based on receptor theory. The effect response E is assumed proportional
to the occupancy of the receptors and thus that the maximal effect is achieved
if all receptors [Rtot] are occupied. This can be stated as
E = α[RD] (33)
Emax = α[Rtot] (34)
where [Rtot] = [R] + [RD] is the total number of receptors and Emax is the
maximal effect and α is the proportionality constant.
The steady state conditions can be stated as
d[RD]
dt
= k1[R][D]− k−1[RD] = 0
[R][D]
[RD]
=
k−1
k1
= Kd (35)
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By substituting [R] with ([Rtot]− [RD])
[D]([Rtot]− [RD])
[RD]
= Kd
[RD]
[Rtot]
=
[D]
[D] +Kd
(36)
Now by inserting the response assumptions
E/α
Emax/α
=
[D]
[D] +Kd
E
Emax
=
[D]
[D] +Kd
E =
Emax[D]
[D] +Kd
(37)
The relationship in (37) is called a Michaelis-Menten relationship between
drug concentration and the effect. This derivation demonstrates the motivation
for the use of saturable models in pharmacodynamic modelling. Physiologically
it also makes sense that at some point increasing the drug concentration will
not result in a increased response.
The disassociation constantKd determines the concentration at 1/2·Emax as
can be seen from (37). An example of the model on both normal and logarithmic
scale is shown in Figure 9.
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(a) Response vs. Conc.
Emax
Kd
50%
0
(b) Response vs. log(Conc).
Figure 9: Michaelis-Menten relationship with response.
5.1.2 Commonly used PD models
The Michaelis-Menten relationship forms the basis of one of the most commonly
used models to describe the relation between effect and concentration. This
model is called the Sigmoid Emax model and is described by
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E = E0 +
EmaxC
n
Cn + ECn50
(38)
where C is the concentration and EC50 is the concentration at E0+1/2 ·Emax.
The extra parameter n is included to provide a more flexible model. The model
is often used with n = 1 and then simply called an Emax model.
In order to be able to estimate parameters in the (Sigmoid) Emax model
it necessary to have estimates of the effect all the way from E0 up to a point
where maximum effect E0+Emax seems to have been reached. If this is not the
case it is often advisable to use a more simple model such a the linear model
E = E0 + S · C (39)
or the log-linear model
E = m · log(C + C0) . (40)
Both of the models will in many situations be able to adequately describe
the observed concentration-effect relationship. A comparison of all three models
are shown in Figure 10. For the Emax model n = 1, E0 = 3, Emax = 8 and
EC50 = 100 and remaining parameters S, m and C0 are chosen so they all have
the same effect at concentrations of 0 and EC50.
0
E0
E0 + Emax
1 10 100 1000 10000
linear
log−linear
Emax
Figure 10: Comparison of standard models in PD analysis.
5.2 Modelling with effect compartments
In many situations it is not enough to directly model the response as a function
of systemic concentrations in the PK model. This can happen if maximum effect
is delayed compared to the maximum concentration.
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This can numerically be handled by adding an additional compartment with
concentration Ce representing the near cell tissue. This is called an effect com-
partment and is assumed to have a negligible volume. There will thus not be
any mass transfer from the PK model. Furthermore a rate parameter govern-
ing the time delay from systemic concentration C1 to near cell concentration is
needed and for identifiability the same parameter is often used as elimination
from the effect compartment. The model for the effect compartment is
dCe/dt = ke1C1 − ke0Ce . (41)
The response from the drug is now modelled as a link from the effect com-
partment to the response. The link can be either a linear, log-linear, Michaelis-
Menten or an even more complex relationship.
The response functions is often extended with the use of subject specific
covariates as this can increase the accuracy of the model.
5.2.1 Case study: pain reliever continued
This example shows how a PD model can be build on top of a PK model to
model the effect after an oral dose of 1000mg paracetamol. The PK-model used
is the two-compartment model shown in Sec. 4.2.1. This is used in combination
with a first order absorption from the gut. The PK model is defined belown in
(42) to (44).
dCgut/dt = −KaCgut (42)
dC1/dt = −k12C1 + k21C2 − k10C1 + FKaCgut (43)
dC2/dt = k12C1 − k21C2 (44)
The PD model used in this example is taken from (Gibb and Anderson
2008). It uses an effect compartment with an Emax model to model the effect.
The effect compartment model is shown in (41) and is only a hypothetical
compartment to introduce a delay of effect. It does thus not influence the PK
model.
The compartment structure of the combined PK/PD model is shown in
Figure 11. The arrows for the effect compartment are shown with dashed lines
to indicate the there is no actual mass transfer.
The effect is measured on a visual analogue scale (VAS) from 0-10 where
reduction below 10 indicates pain relief. The Emax model for the effect is
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Figure 11: PK/PD model for paracetamol.
Effect = 10− EmaxCe
EC50 + Ce
with Emax = 5.17 and EC50 = 9.98mg/L. The rate constants for the effect
compartment are ke0 = ke1 = 0.83h−1 giving a half-life of 50 min. A simulation
of the combined PK/PD model is shown in Figure 12.
By looking at the model for the effect in Figure 12(b) it can be seen that
pain relief following a 1000mg oral dose can be expected after 0.5-1 hour and it
seems to last around 6 hours or more. With the combined PK/PD model it is
now also possible to give estimates of the expected effect at e.g. half or double
dose without actually doing the experiment, although results from extrapolation
should always be treated with care.
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(b) Model of pain relief.
Figure 12: Illustration of PK/PD model for paracetamol.
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6 Modelling data
To work with real life data a model of a system must be able to handle noisy
observations. The models discussed until now has only been concerned with
relatively simple deterministic relationships, but real systems naturally contain
much more variation than suggested by these simple models. The remaining
part of the text will focus on how to extend these models to include a model for
the different types of variation found in data. The aim is to enable the use of
a reliable statistical framework for consistent inference, simulation, prediction
and control by providing a proper description of the variation into the model.
The variation found in data can be caused by a number of sources. The main
sources include ordinary measurement variation and variation due to difference
between individuals, sites, occasions, etc. There may also be stochastic fluctua-
tions of the system within an individual or approximations in the applied model,
which will also lead to variation in data that must be accounted for. Further
more, the model for an individual may depend on an input process (e.g. room
temperature) which is sampled continuously together with the response. Mea-
surements of this process is normally assumed to be done without measurement
error, but if this is not true it will also lead to variation in the data that must
be included in the model.
This section will discuss how to handle all of these different sources of vari-
ation.
6.1 Single individual
The structure of data for a single individual is
yj , j = 1...n (45)
where yj is a possibly multi-dimensional response. The sub-index is short hand
notation referring to the sampling times t0 < tj < tn.
6.1.1 Error model using ODEs
Modelling of PK for single individuals has traditionally been based on ordinary
differential equations (ODEs) as for example done in a classical tool like NON-
MEM (Beal and Sheiner 2004). The observed deviations from the deterministic
part of this model is treated as measurement error, which implies that the in-
dividual is assumed to follow the model exactly, or stated differently that the
model represents the true state of the individual. This class of models can be
stated as a state space model, which is written as
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dxt = f(xt,ut, t,φ)dt (46)
yj = h(xj ,uj , tj ,φ) + ej (47)
where xt is the state (vector) in the model and the model for the state is given
by (46). The parameters in the model are denoted φ, and ut is a vector of input
variables to the system. The second equation (47) in the state space model is
the measurement equation defining how the states are observed. In this case an
additive error model is chosen, but this is only one of several choices. Both the
measurement and state equation can be multi-dimensional.
The states can represent amounts, concentrations, time-varying parameters
or other dynamic parts of a system described by a state space model. At any
point in time the state vector contains all the information about the future
which is known as the Markovian property. The input variables ut is a process
influencing the system and it is observed only at measurement time points and
is often assumed constant in between (known as zero order hold). A typical
input variable could be e.g. body temperature or room temperature that may
affect the system. The input process is assumed to be known exactly and as a
consequence future values of the states in a deterministic model can be predicted
without uncertainty by solving the ODE.
In the following a one-compartment ODE model for an intravenous bolus
dose will be used as an example. The model is described by
dxt = −kxt dt (48)
which is also shown in (3). Here xt represents concentration in the central
compartment and k is the elimination rate constant.
Traditionally there are four main types of error models for the measurement
equation called additive, multiplicative, additive and multiplicative, and log-
normal error. The four error models are shown in (49), (50), (51) and (52)
respectively, where ej , ej,1 and ej,2 are Normal IID random variables. In Figure
13 the error models are illustrated graphically.
yj = xj + ej (49)
yj = xj · (1 + ej) (50)
yj = xj · (1 + ej,1) + ej,2 (51)
yj = xj · exp(ej) (52)
The optimal choice of measurement error model is very dependent on the
data. The additive error model (49) is the simplest but may not always be
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(d) Log-normal noise, Eq. 52.
Figure 13: Error models illustrated with 95% prediction intervals around the
model mean for an intravenous bolus dose.
appropriate. Measurements of concentrations are usually more uncertain for
higher values, and this is not included in the additive model. However, if the
measured concentrations only range over a small interval, the additive model
may still be reasonable. When simulating from a model with concentrations
close to zero the additive model will easily give negative values, see Figure
13(a), and this is often problematic.
The multiplicative error model (50) takes the increasing uncertainty for
higher values into account. In this model the standard deviation of the residu-
als increases proportionally to the mean of the model. The model can still give
negative values in simulations, but it is far less likely than with the additive
model. In some cases it is appropriate to use a combination of the additive and
multiplicative model, as specified in (51). The model still has increasing residual
standard deviation with the mean but also allows for a larger uncertainty for
smaller values.
The last error model shown in Figure 13 is the log-normal error model (52).
This model resembles the multiplicative model as can be seen by comparing
Figure 13(b) and 13(d). Being log-normal the residual distribution is asymmet-
ric and bounded away from zero, which is an advantage for simulation as it will
only give positive values. However, the distribution does not include 0, and
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this is a problem if the observed data has such measurements. The log-normal
error model can be achieved with an additive error structure by using a log-
transformation of the observations, i.e. log yj = µ∗ + ej where µ∗ = logµ. An
effect of this is that if the model for µ∗ is additive then the resulting model for
µ will be multiplicative since µ = exp(µ∗).
6.1.2 Error model using SDEs
In most cases it is not reasonable to assume that the variation in time of the
concentration for an individual follows the model exactly as it is assumed using
an ODE model. As mentioned earlier there may also be some variation due to
incorrect model specification, true random biological variation or uncertainty
from measuring an input process which cannot be explained or included in
the ODE model. A way to describe such sources of errors is to base the state
space model on stochastic differential equations (SDEs) instead of ODEs. This
is called a stochastic state space model and is defined as
dxt = f(xt,ut, t,φi)dt+ σω(ut, t,φi)dωt (53)
yj = h(xj ,uj , tj ,φi) + ej . (54)
The stochastic differential equation in (53) is based on the Standard Wiener
process ωt (Øksendal 1992). This process is characterized by ω0 = 0, it is almost
surely continuous and it has independent normal increments with ωt − ωs ∼
N(0, t− s) for 0 ≤ s < t. The Wiener process can be seen as a process that has
the properties expected from the limit of a discrete random walk
∑t/∆t
i=1 ei with
ei ∼ N(0,∆t) for ∆t→ 0.
Using the Wiener process the simple one-compartment elimination model in
(48) can be extended to a model based on SDEs by writing
dxt = −kxt dt+ σωdωt . (55)
The term dωt is an infinitesimal increment of the Wiener process and the
model can thus in simple terms be described as an ordinary differential equation
where the evolution in time is perturbed by normal distributed noise. The
solution to (55) is
xt = x0e−kt +
∫ t
0
σωe
−k(t−s)dωs (56)
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which can be seen to be the ODE solution plus the integral of Wiener process
increments with exponential weights. The process is known as an Ornstein-
Uhlenbeck process with zero mean. A simulation of the process is shown in
Figure 14.
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Figure 14: Simulation of simple one-compartment SDE model (55).
There are a few problems with the model proposed in (55). There is nothing
limiting the concentration from increasing when the increments of the Wiener
process are positive. This should normally not happen in the real world as this
would require a reverse elimination process. Moreover the model will fluctuate
around zero when the initial dose has been eliminated, and the model will thus
predict negative concentrations. In fact it can be shown that the unconditional
distribution of xt is normal with mean zero which is not suitable in a model for
concentrations.
A more realistic model can be achieved by adding noise to the elimination
rate constant k instead of directly to the concentration. A good first choice is to
model kt as an Ornstein-Uhlenbeck process with a non-zero mean k¯. However,
the elimination rate should never be negative, so the elimination rate used will
be k2t . The model is given by
dxt = −k2t xt dt (57)
dkt = −γ(kt − k¯)dt+
√
2σ2ωγdωt . (58)
It can be shown that the unconditional distribution of kt is normal with mean
E[kt] = k¯ and that kt has the autocorrelation function Ckt(t) = σ
2
ω exp(−γt).
Thus the elimination rate (k2t ) will be χ
2-distributed with mean E[k2t ] = k¯
2+σ2ω.
In Figure 15 a simulation of the model is shown. Since the elimination rate in
Figure 15(b) is always non-negative, the concentration curve will be monotonely
decreasing towards zero as would be expected in real life.
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Figure 15: Simulation of an extended one-compartment SDE model that fulfills
some basic physiological constraints.
6.1.3 Case study: Advantages of using SDEs
In order to illustrate the advantages of modelling using SDEs a small simulation
study will be performed.
It is assumed that the drug of interest is eliminated based on the model
in (57) and (58). That is, the concentration is assumed to follow a first order
elimination with an elimination rate that varies in a non-deterministic way. The
optimal model is thus naturally the SDE model that generates the data, since
the non-deterministic variations of the elimination rate cannot be modelled any
further. However, the example will focus on illustrating the errors that are
introduced if the data is modelled using the simple ODE model shown in (48).
The residual error will be assumed to be independently log-normally distributed
as defined in (52). Combining this the state space model used for generating
data contains two states and one response variable and is thus given by
dxt = −k2t xt dt (59)
dkt = −γ(kt − k¯)dt+
√
2σ2ωγdωt (60)
log yj = log xj + ej (61)
which will in short be denoted the SDE model. The parameters used for the
simulation are k¯ = 0.05, γ = 0.40 and σω = 0.15, which gives an expected
elimination rate of E[k2t ] = 0.025 min
−1 and an expected half-life of 28 minutes.
The measurement variation is ej ∼ N(0, S) where S = 0.202. Dose is 100mg
and volume of distribution is 10L giving an initial concentration of 100mg/L.
The individual is sampled with 5 minute intervals up to 100 minutes giving 21
observations. The simulated data is shown in Figure 16(a).
The data is modeled both using the original SDE model and an ODE model
where the stochastic part is removed. The ODE model is thus a standard one-
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compartment model with first order elimination. The ODE model is defined
as
dxt = −kxt dt (62)
log yj = log xj + ej (63)
which is equivalent to the SDE model with σω = 0. Both the ODE model and
SDE models are fitted using the maximum likelihood method, where the like-
lihood function is evaluated using the Kalman Filter. The estimation method
is explained in more detail in Section 6.3. The estimate of the two states (con-
centration and elimination rate) in the SDE model can be found based on the
estimated parameters using the so-called Kalman smoothing estimate. The re-
sults of the two model fits as given by the estimated concentration profiles are
shown in Figure 16(b) and 16(c).
In order to judge the model fits the residuals for the ODE and SDE models
are shown in Figure 16(d) and 16(e) and the auto-correlation functions for the
residuals are shown in Figure 16(f) and 16(g).
The first obvious observation of the difference between the fits is that the
simple ODE model cannot capture the time varying elimination rate which gives
rise to persistence in time of the residuals. This is not the case for the SDE
model, which assumes a stochastic elimination rate and estimates it based on
the model and data. The result is that the residuals are uncorrelated in time
for SDE model whereas they are strongly auto-correlated for the ODE model.
This in effect falsifies the ODE model in this case, as both models are based on
an assumption of uncorrelated measurement error.
The problem is also apparent from the parameter estimates them selves. The
estimates of the measurement variation in the two models are SˆODE = 0.392
and SˆSDE = 0.222 which should be compared to the true value of S = 0.202.
This shows that the time variation of the elimination rate has been included in
the measurement error in the ODE model, since this is the only place it allows
variation to enter, and hence a wrong interpretation of the measurement error
is provided by the ODE model.
It is of interest to see if the estimate in the SDE model of the time varying
behavior of the elimination rate (k2t ) is accurate. Figure 17 shows the outcome
of the elimination rate process from the simulation compared to the Kalman
smoothing estimate from the SDE model and also the constant estimate from
the ODE model. Generally it appears that the Kalman smoothing estimate is
fairly close to the true elimination rate, but the accuracy will naturally always be
dependent on the kind of measurement noise, sampling rate and appropriateness
of the assumed model.
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Figure 16: Comparison of fitted ODE and SDE models.
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Figure 17: Comparison of estimated elimination rates.
6.1.4 Discussion of SDEs
The previous example in Section 6.1.3 has illustrated some of the issues that
arise in a case where an ODE model provides an insufficient error structure.
The estimate of the measurement variation was seen to be to high since it also
included the stochastic variation of the system, and it resulted in auto-correlated
residuals. Such situations calls for the use of an SDE model. In other situations
an SDE model may be justified by a need to capture variation in the states
introduced by actual stochastic behavior or a too simple deterministic part of a
model or by variation caused by measurement error from the input process.
For estimation in the previous example both models were used in a maximum
likelihood frame work. From a likelihood perspective, the failure of the ODE
model occurs since it is not able to give a sufficient description of the ’true’
likelihood function. Such an error cannot be ignored, as it in turn will invalidate
e.g. likelihood ratio tests for model reduction and other classical statistical tests
that may be used.
In many ways modeling using SDEs seems like an intuitive choice, since it
facilitates a way to include dynamic biological variation in the model. Often
however, the need for an SDE model is hidden by a sparse sampling scheme with
few and distant observations, since it can be hard to detect residual autocorre-
lation in these situations. This may however change in the future with increas-
ing use of modern frequent-sampling equipment within many areas, which very
likely will reveal residual auto-correlation when using standard ODE models.
An example has been shown by Overgaard et al. (2007) using a PK/PD
model of effects on thermo-regulation in monkeys. In this case an ODE model
is shown to be insufficient, and only a model based on SDEs is able to provide
a proper description of the error structure. Due to this the SDE model is able
to give realistic simulations and predictions as opposed to the ODE model.
Generally, in cases where the model should also be used for control purposes it
is important that the model has realistic prediction properties. An example of
an application for control of a biological system could be a model for controlling
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the insulin secretion rate in diabetic patients.
Another application of SDEs in modelling biological systems is to use it as
a tool for model development. In this context SDEs can be used as a tool to
extract information from data about the appropriate model in situations with a
complex underlying deterministic model structure. In Kristensen et al. (2005)
a framework is presented for using an SDE model to allow tracking of time
variations of parameters to reveal new functional relationships. Although this
use aims at improving the deterministic part of a model, it may still result
a final model based on SDEs if all stochastic components cannot replaced by
deterministic relationships.
6.2 Multiple individuals
A typical data set for PK/PD modelling consists of data from several individuals
who all have been exposed to a similar trial. The previous section has been
concerned with modelling a single individual, but it is natural to include all
individuals in the same model.
A mixed-effects model allows this by assuming the same model for each
individual and by further assuming that the parameters in this model can vary
between individuals. The general structure for data in a mixed-effects model is
yij , i = 1, ..., N, j = 1, ..., ni (64)
which is an extension of the data structure in (45). The response yij is a vector
of measurements at time tij for individual i, N is the number of individuals and
ni is the number of measurements for individual i.
In a mixed-effects model the variation is split into intra-individual variation
and inter-individual variation, which is modelled by a first and second stage
model. The first stage model is the (stochastic) state space model and the
second stage model is given by
φi = g(θ,ηi,Zi) (65)
where φi are the individual parameters for the first stage model. The random
effects ηi have the distribution ηi ∼ N(0,Ω), θ are the fixed effects (also called
population parameters) and Zi are possible covariates. The second stage model
will often look like φ = θ+η or φ = θ ·exp η giving either a normal or log-normal
distribution of parameters between individuals.
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6.3 Estimation
Parameter estimation in the mixed effects model is most often facilitated by the
maximum likelihood method. The population likelihood function is based on
the distribution functions for the first and second stage models denoted p1 and
p2, respectively. The distribution function for the second stage model is simply
the normal distribution. For the first stage model based on the stochastic state
space model the likelihood function can be evaluated by using the Kalman filter
(Overgaard et al. 2005). The population likelihood function for the fixed effects
are found by integration over the random effects. This is given as
L(θ) =
N∏
i=1
∫
p1(Yini |θ,ηi)p2(ηi|Ω)dηi =
N∏
i=1
∫
exp(li)dηi (66)
where Yini are all observations for individual i and li is the a posteriori log-
likelihood function for the ith individual. The population likelihood function
in (66) can not be evaluated analytically, and therefore li is approximated by a
second-order Taylor expansion, where the expansion is made around the value
η∗i that maximizes li(ηi) in the value l
∗
i . At this optimum the first derivative
∇li
∣∣
η∗i
= 0 and the population likelihood function therefore reduces to
L(θ) ≈
N∏
i=1
∣∣∣∣−∆l∗i2pi
∣∣∣∣− 12 exp(l∗i ) (67)
as shown in Appendix A. The approximation of the 2nd derivative at the
optimum∆l∗i is obtained using the First-Order Conditional Estimation (FOCE)
method, which is defined as
∆l∗i ≈ −
ni∑
j=1
(
∇TijR−1i(j|j−1)∇ij
)
−Ω−1 , ∇ij = ∂
∂ηi
ij
∣∣∣
η∗i
.
In cases where the fist stage model is non-linear as in the state space model
in (53) and (54) the combined model is called a non-linear mixed effects model.
When working with SDEs there are only a few software tools available that are
able to estimate parameters in this class of models. These tools are listed below.
6.3.1 NONMEM
NONMEM is a software package developed at University of California, San
Francisco (UCSF) for use in population PK/PD modelling (Beal and Sheiner
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2004). It first appeared in 1979 and its name is an acronym for non-linear
mixed effects modeling. NONMEM has become the defacto standard software
tool used for PK/PD modelling as it is a very flexible tool and well tested
throughout many years of development. NONMEM is however only intended
for modelling based on ODEs but it is possible to make it estimate models based
on SDEs as shown by Tornøe et al. (2005). This is basically done by including
the Kalman filter into the model definition, but the Kalman filter has to be
derived and implemented for every new model that is created, and it is thus
cumbersome to work with and only feasible for simple models.
6.3.2 CTSM
CTSM is a program for performing estimation of state space models based on
SDEs (Kristensen and Madsen 2003, Kristensen et al. 2004). The program is
intended for single subject modelling but also handles multiple subjects based
on a pooled likelihood without random effects. It has been developed at DTU
Informatics. CTSM has previously been used for PK/PD modelling using SDEs
in e.g. Tornøe et al. (2004a, 2004b) and Kristensen et al. (2005).
6.3.3 PSM
PSM in an acronym for Population Stochastic Modelling and is a software pack-
age developed at DTU Informatics (Mortensen et al. 2007, Klim et al. 2008). It
is like NONMEM aimed at non-linear mixed effects modelling but it is focused
on modelling using SDEs and as opposed to NONMEM it also directly handles
a multivariate response. PSM supports a typical PK data structure with dosing
information, co-variates and also missing observations. PSM is freely available
as an extension package for R, which is a free software environment for statis-
tical computing. Instructions for download and installation in R can found at
http://www.imm.dtu.dk/psm.
Appendix
A NLME log-likelihood function
The Non-linear mixed effects likelihood function is defined as
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L(θ|YNni) =
N∏
i=1
∫
p1(Yini |θ,ηi)p2(ηi|Ω)dηi (68)
=
N∏
i=1
∫
Li(ηi)dηi (69)
where Li is the individual a posteriori likelihood function. In most cases the
integral cannot be evaluated analytically. For a general evaluation the individual
a posteriori likelihood function can be approximated by a second order Taylor
series expansion of log(Li) around the value η∗i which maximizes log(Li(ηi)).
Also li = log(Li), L∗i = exp(l
∗
i ) = Li(η
∗
i ), ∇l∗i = ∂∂ηi li
∣∣∣
η∗i
, ∆l∗i =
∂2
∂ηi∂η
T
i
li
∣∣∣
η∗i
.
It follows that
li(ηi) ≈ l∗i +∇l∗Ti (ηi − η∗i ) +
1
2
(ηi − η∗i )T∆l∗i (ηi − η∗i ) (70)
≈ l∗i +
1
2
(ηi − η∗i )T∆l∗i (ηi − η∗i ) (71)
Li(ηi) ≈ L∗i exp
(
−1
2
(ηi − η∗i )T (−∆l∗i )(ηi − η∗i )
)
(72)
since ∇li = 0 at η∗i . Based on the approximation the integral can now be
evaluated by moving constants such that the integral is over a Gaussian density
with mean η∗i and co-variance (−∆l∗i )−1 . The result is
∫
Li(ηi)dηi ≈
∫
L∗i exp
(
−1
2
(ηi − η∗i )T (−∆l∗i )(ηi − η∗i )
)
dηi (73)
≈ L∗i
∣∣∣∣ 2pi−∆l∗i
∣∣∣∣ 12 ∫ ∣∣∣∣ 2pi−∆l∗i
∣∣∣∣− 12 exp(−12(ηi − η∗i )T (−∆l∗i )(ηi − η∗i )
)
dηi
≈ L∗i
∣∣∣∣ 2pi−∆l∗i
∣∣∣∣ 12 (74)
≈ L∗i
∣∣∣∣−∆l∗i2pi
∣∣∣∣− 12 (75)
where the step in Eq. (75) is taken to avoid a matrix inversion of the Hessian.
The NLME log-likelihood function can now be approximated by
L(θ|YNni) ≈
N∏
i=1
L∗i
∣∣∣∣−∆l∗i2pi
∣∣∣∣− 12 . (76)
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noise and not for system noise. Extending to SDEs allows for a Wiener noise component in
the system equations. This additional noise component enables handling of autocorrelated
residuals originating from natural variation or systematic model error. Autocorrelated resid-
uals are often partly ignored in PK/PD modelling although violating the hypothesis for many
standard statistical tests.
This article presents a package for the statistical program R that is able to handle SDEs in
a mixed-effects setting. The estimation method implemented is the FOCE1 approximation
to the population likelihood which is generated from the individual likelihoods that are
approximated using the Extended Kalman Filter’s one-step predictions.
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1. Introduction
The use of mixed-effects models based on ordinary differ-
ential equations (ODEs) is the standard for pharmacokinetic
and pharmacodynamic (PK/PD) modelling. The use of stochas-
tic differential equations (SDEs) is an emerging ﬁeld and has
been introduced and motivated in the papers [1–4]. This paper
presents an accessible software package for handling dynamic
models based on SDEs in a mixed-effects setting. The program
is a package for the statistical program R and thereby easy to
install through R’s interface and available for a wide range of
operating systems.
The package implements the (Extended) Kalman Filter for
evaluating the likelihood function in models based on SDEs.
The parameter estimation procedure in the package is maxi-
mum likelihood based with ﬁxed effects estimation based on
the FOCE approximation.
2. Computational methods and theory
The most widely used program to analyze state-space mod-
els in PK/PD-modelling is NONMEM [5], which is focused on
mixed-effects models based on ordinary differential equa-
tions. The use of SDEs in non-linear mixed-effects models
is possible in NONMEM as described in [2]. The trick is an
implementation of the Extended Kalman Filter in the NON-
MEM control ﬁle with corresponding adjustments to the data
ﬁle. This is a non-trivial task even for rather simple models
and must be repeated for every change in model or data. Sin-
gle subject data can be modelled with stochastic differential
equations in the program CTSM [6]. CTSM is a stand alone
program that works across different platforms.
The matlab framework described in [7] handles SDEs in a
mixed-effect setting. The experiences collected in the devel-
opment of theMatlab frameworkhavenowbeenused to create
an extended and more ﬂexible R-package PSM.
The mathematical basis for the PSM package is also
described in the articles [3,7,8]. It should be noted that there
are notation differences between the articles.
For simplicity this article focuses on the class of linearmod-
els but it must be emphasised that the package also handles
non-linear models.
2.1. Single subject
The modelling of observations for a single subject is based on
a continuous-discrete state-space model. The states represent
the internal hidden states of the system. The states reside in a
continuous time domain and their dynamics are described by
stochastic differential equations. The observations are sam-
pled at discrete time points and hence described by a discrete
time relation.
The class of linear models handled by PSM are time-
invariantmodelsmeaning that systemmatrices donot change
over time. More speciﬁcally the linear state-space model can
be stated as
dxt = (A(i)xt + B(i)ut) dt + (i)dωt (1)
yik = C(i)xik + D(i)uik + eik (2)
where xt ∈RdimX is the vector of states at time t. The dimen-
sion of x is denoted as dimX for simplicity. A, B, C and D are
time-invariant matrices deﬁned as functions of i with prop-
erties A(·)∈RdimX×dimX, B(·)∈RdimX×dimU, C(·)∈RdimY×dimX and
D(·)∈RdimY×dimU. i is the parameter vector for the ith indi-
vidual (see Eq. (9) for further details). The exogenous input
u∈RdimU can be used to include other measured variables
which inﬂuence the time evolution of the states in the model.
The input u is assumed to be constant between observation
points which is often refered to as zero-order hold or piece
wise constant. The component (i)dωt is the system noise
consisting of a scaling diffusion term (·)∈RdimX×dimX and ωt
which is a dimX-dimensional Wiener process. The subscript
i denotes the ith subject and the subscript k is a short hand
notation for tk. yik is the observation at time tk for the ith sub-
ject. eik is the residual for individual i at time tk and is assumed
to normal distributed N(0,S(i)) with S(·)∈RdimY×dimY being the
covariance matrix for the errors.
2.2. Kalman Filter
The deterministic behaviour of ordinary differential equations
can be handled with standard differential equation solvers.
The additional component in the SDE systems requires a more
advanced solution method. As mentioned in the introduction
this package uses the Kalman Filter as solution method for
systems of SDEs.
TheKalmanFilter is only brieﬂy explained in this article but
the mathematics behind the Kalman Filter is well described in
the Mathematics guide to CTSM [6] and in the original refer-
ence [9]. Several links and additional material can be found on
the homepage [10].
The assumptions on system noise being driven by a Wiener
process and normally distributed errors will in a linear system
under some regularity conditions [6] result in the conditional
densities for the observations being fully described by their
ﬁrst- and second-order moments. The Kalman Filter can be
used to determine the optimal internal states in the system
conditioning on prior observations. The Kalman Filter updates
the internal state vector after each observation andduring this
process the Kalman Filter needs to weigh the probability of
the residual being due to system noise or measurement noise.
For this purpose the one-step prediction yˆk|k−1 and associated
covariance Rk|k−1 are deﬁned below:
yˆk|k−1 = E[yk|Yk−1,i] (3)
Rk|k−1 = V[yk|Yk−1,i] (4)
where Yk−1 denotes all measurements up to time tk−1.
The description of conditional densities based on ﬁrst- and
second-order moments is only exact for linear models. For
nonlinear models the Extended Kalman Filter can be used
which is based on continous linerazations of the model how-
ever the forming of the conditional densitites will only be
approximate.
The structure of the Kalman Filter is thus an iterative
process with a prediction/updating scheme. The one-step
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Table 1 – The Kalman Filter written in algorithmic form.
Copied from [11].
Algorithm: The Kalman Filter
Given parameters and initial prediction
i, xˆ1|0 and P1|0
For k=1 to ni do
Output Prediction:
yˆk|k−1 = Cxˆk|k−1 + Duk
Rk|k−1 = C Pk|k−1CT + S
State Update:
Kk = Pk|k−1CTR−1k|k−1
xˆk|k = xˆk|k−1 + Kk(yk − yˆk|k−1)
Pk|k = Pk|k−1 − KkRk|k−1KTk
State Prediction:
dxˆt|k/dt = Axˆt|k + But
dPt|k/dt = AtPt|k + Pt|kAT + T
end for
prediction will be based on the deterministic part of the
model as the Wiener component has mean zero. The mea-
sured observation should be considered as a result of the
current states including accumulated system noise since last
observation and current observation noise. An updating of the
internal states based on the residual is weigthed according to
system noise and measurement noise. The iterative structure
restarts with a prediction based on the updated states.
The initial conditions for the Kalman Filter are the initial
states xˆ1|0 and initial state covariance matrix Pˆ1|0. Optimally
the initial conditions and uncertainties are known a priori but
generally none or only the initial state is known. The initial
states can be either speciﬁed directly or estimated simulta-
neously with the remaining parameters. As the uncertainty is
rarely known the package assumes that the initial state uncer-
tainty is equal to the integral of the Wiener noise over a time
interval equal to the interval between the ﬁrst two observa-
tions.
P0 = Ps
∫ t1
t0
eAsT(eAs)
T
ds (5)
where Ps is a scaling factor. One solution method for the inte-
gral (5) is shown in [6].
In Table 1 the iterative structure of the Kalman Filter is
shown in algorithmic form.
The Kalman Filter setup requires a speciﬁc model structure
as shown in Eqs. (1) and (2). Two requirements that should be
noted are the additive noise in the observations and the state
independent Wiener component. The Kalman Filter cannot
handle a multiplicative or full error model in Eq. (2). Using
a log transformation of the observations a log normal error
model can however be dealt with. The limitation with state
independent Wiener component can only be surpassed by
transformation of the system equations or by introducing
more sophisticated methods such as higher order ﬁlters or
Markov Chain Monte Carlo methods.
The residual used in the likelihood function is deﬁned as
k = yk − yˆk|k−1 (6)
The likelihood of the parameters i based on data can be
calculated using the assumption of normality combined with
the conditional covariance which is calculated in the Kalman
Filter.
L(i;Y) =
(
ni∏
k=1
exp(−(1/2)T
k
R−1
k|k−1k)√
det(Rk|k−1)(
√
2)
dimY
)
p(y0|i) (7)
The negative log likelihood can be derived from Eq. (7)
by conditioning on the initial condition y0. The negative log-
likelihood is the objective function used in the parameter
estimation in the Kalman Filter.
− ln(L(i;Y|y0)) =
1
2
ni∑
k=1
(ln(det(Rk|k−1)) + Tk R−1k|k−1k)
+ 1
2
(
ni∑
k=1
dimY
)
ln(2) (8)
2.3. Mixed-effects
The use of non-linear mixed effects models in PK/PD mod-
elling has long been the standard and has been supported
by the functionality in NONMEM. The mixed-effects approach
to model variation in pharmacokinetics was ﬁrst introduced
by Sheiner in [12]. Mixed-effects modelling is a hierarchical
division of the variation, where the ﬁxed effects describe the
population mean and the random effects describe the inter-
individual variation. This is often described in two stages.
The ﬁrst stage model describes the intra-individual vari-
ability and the second stage describes the inter-individual
variation.
The ﬁrst stage model is described in Eqs. (1) and (2) which
are based on the individual parameters. The inter-individual
variation in parameters is covered in the creation of the indi-
vidual parameters in the function h(·) described below:
i = h(, i,Zi) (9)
where  are the ﬁxed effects—also sometimes referred to
as the population parameters. Zi denotes subject covariates
and i ∈N(0,˝) are the random effects. The individual param-
eters can be modelled as either normally or log-normally
distributed by combining the population parameters and the
random effects in either an additive (i =  + i) or an expo-
nential transform (i =  exp(i)).
The likelihood function for the ﬁxed effects can be stated
as below:
L() =
N∏
i=1
∫
p1(Yi|, i)p2(i|˝) di =
N∏
i=1
∫
exp(li) di (10)
where N is the number of subjects. p1(Yi|, i) is the probability
for theﬁrst stagemodelwhich is proportional to Eq. (7). p2(i|˝)
is the probability related to the second stagemodel that relates
the random effects to the inter-individual variation. li is the a
posteriori log-likelihood function for the ith individual. Yi is the
complete sequence of observations for individual i. The pop-
ulation likelihood function in Eq. (10) rarely has a closed form
solution and therefore li is approximated by a second-order
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Taylor expansion, where the expansion is made around the
value ˆi that maximizes li. At this optimum the ﬁrst derivative
∇li|ˆi = 0 and the population likelihood function will under
some assumptions reduce to
L() ≈
N∏
i=1
∣∣∣−li2 ∣∣∣−(1/2) exp(li)| ˆi (11)
The approximation of the 2nd derivative li is done using
the First-Order Conditional Estimation (FOCE) method, which
is deﬁned as
l∗i ≈ −
ni∑
j=1
(∇TijR−1i(j|j−1)∇ij) − ˝−1, where ∇ij =
∂
∂i
ij|∗
i
(12)
When the random effects have a non-linear inﬂuence on
the likelihood through the ﬁrst stage model, the combined
model is called a non-linear mixed effects model.
The conditional residual covariance R−1
i(j|j−1) is calculated in
the (Extended) Kalman Filter and the gradient in the residual
with relation to the random effects ∇ij is typically found by
numerical methods.
2.4. Maximum likelihood estimation
The population likelihood function in (11) is used in max-
imum likelihood estimation of the population parameters.
This optimization becomes a nested optimization as the FOCE
approximation is based on the optimal random effects (∗
i
).
Each calculation of the population likelihood thus requires N
optimizations of the random effects. This nested optimization
makes the computational effort substantial and highly depen-
dent on the number of subjects, number of observations and
the number of ﬁxed and random effects. The optimization
in the PSM package is performed with the default optimizer
(optim) which is a quasi-Newton based optimizer.
The optimization can be constrained using boundaries
on the population parameters using a logit-transform. It
is assumed that the optimizer works on a unconstrained
parameter space so the logit transform maps the bounded
parameters into anunbounded space. In order to avoidﬂat gra-
dients in population parameters in the outer parts of the logit
transform a penalty function has been added. The penalty
function is deﬁned as below:
P(, , min, max) = 
⎛⎝ p∑
j=1
|min
j
|
j − minj
+
p∑
j=1
|max
j
|
max
j
− j
⎞⎠ (13)
where p is the number of parameters and min
j
and max
j
denotes the lower and upper limit for the jth parameter.
The computational effort in the parameter estimation can
as already mentioned be substantial and it is advised to ﬁnd
good initial estimates for the parameters in advance.
3. Program description
The framework for handling mixed-effects models based on
SDEs has previously been implemented in Matlab [7]. The R
package PSM presented here is a ported and extended ver-
sion. The switch in platform was motivated by R being an open
source program and its availability on different platforms. The
PSM package was extended from the Matlab framework by
extending the ﬂexibility, improving performance by low level
implementations and enabling capabilities for bolus doses.
The dosing capability is crucial for modelling in drug devel-
opment.
The package is able to handle multivariate observations,
which are useful when performing simultaneous ﬁts of mul-
tivariate data such as insulin and glucose. Another feature is
that it is possible to have input into the model and include
subject covariates. Finally, the package handles missing obser-
vations.
The package is mainly implemented in the R-language
which is closely related to the S-language. Core components of
the code have been implemented in FORTRAN for faster com-
putation.
The current PSM version is 0.8-3. The package has depen-
dencies for three other R packages. MASS is used in the
simulation part to sample from the multivariate normal dis-
tribution. MASS is an integrated part of the R installation. The
package odesolve is used in the non-linear models to solve
systems of differential equations. The package numDeriv is
used to calculate the Hessian which is used in the calculations
of the conﬁdence intervals for the estimated parameters.
The PSM package is available as a standard R package.
Installation can be performed using the R interface or by exe-
cuting the command.
> install.packages(“PSM”)
The package comes with complete documentation and
“get-started” guide. The documentation can be found by exe-
cuting the command help(“PSM”). A more thorough guide to
the package and its usage can be obtained with the command
> vignette(“PSM”)
The package is divided into three parts according to func-
tionality. The three parts are
• Simulation
• Estimation
• Smoothing
Simulation is the creation of observations based on a given
model and model inputs. The Estimation part performs a
maximum likelihood estimation of the population parameters
based on the one-step predictions in the Kalman Filter. The
smoothing functionality creates the optimal state estimates
based on the entire data series and a set of parameters.
All three functions operate on a model object and a data
object. The following sections introduce the model and data
objects before going into detail with the three functions.
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Table 2 – Model speciﬁcation.
Functions Output
Matrices List with system matrices see Eq. (1)
X0 Matrix with initial state condition(s)
SIG Matrix with diffusion scaling term 
S Matrix with residual covariance
h Vector with individualized parameters i
ModelPar List with ﬁxed effects  and inter
individual variation ˝
3.1. Model speciﬁcation
The model speciﬁcation is divided into components corre-
sponding to the mathematical parts of the state-space model.
For the linear case the state-space model can be stated in
matrix form as seen in Eq. (1), but variance components and
initial conditions are also needed. Table 2 shows the compo-
nents in the model. The components are collected in a list to
have a single object that contains the model. The individual
components are all functions that return either a matrix or a
list, if multiple outputs are needed.
Fig. 1 shows the model speciﬁcation in a diagram with
mathematical references displayed. The sequence for these
components needs some elaboration. The ModelPar function
is used to split the vector of parameters to be optimized 	
into the ﬁxed effects vector  and the random effects covari-
ance matrix ˝. The individual parameters are created with the
h function that uses the ﬁxed effects, the random effects and
the subject covariates to create the i vector. The remaining
components in the dynamical system can be evaluated using
i and the system input u.
3.2. Data speciﬁcation
The data speciﬁcation in the simulation procedure is differ-
ent from the speciﬁcation in the parameter estimation and
smoothing. In the simulation part the observations are sim-
ulated based on the model. Time points for the observations
and potentially system input, doses or subject covariates still
need to be provided. The time points, system input, doses or
covariates are speciﬁed per subject in a list. Names in the list
need to be according to the PSM speciﬁcations as the refer-
Fig. 1 – Model components.
Table 3 – Data speciﬁcation.
PSMnotation Description
Time Vector with dose and observation times
Y Matrix with observations. Multivariate
observations in columns
U Matrix with input
Dose List with Time, Stateand Amount
covar Subject covariates
encing in the package is done with names. The naming of the
components can be seen in Table 3. The lists for all subjects are
ﬁnally collected in a list which makes the overall data object
a list of lists.
The observations are speciﬁed in the element Y which is
a matrix with dimensions [dimY, dimT]. dimT is the length of
the Time vector. As can be seen from the dimensions of Y,
multivariate observations are speciﬁed in columns. Missing
observations are indicated using the NA identiﬁer. Y can be
omitted if the data object is used in a simulation.
The Dose component contains the bolus doses informa-
tion. The elements used to describe a bolus dose are the time
of dosing, the amount dosed and the state in the model into
which the bolus is given. The Time vector in Dose contains the
times to which doses are given. It is important that the time
points in the Dose component is a subset of the overall Time
vector otherwise the dose will not be given. The dose is given
post-observation and prediction. This means that predictions
to observations at times where a bolus dose is also given
are formed prior to the “injection” of the dose. The elements
State and Amount speciﬁes in which compartment/state the
dose shouldbe givenandwhat amount is given.Multiple doses
are allowed at the same time point. Infusions can be speciﬁed
using the input element u. The covar element contains the
subject covariates (Zi in Eq. (9)) and can be an array or list
however the choice should be consistent with the referencing
in the hfunction in Table 2.
3.3. Package functionality
Each of the three previously mentioned functionality parts is
enclosed in a single function. The three functionality parts
with corresponding functions are described in detail in the
following sections.
3.3.1. Simulation
The function PSM.simulate performs the simulation of the
system using an Euler based scheme. The simulation also
includes inter-individual variation if the ˝ matrix is speciﬁed.
The stochastic noise term in the system equation is included
by perturbing the states after each Euler step. The size of the
pertubation is found by randomly sampling from a multivari-
ate normal distribution with covariance proportional to the
time step scaled with the diffusion scaling term. The default
time step in the Euler scheme is 0.1 unless speciﬁed differ-
ently. It is upon the user to ensure that the observation times
are a multiple of the time step.
The function arguments to PSM.simulate are as follows:
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Table 4 – Simulation output.
Element Type
Time Vector
X Matrix with the simulated states
Y Matrix with the simulated observations
U Matrix with the input used in the
simulation
Dose Dose list used in the simulation
eta Matrix with the random effects used in
the simulation
longX Matrix with states at all sub-sampled
timepoints
longY Matrix with observations at all
sub-sampled timepoints
PSM.simulate(Model, Data, THETA, deltaTime,
longX)
where Model and Data are lists as described in previous
sections. Any observations in Data are disregarded as the sim-
ulation returns a set of observations Y. THETA is a vector with
the population parameters to be used. deltaTime is the time
step in the Euler scheme and the longX option is used to indi-
cate whether the output should include all generated data at
all sub-sampled time points or only return observations at
prespeciﬁed time points.
The output from the simulation function is a list of lists
where each underlying list contains the data for one subject.
The list contains the elements shown in Table 4.
3.3.2. Estimation
The function PSM.estimate performs maximum likelihood
estimation for the population parameters in the model. The
objective function for the optimization is the negative log
likelihood as deﬁned in Eq. (11). The function calculates the
numerical gradients and determines the optimal random
effects needed in optimization of the likelihood function.
Functionality has been included to allow for constrained
optimization using the logit transformation. A logit parame-
ter transformation is used to convert the bounded parameters
to unbounded parameters. In order to stabilize the opti-
mization with boundaries a penalty function has also been
included. The penalty increases as the parameter estimate
approaches the boundary. The penalty function is introduced
to ensure that the optimization will not get trapped in the ﬂat
regions of the logit transformation. For very large values in
the unbounded parameter domain the transformed param-
eter will be close to the upper boundary. This also means
that changing an extreme value in the unbounded parameter
domain will hardly change the bounded parameter estimate.
The optimizer stops when a change in the unbounded param-
eters does not change the likelihood function. The penalty
function stabilizes this problem.
The currently used optimizer does not allow for NaN to be
returned from the likelihood function. The search path for the
optimization can lead to parameter values that generate NaN
resulting in the search failing. This problem can be solved by
using tighter boundaries and restarting the optimization with
new boundaries in the recently found parameter values.
The parameter estimation based on the likelihood function
consists of nested optimizations which makes the likelihood
function highly nonlinear in parameters. The optimizer does
not guaranty that the found minimum is the global minimum
so the user should be aware of local minima and the impor-
tance of initial parameter values in the optimization. The user
should preferably start the minimization in different initial
parameter values to eliminate the risk of using parameter
estimates from a local minimum in the modelling onwards.
To evaluate the quality of the parameter estimates the
related uncertainties can be calculated. The uncertainties
are based on the Hessian of the likelihood function. The
parameter conﬁdence bands are returned from the estima-
tion procedure by setting the argument CI=TRUE. The Hessian
is calculated using the numDeriv package.
The argument list for the estimation can be seen below:
PSM.estimate(Model, Data, Par, CI, trace, con-
trol, fast)
where the Model and Data are as previously described. Par
is a list containing the initial parameter value in Init and
optionally the upper and lower boundaries in UB and LB. CI
speciﬁes if the conﬁdence intervals for the parameters should
be calculated. trace is an integer controlling the amount
of output from the optimization. The control argument is
passed directly on to the optimiser—for further details see
the help ﬁles for optim. The fast argument speciﬁes whether
the FORTRAN code should be used when possible. This can be
useful for debugging purposes.
The Kalman Filter has been implemented in FORTRAN for
linear models with non-singular system matrix. Non-linear
models and singular linear models are implemented in R-
code. The matrix exponential used for solving linear systems
is also implemented in FORTRAN. Hence linear models with
fullmatrices are estimated faster thanothermodels. For initial
modelling purposes it can often be extremely helpful to con-
vert a singular model into a non-singular by adding a small
rate constant to the diagonal.
The output from the estimation function can be seen in
Table 5.
3.3.3. Smoothing
The estimation procedure relies on one-step predictions of
observations based on previous data but in order to determine
the overall most likely proﬁle based on all data smoothing can
be employed. The inclusion of all data allows noise effects
occurring later in the time series to inﬂuence the proﬁle earlier
Table 5 – Estimation output.
Element Description
NegLogL Negative log likelihood in the found optimum
THETA Vector of parameters in optimum
CI Conﬁdence intervals based on the Hessian
SD Standard error for the optimal parameters
COR Correlation matrix for the optimal parameters
sec Optimization time in seconds
opt Messages from the optimizer
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Table 6 – Smooth output.
Element Description
Time Sub-sampled time
Xs, Ps Smoothed states and uncertainty
Ys Predictions based on smoothed states
Xf, Pf Filtered state and uncertainty
Xp, Pp One-step state predictions and uncertainty
Yp, R One-step observation predictions and uncertainty
eta Estimated random effects
NegLogL Negative log likelihood
on. Smoothing constructs the optimal state vector to all time
points given both prior and future observations as opposed
to ﬁltered states that only depend on prior observations. The
smoothed estimate is commonly used in post-processing of
data as it represents the best ﬁt based on all available data.
The function PSM.smooth performs smoothing of states
using a Bryson Frazier algorithm [13].
The smoothing function argument list is shown below:
PSM.smooth(Model, Data, THETA, subsample, trace,
etaList)
where Model and Data are as described ealier. THETA is a vec-
tor with the population parameters for the evaluation, i.e.
the returned parameter vector from the estimation. subsam-
ple is the number of sub-samples in between observations.
Sub-sampling can be used to display the system behaviour
in between observations. trace is an integer controlling the
amount of text output. etaList is a matrix, where each col-
umn is the random effects for a subject. If etaList is set to
NULL the random effects will be determined.
The complete listing of output from the smoother is shown
in Table 6.
Several internal functions are used in simulation, estima-
tion and smoothing functions and they can all be found in the
documentation. For general use the three described functions
will form a good base.
In the next section an application of the package is
described.
4. Application: insulin secretion rates
In the article by Mortensen [7] the insulin secretion rate is
determinedby stochastic deconvolutionusing aMatlab frame-
work. The insulin secretion rates are modelled as random
walks and the Kalman Filter is used to determine the trajec-
tory that most likely resulted in the observations. This section
describes an extension implementing an intervention type
model as known from Time Series Analysis in order to better
characterize the insulin secretion.
The challenge in describing the insulin secretion is that
the kinetic system for insulin is potentially non-linear and
partly unknown. This makes insulin itself a poor descriptor
for insulin secretion. During the production of insulin a by-
product called connecting peptide (C-peptide) is produced in
equimolar amounts. Insulin and C-peptide are split just as
insulin is secreted into systemic circulation.
Fig. 2 – C-peptide PK model.
The pharmacokinetic system for C-peptide has been
described in a population model by Van Cauter [14] with
parameters based on subject covariates. The model structure
is a linear two compartment model with elimination from
the central compartment. The well known kinetics and longer
half-life of C-peptide makes it a better descriptor of the actual
insulin secretion even though the determined secretion rates
are C-peptide secretion rates and not insulin secretion rates.
The graphical representation of the C-peptide model can
be seen in Fig. 2. The exchange rate parameters and the elimi-
nation rate are all ﬁrst order and the mathematical equations
are given in (14)–(16):
dA1
dt
= SR − (k + k12)A1 + k21A2 (14)
dA2
dt
= k12A1 − k21A2 (15)
y = A1
V
+ e (16)
where A1 and A2 are amounts in compartment 1 and 2. S R is
the secretion rate measured as [amount/min]. k, k12 and k21
are rate constants [min−1]. V is the distribution volume [L].
The data originates from a meal tolerance test where the
test subject is served three standardized meals over a period
of 24 h. The insulin, C-peptide and glucose concentrations are
measured throughout the 24 h and more frequently during
meals. TheC-peptideproﬁles canbe seen in Fig. 3. The subjects
are newly diagnosed type II diabetes patients with relatively
intact insulin secretion.One complicationwith type II diabetes
is decreasing beta cell mass, i.e. decreasing insulin secre-
tion. To determine if the insulin secretion is intact, stochastic
deconvolution [15] can be used.
Fig. 3 – C-peptide proﬁles.
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Fig. 4 – Intervention C-peptide model.
In the article [7] the insulin secretion is assumed to be a ran-
domwalk and themost plausible trajectory is determined. The
smoothed estimate is a compromise between the expected
variation in the system and the observed variation in the
observations. The scaling diffusion term  is overestimated
due to the physiological structure of the insulin secretion,
where the secretion can only assume positive values. To rem-
edy this assumption an intervention model is added to aid the
structure of the secretion. The intervention model scheme is
implemented by a step function located at meal time. A two
compartment structure is assumed to allow for some ﬂexibil-
ity in the form of the secretion rate proﬁle. The secretion is
furthermore assumed to have an underlying basal secretion
rate. The basal rate, the rate parameters and the ampliﬁcation
are now estimated in this underlying structure for the secre-
tion and the random walk is used to determine the deviations
from this structure (Fig. 4).
The states of the system for further use in the equations
are deﬁned as below:
x = [A1, A2, SR,Q]T (17)
The mathematical equations describing the system can
now be written as
dx =
⎛⎜⎝
⎡⎢⎣−(k12 + k10) k21 1 0k12 −k21 0 00 0 −a1 a1
0 0 0 −a2
⎤⎥⎦x
+
⎡⎢⎣ 0 00 00 B exp(2)
a2K exp(1) 0
⎤⎥⎦u
⎞⎟⎠ dt + diag
⎡⎢⎣ 00
	SR
0
⎤⎥⎦ dω
(18)
where kx and ax are rate constants. The input variable ut =
[u1, u2]
′ is used to model the baseline level of secretion (u1)
and the impulse effect from a meal (u2). u1 is equal to one
for the entire time series whereas u2 is only equal to one just
after meals (i.e. from meal start and 30 min on). The B param-
eter speciﬁes the baseline level in the secretion compartment
and K speciﬁes the amplitude of the meal impulse. Both B and
K are modelled with an individual random effect (1, 2). 	SR
is the scaling diffusion term for remaining description of the
secretion rate.
The observation equation linking the model states to the
C-peptide observations is shown below:
y =
[
1
V
,0,0,0
]
x + e = A1
V
+ e, where e∈N(0, S) (19)
This model is a simpliﬁcation as the secretion responses to
the meals are assumed equal over all three meals. An exten-
sion to make an individual secretion response per meal can be
made by extending the input and the parameter list accord-
ingly. This will however increase the number of parameters
and thereby the estimation time.
Individual random effects have been added to the ampli-
ﬁcation of the response and the basal level so that each
individual can have different secretion responses.
The parameters in the model to be estimated are the secre-
tion parameters a1, a2, K, B and the variance parameter 	SR.
The inter-individual variance in ˝ is assumed to be 0.1. The
residual variance is assumed to be (50pmol/L)2 which was
derived from the plot of the proﬁles.
4.1. Model speciﬁcation
The model speciﬁcation in PSM is described element by ele-
ment in the next section.
Initially the model is setup by creating an empty list. The h
function that translates the population parameters into indi-
vidual parameters is speciﬁed. Function arguments that can
be used in the creation of phi are population parameters,
random effects and covariates. It can be seen that four indi-
vidual parameters are extracted from the covariates and the
twopopulationparametersK andB are expandedwith random
effects.
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The ﬁrst element created here is the time invariant matri-
ces. In this example all four matrices need to be speciﬁed.
First the individual parameters are extracted from phi and
matrices are set up in a list named Matrices.
The initial conditions for the states are added to the list
as an element named X0. The initial conditions used here are
steady state conditions calculated using the basal secretion
and kinetic parameters. The initial conditions are speciﬁed as
a function with arguments Time, phi and U. The Time argu-
ment is the ﬁrst time point speciﬁed and can be useful if
the subjects start at different time points. The U can contain
exogenous input to the system which enters into the initial
conditions.
Table 7 – Estimated parameters.
Parameter MLE 95% CI
K 1911.2 [1511.5; 2310.9]
B 7.019 [5.0; 9.037]
a1 0.029 [0.022; 0.036]
a2 0.011 [0.0089; 0.014]
SIG33 30.3 [26.05; 34.55]
Fig. 5 – Fitted C-peptide concentrations for subject 11.
The diffusion scaling term and the residual variance are
speciﬁed using the elements SIG and S. Both are speciﬁed as
functions of phi. It can be seen that SIG is a 4 × 4 matrix with
only an element at position [3,3]. S is speciﬁed as a matrix
even though it is one-dimensional.
The ﬁnal element in the model is the function that splits
the parameter vector containing parameters to be optimized
into population parameters and inter individual covariance
matrix ˝.
The list Cpep.Model now contains all the elements
required in the model speciﬁcation and the model can now be
used to estimate parameters and create the smoothedproﬁles.
4.2. Results
The parameters in the C-peptide intervention model are
estimated using PSM.estimate with constraints on the
parameters. The optimal parameters and conﬁdence bands
are shown in the Table 7.
Twomodel ﬁts forC-peptide canbe seen in Figs. 5 and6. The
plots show the observations as circles and the intervention
Fig. 6 – Fitted C-peptide concentrations for subject 12.
288 computer methods and programs in b iomed ic ine 9 4 ( 2 0 0 9 ) 279–289
Fig. 7 – Secretion for subject 11.
model ﬁt is shown in blue. The dashed line represents the
deterministic model ﬁt where the diffusion scale term has
been ﬁxed to zero in the intervention model in order to mimic
an ODE model like in NONMEM. The dashed line is thus equal
to a simulation with the intervention model.
The failure of the assumption of equal responses to all
meals is obvious in the ﬁt between the dashed red line and
the observations. Large peaks are underestimated and small
peaks overestimated. This is clear as the model describes the
average response after a meal. The solution could be to extend
the model so that every meal has it’s own ampliﬁcation.
As the model is used for deconvolution purposes the actual
ﬁt to the observations is of less importance, but more interest-
ing is the secretion rate proﬁle and the split between themodel
and the Wiener component.
The two corresponding secretion rate proﬁles to the C-
peptide ﬁts are found in Figs. 7 and 8. The full line is the
optimal secretion rate determined by the Kalman Filter and
the dashed line represents the deterministic part of themodel.
The secretion model captures the overall trends but the com-
promise with the equal response assumption is clear.
The deconvoluted insulin secretion rates have some jumps
which seem unphysiological. The solution could be to use
an integrated random walk as driver for insulin secretion.
This would make the deconvoluted insulin secretion rate less
erratic.
This section has shown a simple application of the PSM
package for modelling purposes. Classic log likelihood ratio
testing can also be applied in the model development as well
as visual predictive checks of the model ﬁts.
Fig. 8 – Secretion for subject 12.
5. Discussion and conclusion
The PSM package provides a new general framework for
handling dynamic models based on stochastic differential
equations in a population setting. The package is available
in R to ease availability, ease installation and enable a sin-
gle working environment for data handling, modelling and
visualization.
The package is an extension to the Matlab framework of
the same name. The package functionality is a combination
of the functionality available in CTSM and NONMEM. CTSM
and NONMEM have also been used to validate the package as
described further on the homepage [16].
The package enables the feature of dosing capabilities
whichmakes thepackageuseful in PK/PDmodel development.
This is further supported by the ability to handle multidi-
mensional observations which aids in modelling work with
observations from both PK and PD.
The package includes functionality for modelling tasks
such as simulation, parameter estimation and smoothing.
The stochastic deconvolution example with an underlying
secretion model in this article showed an application of the
package.
The computational effort in working with larger models is
substantial and the use of parallelization could decrease the
time considerably in the modelling. It is currently being inves-
tigated how to implement parallelization in a general manner
in R. Parallelization is an obvious solution due to the fact that
future computer systems will be massive multicore systems.
The package is a promising tool to get started with stochas-
tic differential equations or the inclusion of mixed-effects in
continuous-discrete state-space models.
More information can be found on the webpage http://
www.imm.dtu.dk/psm.
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1 Introduction
In many applications one may encounter discretely sampled data that has a
finite sample space. Examples of such are financial data with credit ratings,
observations of cloud cover or observations of sleep stages during human or
animal sleep. A first assumption for such data will often be that the data is
generated by a time homogeneous Markov process. The homogeneous Markov
assumption is often approximately valid over short time intervals, but if data is
sampled over longer time periods this may no longer be the case due to changes
over time of the system. Relating to the above mentioned examples the cause
could be new financial market conditions, changes of season and changes in the
sleep process.
One way to handle such changes in the dynamics of the process is to apply
an inhomogeneous continuous time Markov model. This is an attractive model
as it has a simple model structure but is still very flexible. Being inhomogeneous
the model is able to reflect changes in the system and by further formulating
the model in continuous time will often allow a more simple parameterization of
the model that can be related to physical constraints in the system. This paper
suggests a novel estimation procedure that based on discrete measurements will
estimate changes in the model parameters over time for the continuous Markov
process.
The theory of the method is presented in Section 2 and 3 and in Section 4
its application is illustrated with data from a study of EEG sleep stages in rats.
2 Model
Let {X(t) ∈ S; t ∈ T} be a continuous time inhomogeneous Markov process with
a finite state space S = {1, ...,m} and T = [0, tmax]. The process is defined by
a stochastic matrix of transition probabilities P (t, u) = {pij(t, u)} with
pij(t, u) = Pr{X(u) = j|X(t) = i}. (2.1)
By introducing the corresponding intensity matrix Q(t) = {qij(t)} it can be
shown that
∂
∂u
P (t, u) = P (t, u)Q(u), u, t ∈ T, (2.2)
which is known as the Kolmogorov forward differential equation. The equation
shows that the process is also defined completely through the Q(t) matrix (Cox
and Miller, 1965, p. 181). The Q(t) matrix has diagonal elements qii ≤ 0 and
off-diagonal elements qij ≥ 0, i 6= j, and the matrix will always be defined given
a Markov process with a stochastic matrix P (t, u). It can be shown that if Q(t)
is time invariant then times between jumps (holding times) are exponentially
distributed and the diagonal elements qii(t) of Q(t) contains the negative rate
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for leaving a state. The fraction −qij(t)/qii(t) is the probability of going to
state j when a jump from state i occurs. Consequently, the row sum of Q(t)
is 0 since
∑
j 6=i−qij/qii must be 1, meaning that the process must jump to a
state in S with probability one when a transition occurs.
The process X(t) is observed at N discrete time points that are chosen inde-
pendent of the observed process. The model dynamics are assumed to be slowly
varying relative to the time between observations. The observation sequence
is denoted {xk} and contains the state at time tk where k = 1, ..., N . There
is no requirement of an equidistant sampling scheme, and therefore “missing”
observations do not need to be handled separately.
3 Estimation
Given a set of observations we wish to find an estimate of Q(tc) at a time
point tc ∈ T using a locally-weighted maximum likelihood frame work. To
further estimate the time variations ofQ(t) over the entire interval T one simply
applies the local model sequentially for a series of suitably close time points in
T . The presentation of the estimation method is thus only concerned with the
point estimate Q(tc) the remaining part of the section. The dependence on the
chosen time point tc is suppressed in the notation to ease readability, but it is
important and should be kept in mind.
It will often be the case that the estimation of Q(t) should be limited to a
particular structure of interest. For this purpose we define in f a parameteriza-
tion for the Q(t) matrix with a set of parameters θ(t) = (θ1(t), ... , θv(t)) such
that
f : θ(t) → Q(t). (3.1)
The parameterization in (3.1) can be used to define a particular structure of
Q(t) based on a knowledge of the process. Thus instead of estimating the full
Q(t) matrix it is only nescessary to estimate the parameters representing possi-
ble jumps in continuous time. This typically limits the number of parameters in
Q(t) that has to be estimated. The parameterization in (3.1) can also be used
to define a more suitable transformation of the elements in Q(t) to be used in
the maximum likelihood estimation. The elements {qij(t)} are all rate related
parameters and it may thus be desirable to estimate the logarithm of these to
make the parameter space unbounded.
Next, define in g a series of local polynomial models of order r for the
parameters (θ1(t), ... , θv(t)) such that
g : (β, t) → θ(t) (3.2)
where
θs(t) = βs0 + (t− tc)βs1 + ... + (t− tc)rβsr (3.3)
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with the matrix β = {βkl }, s = 1, ..., v and l = 0, ..., r. It then holds that a
local estimate of the Q(tc) matrix is given by Qˆ(tc) = f(g(βˆ, tc)), where βˆ is
an estimate of β. This estimate will be based on a locally-weighted likelihood
function, which will be described in the following.
First we define a series of stochastic matrices
P k = {pij}k = {pij(tk, tk+1)} (3.4)
containing the probabilities for observing xk+1 = j given xk = i. These transi-
tion probabilities are found by solving (2.2) with initial condition P (tk, tk) = I
and using Q(u) = f(g(β, u)). The solution can be found numerically using
standard algorithms for solving ordinary differential equations. Alternatively,
if the time interval ∆tk = tk+1 − tk is small, one may as an approximation use
a zero or first order Taylor expansion of Q(t) around tk. The most simple and
in many cases sufficient approximation is the zeroth order expansion where the
intensity matrix is assumed constant in each time interval tk to tk+1. In this
case the solution to (2.2) is given explicitly as
P k = exp[Q(tk)∆tk ]
= exp[f(g(β, tk))∆tk ] (3.5)
where exp[·] represents the matrix exponential function. This approximation is
computationally faster, and will in many cases be sufficiently accurate as long
as the time variations in Q(t) are small compared to the time interval between
consecutive observations.
In order to simplify the description of the likelihood function for β an indica-
tor observation {yij}k is defined from xk with i, j = 1, ...,m and k = 1, ..., N−1.
Let yijk = 1 when xk = i and xk+1 = j and otherwise yijk = 0 . The obser-
vation yijk thus indicates if a change of state from i to j is observed from time
tk to tk+1. This new set of indicator observations contains all the information
in the original set of observations {xk} and is thus also a sufficient statistic for
estimating β. Using the transition probabilities defined in (3.4) we know that
the likelihood of observing xk = i followed by xk+1 = j is pijk. The contribution
to the log-likelihood for one observation yijk can thus be written as yijk log pijk
and combining all m2 indicator observations at time tk this gives
logLk(β) =
∑
i
∑
j
yijk log pijk(β). (3.6)
We now define weights for the observations as wk(tc) = Kh(tk − tc) using a
symmetric probability function K (also often referred to as a kernel function).
The parameter h is the bandwidth controlling the size of the local neighborhood
such that Kh(t) = K(t/h)/h (Fan and Gijbels, 1996, p. 15). This can be used
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to form a locally weighted log-likelihood function for β as
logL(β, tc) =
∑
k
wk(tc) logLk(β) (3.7)
=
∑
k
∑
i
∑
j
wk(tc) yijk log pijk(β) (3.8)
and β may thus for a given time point tc be estimated locally as
βˆ = argmax
β
logL(β, tc). (3.9)
Given that the local polynomia in (3.3) are centered around tc, a local esti-
mate of each parameter θs(tc) for a given tc is directly βs0. The estimate of all
parameters in Qˆ(tc) is thus given as
θˆ(tc) = g(βˆ, tc) = βˆ0
= [ βˆ10, βˆ20, ... , βˆv0 ].
3.1 Local constant model
The estimation method can be simplified if sample times are equidistant with
tk = t1 + (k− 1)∆tk and if it is chosen to use a local constant model instead of
a higher order polynomial.
Thus, if we in (3.3) let r = 0 such that θs(t) = βs0 then Q(t) modelled as
f(g(β, t)) will be constant with respect to t for a given β and the transition
probabilities can be found using the matrix exponential in (3.5) without ap-
proximation. Note that when using a local constant model in (3.3) the estimate
Qˆ(tc) is still varying with respect to tc due to the weighing of the observa-
tions that depend on tc. Assuming equidistant sampling times then also ∆tk
will be constant, and this results in time invariant transition probabilities for a
given β. It is therefore only necessary to solve (2.2) one time instead of N − 1
times to evaluate the likelihood function for β and we may write the transition
probabilities pijk(β) as pij(β) for any k to emphasize this.
By defining a “weighted” number of jumps from i to j as n′ij =
∑
k wk(tc) yijs
the locally-weighted log-likelihood function in (3.8) can be written as
logL(β, tc) =
∑
k
∑
i
∑
j wk(tc) yijk log pijk(β)
=
∑
i
∑
j log pij(β)
∑
k wk(tc) yijs
=
∑
i
∑
j log pij(β)n
′
ij ,
(3.10)
where the sum over all observations is removed from the log-likelihood function.
This formulation of the estimation problem gives a significant computational
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advantage. The matrix {n′ij} can be pre-computed for a given tc since it does not
depend on β and an evaluation of the log-likelihood function then only requires
solving (2.2) once to compute {pij(β)}. This not only reduces time required
for estimation, but also improves the numeric stability of the log-likelihood
evaluation.
3.2 Bias vs. variance of estimate
The local estimation method provides a point estimate of the parameters θ(tc)
defining Q(tc) via the parameterization given in f . For any local estimation
procedure there will be a trade-off between reducing bias and variance of this
point estimate.
To find an estimate of the variance we may rely on the asymptotic distri-
bution theory of the maximum likelihood estimator, since the local estimation
method is based on a likelihood function (Pawitan, 2001). The observed Fisher
information for βˆ0(tc) is
I0(tc) = − ∂
2
∂β20
logL(β, tc)
∣∣∣
β0=βˆ0
(3.11)
and using that θˆ(tc) = βˆ0(tc) it thus holds asymptotically that
var θˆ(tc) = I−10 (tc). (3.12)
if θˆ(tc) is unbiased. From likelihood theory it is known that the variance esti-
mate in (3.12) will decrease for an increasing bandwidth, since this will include
more observations in the likelihood function. However, θˆ(tc) will only be unbi-
ased if the local model is correct on a global level, and this can generally not be
assumed. The polynomial model is chosen because it is well suited for locally
modelling a true function of any any shape. If the bandwidth is increased to
much this will no longer be the case and the decreasing variance will come at
the cost of increasing bias. The bandwidth should thus not be increased beyond
a range where the polynomial approximation is expected to be sufficient and
the variance estimate in (3.12) should only be seen as a an indication of the
precision of the estimate in situations where bias is expected to be relatively
small.
For local estimation in a least square setting (also known as non-parametric
regression) with a model of the type zk = g(tk) + k the problem of balanc-
ing bias and variance in estimation of the unknown regression function g has a
long history. Classical methods for finding an optimal bandwidth include cross
validation criterion and related methods (Wahba and Wold, 1975; Rice, 1984;
Mu¨ller, 1985; Mu¨ller et al., 1987). With cross validation we define a cross valida-
tion function CV (λ) = 1n
∑
k (zk − gˆ∗λ(tk))2 where gˆ∗λ(tk) is the non-parametric
estimate of g(tk) using all observations except observation zk. The parameter
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λ is the reciprocal of the bandwidth, and minimizing the cross validation func-
tion with respect to λ gives an objective choice of the optimal bandwidth. The
cross validation criterion can be generalized to other types of responses using
the theory of generalized linear models where deviance is introduced to measure
agreement between observations and model (McCullagh and Nelder, 1983). If
we assume a Gaussian distribution of k and use µk = g(tk) the deviance for one
observation is defined as D(zk, µk) = (zk−µk)2. In this way the cross validation
function can be defined as CV (λ) = 1n
∑
kD(zk, µˆ
∗
k) where D is the individual
deviance contribution for observation zk and µˆ∗k = gˆ
∗
λ(tk). In this form the cross
validation technique can be extended to all types of responses in the exponential
family distribution (O’Sullivan et al., 1986) and this also includes the binary
observations yijk of a Markov process presented here.
For binary observations it can be shown that the deviance is equal to minus
2 log-likelihood of the binary observation. For the indicator observations yijk
we are only interested in the deviance contribution when yijk = 1 since this
indicates an actual observation. The deviance can thus be defined as
D(yijk, pijk) = −2yijk log pijk.
This can be used for defining a cross validation criterion as
CV (λ) =
2
n
∑
i
∑
j
∑
k
−yijk log pˆ∗ijk
where pˆ∗ijk is found using a bandwidth h = 1/λ and excluding observation yijk.
The cross validation criterion gives an objective measure for the optimal band-
width in the local Markov model. The criterion will however quickly become
computationally demanding to evaluate with increasing number of observations,
since it requires a local estimate pˆ∗ijk at each time point tk to evaluate CV (λ).
In practical situations it is thus only feasible to compute if the number of ob-
servations is relatively small.
In problems where the number of observations is large as in the example
presented in Section 4 other approaches are needed. Instead the situation can
be seen in analogy to estimation of the spectral density function in time series
analysis, where it is well known that some degree of smoothing is nescessary
to achieve a consistent estimate (Priestley, 1981). The degree of smoothing is
chosen such that it seems to reasonably balance bias and variance. The same
approach is suggested here, that is simply to redo the local estimation method
for a range of bandwidth values to find the most suitable value.
3.3 Type of bandwidth and kernel function
The type of bandwidth and kernel function K is also important in order to
achieve the best performance of the local estimation. There are a number of
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commonly used kernel functions available, such as the Gaussian kernel, tricube
kernel and the uniform, Epanechnikov, biweight and triweight kernels that are
derived from the symmetric Beta family (Fan and Gijbels, 1996). A number of
the kernels are shown in Figure 1. The Gaussian kernel has the disadvantage
of unbounded support and hence positive weights for all data points. This
makes the local estimation procedure computationally more demanding, since
all data has to be considered at any chosen time point tc. The remaining kernel
functions have only bounded support in the interval [−1; 1] which is mapped to
the interval [−h;h] in the scaled kernel function Kh. The tricube kernel is often
preferred because it approaches its bounds smoothly.
−2.0 −1.5 −1.0 −0.5 0.0 0.5 1.0
0.0
0.5
1.0 tricube
Epanechnikov
uniform
Gauss
Figure 1: Kernel functions.
As discussed in the previous section a smaller bandwidth reduces estimation
bias but increases the variance and vice versa. Two types of bandwidth have
been considered here.
The first type of bandwidth is to use a common fixed bandwidth h. This is
the most simple way of specifying the bandwidth. It can be useful in many cases,
but it can give large differences in the precision of the parameter estimates over
time. This happens if the observations are sampled with varying frequency and
thereby results in varying numbers of observations in the fixed length intervals
tc + [−h;h]. The fixed bandwidth h must naturally be positive, but it is not
upwards bounded as increasing h just results in an increasingly smooth estimate
of the time variations.
The second choice for a bandwidth is to choose a data dependent bandwidth
htc such that the interval tc + [−htc ;htc ] always includes a fixed proportion α
of the total number of observations. This is often denoted a nearest neighbor
(NN) bandwidth. The definition can be extended to allow α > 1 by scaling
htc by max(1, α). The nearest neighbor bandwidth will help control estimation
variance when the frequency of observations varies.
If sample times are equidistant the two types of bandwidths are almost equiv-
alent, since a fixed time window contains a fixed proportion of the data. They
will only be different near the boundary, where the data dependent bandwidth
increases to contain the fixed proportion of the data. It is noted that for both
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choices of bandwidth, when h→∞ or α→∞ the local estimation will approach
a global polynomial estimation.
There are further aspects that can be considered when choosing kernels and
bandwidth. For local estimation in a least square setting the estimation near
the boundary (when tc < h or tc > tmax − h) can give problems with increased
bias. A common way to avoid this is to use special boundary kernels, see e.g.
Gasser et al. (1985). Similar approaches could also be considered in this context
to improve the estimate at the boundary.
A special issue that in only relevant for the local estimation presented here
is that a chosen bandwidth must contain observations of all states in order to
estimate all parameters in the model. If a particular state in the process is
observed much less frequently than other states, this will set a lower bound on
the possible bandwidth. A way to give more robust local estimates is thus to use
a state dependent bandwidth such that e.g. a proportion α of the observations
of each state is included in the estimation. This can be done by using state
dependent weights wik(tc) instead of wk(tc) in (3.8) where wik(tc) is found with
a different bandwidth depending on from which state the observed jump yijk
occurs.
4 Example
To illustrate the use of modelling based on local estimation of a continuous
time inhomogeneous Markov process, the method will be applied to data from
a study monitoring the sleep cycle of rats.
The data has been collected in a pre-clinical trial using 6 rats that have
been observed for 23.5 hours (Anderson et al., 2005). At the beginning of
the period the rats were given an oral dose of 20mg Gaboxadol, which is a
sleep promoting compound. Previous experience has indicated that the drug
is present in the brain for about 8 hours and reaches the highest concentration
after approximately 1 hour. During the first 12 hours the lights were on, and in
the remaining time the lights were off. Since rats are most active in the dark,
this study design is meant to resemble a human taking a sleep drug before bed
time.
The sleep cycle is monitored using electroencephalography (EEG) which is
used to determine the sleep stage of the rat. Three states are classified, namely
wake (W), delta sleep (DS) and paradoxical sleep (PS) and the states are num-
bered in that order. These states are determined every 10 seconds giving 8,460
equidistantly spaced observations for each rat. In order to simplify the example
it is chosen to regard the observations from all six rats as realizations of the
same Markov process. The local estimation thus reflects an average individual
process.
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The implementation of the estimation method has been done in R (R De-
velopment Core Team, 2008) and it was chosen to use the matrix exponential
in (3.5) to solve (2.2) since data is sampled at high frequency compared to the
expected variations it Q(t). The matrix exponential is not part of base R so it
was chosen to use the Fortran routine DGPADM from Expokit (Sidje, 1998) for
this purpose.
The parameterization f of the Q(t) matrix is shown in (4.1). The structure
is based on Madsen et al. (1985), where Q(t) is parameterized with two param-
eters for each state, one rate parameter for leaving the state and one parameter
for the probability of changing one state down when a jump occurs. This param-
eterization is advantageous if it is only possible to jump to neighboring states,
since the number of parameters only increases linearly with the number of states
instead of quadratically when using a full matrix. In this example we will use
the model
f : θ(t) → Q(t) :
Q(t) =
 −q1(t) q1(t) 0w2(t)q2(t) −q2(t) (1− w2(t))q2(t)
(1− w3(t))q3(t) w3(t)q3(t) −q3(t)

qi(t) = exp[θi(t)], i = 1, 2, 3
wi(t) = logit−1[θi+2(t)], i = 2, 3 ,
(4.1)
which is illustrated in Figure 2. Since the rats have only three states, the struc-
ture with two parameters per state does not reduce the number of parameters
needed, but it is still used to illustrate the use of the approach.
W
1
DS
2
PS
3
λ1 λ2 w2 , λ3 w3 ,
Figure 2: Model for sleep stage transitions.
In the parameterization in (4.1) we furthermore use the constraint that
w1(t) = 0 meaning that jumps from W to PS should never occur. This re-
flects that it is known from physiology that the PS state is always preceded by
the DS state. There is a very small number of observations in the data where W
is followed by an observation of PS, but by using w1(t) = 0 we thereby assume
that the process has been in the DS state in between observation times.
For the local estimation we use a second order polynomial in g and a tricube
kernel with a nearest neighbor bandwidth of α = 0.40. The result of the esti-
mation is shown in Figure 3 together with Wald 95% confidence intervals found
using (3.12).
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Figure 3: Estimate of the Q(t) matrix as a function of time using 2nd order local
polynomials and a NN bandwidth α = 0.40. The surrounding lines are Wald 95%
pointwise confidence intervals.
The first row in Figure 3 shows the expected time in each state before leav-
ing (holding times), which is found as 1/qi(t) since the time in each state is
approximately exponentially distributed. Looking at holding times is chosen
here since it can be a more intuitive way to view the rate parameters, but it is
only valid if the holding times are short compared to the time variations of the
parameters as discussed previously. It is seen that the estimate of time in W
increases after 12 hours (lights off) along with the probability of jumping from
DS to W when leaving DS, and this seems reasonable as the activity should
increase in the dark period. The expected time in DS reflects the influence of
the drug, as it peaks at about three hours, which indicates a delay of 2 hours
with respect to the peak of the drug concentration. The most notable effect on
the pointwise confidence intervals is seen for w3 between 0 and 6 hours. This
reflects that there is only limited information about the probability of going
from PS to DS or W, since the process only rarely enters the PS state in this
period as seen in the figure for 1/q3.
In the example shown in Figure 3 the estimation is done using a second
order polynomial with an NN bandwidth α = 0.40. To demonstrate the effect
of using lower orders, this is done for the DS state and shown in Figure 4(a)
for the interval 0 to 18 hours. Both the zero and first order approximations
are expected to give negative bias around peaks, and this is seen clearly from
the figure around the peak at 2-3 hours. For the later times in the interval 6
to 18 hours the three approximations perform equally well. In Figure 4(b) the
bandwidth is further reduced to α = 0.30. This gives increased sensitivity and
the second order local model is here seen to capture a stronger peak, which
further strengthen the evidence for a true significant increase in the expected
time in DS is present. It has been tried to use an even lower bandwidth, but
unfortunately the estimation of especially w3 becomes unstable. This is due
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to a very limited number of observations of the PS state during the first hours
of the study, and for lower choices of bandwidth the estimation was no longer
possible. To further reduce the bandwidth it is nescessary to consider a state
dependent bandwidth as mentioned in Section 3.3.
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Figure 4: Expected time in DS state for different order of local polynomial using two
choices of NN bandwidths.
It is also of interest to get an impression of whether the Markov assumption
is valid. As noted earlier the holding times should be exponentially distributed
when the Markov process is homogeneous. Based on Figure 3 it can be seen
that the process can be assumed to be roughly homogeneous in the time between
14 and 22 hours. Since data are sampled equidistantly the distribution of the
observed holding time follows a geometric distribution. It is chosen to look
at the run lengths as this is proportional to the observed holding times. The
distribution of the run lengths K is given as
Pr(K = k) = pk−1ii (pii − 1), k ∈ N, (4.2)
where pii is the (assumed constant) probability of staying in the same state. The
observed distribution of the run lengths can be seen in Figure 5. This histogram
is shown on log-scale, so it is expected to show a straight line. The solid line
is the expected distribution based on p = nii/ni·, i.e. the observed number of
jumps from state i to state i divided by total number of jumps from state i. It
is seen that the overall picture is reasonable, but for both Wake and Delta Sleep
there seems to be too many long runs compared to the linear decline in the first
part of the histogram.
5 Discussion
We have presented a method for analyzing time series data with a discrete
sample space based on the assumption data is generated by a continuous time
inhomogeneous Markov jump process. A first objection to this choice of model
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Figure 5: Histogram of run lengths for data between 14 and 22 hours.
could be: why assume a model in continuous time when data is sampled dis-
cretely? In particular when data is sampled equidistantly as in the example in
Section 4 it could seem appealing to instead assume a discrete Markov process.
The first answer is that if the process is in fact evolving in continuous time is
should also be modelled as such. An example is the observation of sleep cycles
from the previous section which is most naturally understood as a continuous
process. Also e.g. the example of observations of cloud cover mentioned in the
introduction is by nature a continuous process. It is only due to the physical
limitations that we are forced to consider discrete observations of the processes.
When the model is handled in continuous time it allows us to apply con-
straints to the parameterization. This is used in the model for the sleep data
in (4.1) where jumps between W and PS are restricted. Another example is
found in Madsen et al. (1985) where data from observations of cloud cover is
analyzed using a continuous time Markov model. On a short time scale it is
known that the weather conditions cannot jump from few to many clouds – the
process must visit all stages in between seen on a continuous time scale. This
allows a parameterization of the Q(t) matrix where only jumps to neighborings
states are possible. If the same process were analyzed in discrete time such a
constraint could not be applied, since observations of jumps between all states
becomes probable. Constraining jumps to neighboring states is only valid in
the limit when the time step approaches zero, and this limit is the continuous
representation of the model.
The continuous time model also gives a more natural parameterization of the
process, where rates or holding times are estimated instead of probabilities. For
most people it is more natural to look at the expected holding time for a state
instead of the probability for leaving at the next observation time. Of course
these two quantities are to some extent equivalent, and the relation in (3.5) could
suggest that one could simply find the continuous representation by solving the
equation P t = exp(Q(t)∆t) for Q(t) for a given estimate of P t. However,
this equation will not always have a solution due to the imbedding problem for
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Markov chains (Bladt and Sørensen, 2005). In general terms the problem will
arise in cases where the process moves to fast between states compared to the
sampling rate. This is in fact the case in the sleep example data (Section 4)
due to the PS state, which has very short holding times. The problem with the
imbedding problem for Markov chains are only avoided by doing the estimation
directly in continuous time.
In the formulation of the inhomogeneous Markov model it is assumed that
the model dynamics are slowly varying. This formulation does not include a
process that has discontinuities in model parameters as a function of time. It
could be argued that such a discontinuity is present in the sleep data when lights
are turned on after 12 hours. The smooth change in the parameters around
12 hours seen in Figure 3 is thus only an effect of averaging data from both
sides of this discontinuity. However, if the estimation around a discontinuity is
of particular interest it can be accommodated using standard techniques from
local estimation. Either it can be chosen to use a smaller bandwidth where a
discontinuity is suspected, or one could choose to use a type of boundary kernel,
such that data on one side is not used in the estimation on the other side.
To summarize, the proposed estimation method is aimed at analyzing time
series data with a discrete sample space by assuming an inhomogeneous Markov
model in continuous time. The formulation of the model in continuous time
can reduce the number of parameters in the model by introducing constraints
on jumps that exist in the physical system. The estimation method makes it
possible to make local non-parametric estimates of changes in model parameters
as a function of time. Such changes in the model dynamics can otherwise easily
be overlooked or ignored by assuming a homogeneous Markov model, but as
illustrated with the sleep data example it can provide valuable information about
the underlying process.
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Abstract
The multivariate Laplace approximation to the marginal likelihood is a fast
and accurate approach for estimation in nonlinear mixed models. Our aim is to
show how this approximation is easily implemented on a case-by-case basis in
general programming environments such as R, S-plus or Matlab. The approach
is very flexible compared to what is possible in standard statistical software
allowing estimation of models with e.g. crossed random effects and arbitrary
correlation structures for the residuals. Such models are not easily, if at all
possible, fit with standard statistical software or software specially designed for
nonlinear mixed models. The approach also allows graphical assessment of suc-
cessful convergence and can produce profile likelihoods for selected parameters,
neither of which is generally possible with standard statistical software.
Keywords: Crossed random effects, orange tree data, R.
1 Introduction
This paper is concerned with estimation of nonlinear mixed models (NLMMs) where
the conditional distribution of the response given the random effects as well as the
distribution of the random effects are Gaussian. The model can be expressed generally
as
(Y |B = b) ∼ N(f (β, b),Σ(λ)), B ∼ N(0,Ψ(ψ)), (1)
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where β are fixed regression parameters, b is a q-vector of random effects, λ and
ψ are variance parameters parameterizing the covariance matrices Σ and Ψ and f
is the model function. NLMMs can be viewed as a generalization of the ordinary
fixed effects nonlinear model (NLM) (Bates and Watts, 1988) to include random
effects, and it can be viewed as a generalization of the linear mixed model (LMM)
(Laird and Ware, 1982) to allow the conditional mean to be a nonlinear function
of the regression parameters. Despite these conceptually small changes, maximum
likelihood estimation in NLMMs has been a fair challenge and still is to some extent.
The likelihood function of a NLMM is the marginal density of the response where the
random effects are integrated out
L(θ;y) =
∫
Rq
p(y|θ, b)p(b) db, (2)
where p denotes a normal probability density function and θ = [βT ,λT ,ψT ]T denotes
the vector of fixed parameters. It is this q-dimensional integral that is difficult to
solve in general, because approximations have to be invoked. The likelihood can be
reduced to a multiple of integrals of lower order when the random parameters arise
from only one level of grouping (indexed by i, say); the model can be written as
(Yi|Bi = bi) ∼ N(fi(β, bi),Σi), Bi ∼ N(0,Ψ), i = 1, . . . ,M,
and the likelihood simplifies to a multiple of qi-dimensional integrals
L(θ;y) =
M∏
i=1
∫
Rqi
p(yi|θ, bi)p(bi) dbi,
where qi is the number of random effects for the ith group. In particular, the likeli-
hood reduces to a multiple of one-dimensional integrals when only a single random
effect occurs for each group in the data. We will refer to a set of random effects
corresponding to a single grouping variable as a random component.
In this paper we shall be concerned with the multivariate Laplace approximation
to solve the full q-dimensional integral (2) and thereby allow for any structure of the
random effects: scalar or vector-valued random effects, nested, crossed or partially
crossed; linear, as well as nonlinear.
Pinheiro and Bates (1995) and Vonesh (1996) studied the Laplace approximation
(Barndorff-Nielsen and Cox, 1989; Tierney and Kadane, 1986) for models with a
single level of grouping, and Pinheiro and Bates (2000) also studied it for models
with nested random effects. Statistical software packages that fit NLMMs (e.g. nlme
in R and S-plus (Pinheiro et al., 2008), SAS NLMIXED (SAS Institute Inc., 2004)
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and NONMEM (Beal and Sheiner, 2004), hereafter denoted “standard software”) are
designed for models with a single level of grouping or with nested random effects. We
show in this paper how the Laplace approximation can be implemented on a case-by-
case basis in around 20 lines of code providing fast convergence to accurate maximum
likelihood estimates (MLEs) for the general NLMM.
Convergence of NLMMs can be hard to achieve and software can be fooled to
declare convergence at a local optimum rather than the global optimum or simply far
from optimum due to correlation among the parameters. It is therefore important that
the user is able to assess, preferably by graphical methods, that a global optimum has
been reached at convergence and whether several local optima with high likelihood
exist. We suggest to use pseudo-likelihood curves to facilitate this assessment because
they are simple and fast to compute.
While the standard error is a convenient summary of uncertainty in a parameter
estimate, it is not always appropriate for regression parameters in NLMMs due to
nonlinearities (Bates and Watts, 1988) and almost never appropriate for the variance
parameters. Profile likelihood curves and corresponding confidence intervals are nat-
ural alternatives to standard errors when these are inappropriate. Regrettably, we do
not find them easy to obtain with standard software and it seems that the user is left
with likelihood ratio tests of the parameters as the only appropriate inferential tool.
Profile likelihoods and corresponding confidence intervals for the variance parameters
are easy to obtain from the estimation scheme that we propose.
To illustrate our approach to estimation of NLMMs, we use the orange tree data
set that has been used repeatedly in the literature to illustrate estimation of NLMMs.
These data and appropriate models for them will be presented in section 1.1. In Sec-
tion 2 we outline the Laplace approximation and motivate it as a natural approxima-
tion to the marginal likelihood for NLMMs. In Section 3 we describe how estimation
of NLMMs via the multivariate Laplace approximation can be achieved in few lines
of code, and we illustrate the flexibility of the approach. In Section 4 we discuss
profile likelihoods and assessment of convergence, and we illustrate how the accuracy
of the Laplace approximation can be assessed post hoc. In Section 5 we compare our
approach with standard software, and we end with a discussion and conclusions in
Section 6.
We illustrate estimation using the statistical programming environment R (R De-
velopment Core Team, 2008) and include R-code in the text for illustration, but the
approach can be implemented in any functional programming environment (e.g. Mat-
lab) that provides access to a general optimizer (preferably of quasi-Newton type),
finite difference approximations to Jacobians and Hessians of user defined functions
and allows basic matrix operations.
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The complete R-code to produce all fits and figures can be downloaded from
http://imm.dtu.dk/~sbm/nlmm/.
1.1 The orange tree data set and appropriate models
To illustrate our approach to estimation of NLMMs, we use a study of the growth of
orange trees reported by Draper and Smith (1981, p. 524), see the appendix, where
the circumference of five trees is measured at seven time points. This data set has been
used by Lindstrom and Bates (1990) to illustrate their algorithm, by Pinheiro and
Bates (1995) in their comparison of estimation methods and in Wolfinger (1999) to
illustrate the NLMIXED procedure. A logistic growth model is fitted in all cases with
a single random component bi allowing for a tree specific asymptotic circumference
yij =
β1 + bi
1 + exp[−(tj − β2)/β3] + ǫij , i = 1, ..., 5, j = 1, ..., 7, (3)
with ǫij ∼ N(0, σ2) and bi ∼ N(0, σ2b ) and mutually independent. The matrices Σ
and Ψ are both diagonal. Here, β1 determines the asymptotic circumference, β2 is
the age at half this value, β3 is related to the growth rate and tj is the time in days
since the beginning of the study. The maximum likelihood estimates (MLEs) of the
fixed parameters along with standard errors for model (3) are given in Table 1. A
plot of the data and model (3) is shown in Figure 1(a).
Table 1: Parameter estimates (standard errors) and log-likelihoods for models esti-
mated in section 3.2 for the orange tree data.
Model β1 β2 β3 β4 σ σb1 σb2 ρ log(L)
(3) 192.1 727.9 348.1 7.84 31.6 -131.57
(15.7) (35.3) (27.1)
(4) 196.2 748.4 352.9 5.30 32.6 10.5 -125.45
(19.4) (62.3) (33.3)
(5) 217.1 857.5 436.8 0.322 4.79 36.0 -116.79
(18.1) (42.0) (24.5) (0.038)
(4) + (6) 192.4 730.1 348.1 6.12 32.7 12.0 0.773 -118.44
(19.6) (63.8) (34.2)
(5) + (6) 216.2 859.1 437.8 0.330 5.76 36.7 0.811 -106.18
(17.6) (30.5) (21.6) (0.022)
A plot of residuals versus time (sampling occasion) shown in Figure 1(b) reveals
an unmodeled variation with time as is also noted by Millar (2004). Millar proposes
to include a second random component, b2j for the sampling occasion, that is, crossed
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(a) Orange tree data and model fit.
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(b) Residuals versus time.
Figure 1: Plots for model (3) for orange tree data.
with the random component for trees. He suggests the model
yij =
β1 + b1i + b2j
1 + exp[−(tj − β2)/β3] + ǫij (4)
with b2j ∼ N(0, σ2b2) and independent of b1i and ǫij , which successfully removes the
most significant structure in the residuals. In this model, the effect of the sampling
occasion, b2j is proportional to the model prediction. This is reasonable during the
initial growth period, but unreasonable when the trees reach their asymptotic circum-
ference. Rather, we find it more natural to include b2j additively in the exp-term in
the denominator in model (3) to make the random effects additive on the logit-scale.
This makes the effect of the sampling occasion vanish as the trees approach their
asymptotic circumference.
A closer look at the sampling scheme reveals, however, that the apparently random
effect of the sampling occasion is caused by a seasonal effect and an irregular sampling
pattern. In the residual plot in Figure 1(b), it is seen that all samples are taken either
in the spring (April or May) or in the fall (October) and that two periods are missing.
We include a categorical seasonal effect, β4 such that
yij =
β1 + b1i
1 + exp[−((tj − β2)/β3 + sjβ4)] + ǫij (5)
where sj is −1/2 and 1/2 for samples taken in the spring and fall respectively. The
models (4) and (5) still show significant unmodeled serial correlation in the residuals
within trees. This may be modelled with a continuous auto-regressive (CAR) process
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(e.g. Diggle et al., 2002; Pinheiro and Bates, 2000) for the residuals by assuming
cov(ǫij , ǫij′) = σ
2 exp(−φ|tj′ − tj |/(365/2)), φ ≥ 0 (6)
so the full covariance matrix is block diagonal with Σ(φ, σ) = I5 ⊗ cov(ǫi) where
⊗ denotes the Kronecker product. The time is scaled so that ρ = exp(−φ) can be
interpreted as the correlation over half a year and therefore roughly between sampling
occasions. Model (4) with crossed random effects cannot easily, if at all, be fitted with
standard software for NLMMs. We return to the models described above in Section 3
and show how they can all be easily estimated by means of the Laplace approximation
and implemented on a case-by-case basis.
2 The Laplace Approximation
In this section we outline the Laplace approximation to the full q-dimensional integral
in the marginal likelihood function (2) for easy reference in later sections. For more
details, see Wolfinger and Lin (1997).
The Laplace approximation consists of approximating the logarithm of the inte-
grand in the marginal likelihood (2), i.e. the joint log-likelihood
h(θ, b;y) = log p(y|θ, b) + log p(b) (7)
by a second-order Taylor expansion,
t(θ, b;y) = h(θ, b˜;y)− 1
2
(b− b˜)TH(θ, b˜)(b− b˜)
for which the integral has an explicit solution. The expansion is performed around
the maximizer of the joint log-likelihood function (conditional mode), i.e. b˜ =
argmaxb h(θ, b;y), which gives the best approximation of the integrand (Barndorff-
Nielsen and Cox, 1979). The negative Hessian, H(θ, b˜) = f ′bΣ
−1f ′b
T − f ′′bbΣ−1(y −
f ) +Ψ−1|b=b˜, can be approximated by
D(θ, b˜) = f ′bΣ
−1f ′b
T
+Ψ−1
∣∣
b=b˜
, (8)
where the second-order term that usually contributes negligibly (Bates and Watts,
1980) has been omitted. This approximation is the expected Hessian similar to the
approximation used in the Gauss-Newton nonlinear least-squares and Fisher scoring
methods. The Laplace approximation using D rather than H is refered to as the
modified Laplace approximation by Pinheiro and Bates (1995) and in its most general
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form reads
lLA(θ;y) = log
∫
Rq
exp {t(θ, b;y)} db
= h(θ, b˜;y)− 1
2
log |D(θ, b˜)/(2π)|. (9)
There are no constraints on how the random effects enter the model function and
thus arbitrary vector-valued, nested, crossed or partially crossed random effects are
accommodated.
If the random effects, b appear linearly in the model function, f , the Laplace
approximation is exact because the second-order Taylor expansion is exact in this
case. The modified Laplace approximation (9) is also exact in this case because
the second-order term ignored in D is zero. We will sometimes refer to (9) as the
Laplace likelihood because it depends on the particular model whether it is exact or
an approximation.
We can view the Laplace likelihood as an approximation of the integrand in the
marginal likelihood (2) by a Gaussian curve. The approximation therefore improves
as the integrand, i.e. the joint likelihood, gets closer to a Gaussian curve or equiva-
lently as the joint log-likelihood (7) gets closer to quadratic function. Vonesh (1996)
shows that as the number of observations increase per random effect, the joint log-
likelihood tends to a quadratic function – a fact also supported by the Bayesian
central limit theorem (Carlin and Louis, 2000, p.122-124). Because the integral of the
joint likelihood is exactly or closely approximated by the integral of an approximating
Gaussian curve, we find that the Laplace approximation is a natural approximation
for estimation in NLMMs.
3 Model Estimation
This section demonstrates how the Laplace approximation to the marginal likelihood
can be used to implement NLMMs on a case-by-case basis with a very limited amount
of coding required. This estimation scheme opens up for a great deal of flexibility and
enables estimation of a range of models that are not otherwise supported by today’s
standard software packages. We describe the computational approach in section 3.1
and illustrate the implementation in section 3.2.
3.1 Computational approach
Our computational approach is based on estimating the parameters of the Laplace
likelihood (9) by a general purpose quasi-Newton optimizer, for instance of the BFGS-
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type (e.g. Nocedal and Wright, 2006). To evaluate the Laplace likelihood (9) for a
set of parameters, θ, two quantities b˜ and D(θ, b˜) has to be available. This leads to
a nested optimization, since for every evaluation of the Laplace likelihood with a set
of parameters, θ in the outer optimization, the joint log-likelihood, h has to be opti-
mized over b in the inner optimization. We also use a general purpose quasi-Newton
optimizer for the latter task. The only unknown quantity needed to evaluate D(θ, b˜)
given θ and b˜ is the Jacobian, f ′b for which we use a finite difference approximation.
Implementation of any NLMM consists of three functions: The model function, f ,
the joint log-likelihood, h in (7) and the Laplace likelihood in (9).
The starting values in the inner optimization is simply zero; the expectation of the
random effects. Starting values for the regression parameters, β are based on plots
of the data or previous fits of other models, potentially fixed effect versions. Starting
values for variance and correlation parameters are qualified guesses based on plots of
the data.
At convergence of the outer optimization, we use a finite difference approximation
to the Hessian to obtain the variance-covariance matrix of the parameters.
Any inaccuracies in the estimation of b˜ and f ′b are directly reflected as noise in
the Laplace likelihood. For the gradient based estimation of the model parameters to
converge smoothly, it is therefore important to obtain sufficiently good estimates of
these quantities.
The variance parameters are optimized on the scale of the logarithm of the stan-
dard deviation to make the estimation unbounded and to make the log-likelihood sur-
face more quadratic facilitating faster convergence. Because all terms in the Laplace
likelihood (9) are evaluated on the log-scale, it can be evaluated for any variance
parameter arbitrarily close to the boundary at zero (in finite computer arithmetic).
This ensures that the optimization will proceed smoothly even if the (MLE) is zero.
Further, it allows the likelihood to be profiled with respect to the variance parameters
arbitrarily close to zero.
The optimizer nlminb in the base package in R is chosen for the inner and outer
optimizations. The Jacobian is estimated using the numerical approximation imple-
mented in jacobian in the numDeriv package (Gilbert, 2009). The hessian function,
also from the numDeriv package, is used to obtain a finite difference estimation of the
Hessian at the convergence of the outer optimization.
The computational approach described above can be optimized with respect to
speed and robustness in a number of respects – generally at the cost of flexibility and
more complex coding. Analytical gradients of the joint log-likelihood with respect
to the random effects can be found via the general expression h′b(b) = f
′
bΣ
−1(y −
f ) − Ψ−1b and will increase the speed of convergence of the inner optimization.
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The analytical Jacobian will also increase the speed of computation of the Hessian
approximation. A Gauss-Newton type estimation of the random effects can replace
the quasi-Newton optimization of the inner optimization using the gradient and the
Hessian, D from above. This often leads to further speed improvements. In models
with many random effects, the quasi-Newton estimation in the inner optimization
can benefit from memory-limited BFGS updates (Nocedal and Wright, 2006), and
the Gauss-Newton estimation can benefit from the use of sparse matrix methods (e.g.
Davis, 2006). Lastly, the residual variance can be profiled out of the likelihood thus
reducing the dimension of the outer optimization (Pinheiro and Bates, 1995).
3.2 Implementation in R
In this section we show how the models for the orange tree data presented in sec-
tion 1.1 can be estimated in a few lines of code with the computational approach for
the Laplace approximation described in section 3.1. First, we show how the simple
model (3) with a single scalar random effect is implemented. Subsequently we show
how this code can be altered in only a few places to fit model (4) with crossed ran-
dom effects, model (5) with a seasonal effect, and how the CAR process in (6) can be
allowed for in the latter models.
The model function, f for model (3) is defined as
> f <- function(beta, b) {
(beta[1] + rep(b[1:5], each = 7))/
(1 + exp((beta[2] - time)/beta[3])) }
The function returns a vector of the same length as the data with model predictions
based on the 3 fixed effects in beta, the 5 random effects in b and the 7 time points
in time. The joint negative log-likelihood based on (7) is defined as
> h <- function(b, beta, sigma, sigma.b) {
-sum(dnorm(x = circumference, mean = f(beta, b),
sd = sigma, log = TRUE)) -
sum(dnorm(x = b[1:5], sd = sigma.b, log = TRUE)) }
using two vectorized calls to the univariate normal density function dnorm, because
the conditional distribution of the observations and the distribution of the random
effects are mutually independent normal. This is the negative joint log-likelihood,
because standard optimization algorithms by default minimize rather than maximize.
Based on the implementations of the model function and the joint log-likelihood,
the Laplace approximation to the marginal log-likelihood lLA(θ) is implemented as
> l.LA <- function(theta) {
beta <- theta[1:3]
sigma <- exp(theta[4])
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sigma.b <- exp(theta[5])
est <- nlminb(start = rep(0,5), objective = h, beta = beta,
sigma = sigma, sigma.b = sigma.b)
b <- est$par
h.b <- est$objective
Jac.f <- jacobian(func = f, x = b, beta = beta)
D <- crossprod(Jac.f)/sigma^2 + diag(1/sigma.b^2, 5)
h.b + 1/2 * log(det(D/(2 * pi))) }.
where the parameters to be estimated are θ = (β, log σ, log σb). The call to nlminb
in l.LA performs the inner optimization and computes b˜, and the Hessian, D is
computed as in (8) based on the Jacobian, f ′b.
The maximum likelihood fit of model (3) is obtained by performing the outer
optimization with the call
> fit <- nlminb(theta0, l.LA)
where the starting values, θ0 are infered from Figure 1(a). The estimation converges in
a few seconds on a standard personal computer to the model fit presented in Table 1.
This concludes the estimation of model (3). Next, we show how this code can be
changed to estimate model (4) with crossed random effects. We mention all changes
to the code apart from updates to the parameter sets passed between functions and
similar trivialities. Only small changes to the code are required to estimate a model
that is not within reach with standard software for NLMMs. This illustrates the
power and flexibility of the proposed estimation scheme.
Model (4) has two crossed random components b1i and b2j for tree and time
and the full vector of random effects is thus b = [b11, ..., b15, b21, ..., b27]
T . The
model function f is modified to include the 7 new random effects for sampling oc-
casion by adding the term rep(b[6:12], 5) to beta[1] + rep(b[1:5], each = 7).
To accommodate the additional random effects with standard deviation σb2 in the
joint log-likelihood, the function h is updated by adding -sum(dnorm(x = b[6:12],
sd = sigma.b2, log = TRUE)) to the existing code. The only change to the Laplace
likelihood, l.LA is in the adaption of the change in the covariance matrix for the ran-
dom effects, Ψ to the Hessian, D in (8); the term diag(1/sigma.b^2, 5) is replaced
by diag(c(rep(1/sigma.b^2, 5), rep(1/sigma.b2^2, 7))). Model (4) is estimated
similarly to model (3) and the optimization converges in a matter of seconds to the
results shown in Table 1.
While model (4) is a significant improvement to model (3), model (5) with a
seasonal effect might be more appropriate than model (4) with a random effect of
sampling occasion. To fit model (5), the only change to the previously defined func-
tions; f, h and l.LA for model (3) is the addition of the term beta[4] * season in
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the exp-term in f. The estimate of model (5) is also shown in Table 1. Because the
likelihood of model (5) is considerably higher than that of model (4) at the same
expense of parameters and producing almost exactly the same predictions, we prefer
model (5).
The model fit for model (5) is shown in Figure 2(a). By comparing this to the fit
of model (3) in Figure 1(a), it appears that model (5) seems to capture the variation
between sampling occasions. This is also verified by a plot of residuals versus time
in Figure 2(b), where the residuals within sample occasions are now centered around
zero and smaller than in Figure 1(b). The plots for model (4) are very similar to
those in Figure 2 for model (5).
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(b) Residuals versus time.
Figure 2: Plots for model (5) for orange tree data.
In Figure 2(b), the residuals for each tree have been connected by lines to illustrate
that a positive auto-correlation is present. Only small changes to the estimation
scheme are required to accommodate any correlation or covariance structure in the
residuals. In the following we will describe how the CAR process in (6) for the within
tree residuals can be implemented and included in the estimation of the models (4)
and (5). We implement the covariance matrix, Σ in (6) as
> Sigma.CAR <- function(phi, sigma) {
diff <- (time[1:7] - rep(time[1:7], each=7))
delta.t <- matrix(diff / (365 / 2), nrow = 7, ncol = 7)
P <- sigma^2 * exp( - phi * abs(delta.t))
kronecker( diag(5), P) }
where delta.t is a matrix of time differences and P is cov(ǫi). To accommodate the
CAR process in the residuals in models (4) and (5), the model functions remain as
previously described and the joint log-likelihood is defined as
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> h <- function(b, beta, sigma, sigma.b, sigma.b2, phi) {
Sigma <- Sigma.CAR(phi, sigma)
resid <- circumference - f(beta, b)
0.5 * (log(det(2*pi*Sigma)) + crossprod(resid, solve(Sigma,
resid))) - sum(dnorm(x = b[1:5], sd = sigma.b, log=TRUE)) -
sum(dnorm(x = b[6:12], sd = sigma.b2, log=TRUE)) }
where the notable difference from previously is that the first part of h is now writ-
ten as the logarithm of a multivariate normal density using the full residual co-
variance matrix Sigma (in model (5) the last call to dnorm concerning σb2 is ex-
cluded). The term (y − µ)TΣ−1(y − µ) in the normal density function is com-
puted using crossprod(resid, solve(Sigma, resid)), since this is numerically more
stable and more efficient than computing the term directly as defined. The only
change to l.LA to accommodate (6) is in the computation of the Hessian, D, where
crossprod(Jac.f)/sig^2 is changed to crossprod(Jac.f, solve(Sigma, Jac.f)). To
make the estimation of the correlation parameter, φ in the CAR process (6) un-
bounded, it is optimized on the log-scale. The estimates of models (4) and (5) with
the CAR process (6) are shown in Table 1. For both models, the CAR process is a sig-
nificant improvement with p-values <0.001 based on likelihood ratio tests. For model
(5), the correlation over half a year, and therefore roughly between sampling occa-
sions, is ρˆ = 0.81, which is equivalent to the correlation coefficient in a discrete AR(1)
model, where account is taken of missing sampling occasions. This corresponds to the
strong auto-correlation seen in Figure 2(b) between successive sampling occasions.
4 Graphical Methods for Inference and Validation
In this section we illustrate a number of graphical methods that are useful for inference
and validation of a model fit. First, we discuss how to obtain the profile likelihood
and corresponding confidence intervals, next we discuss the use of pseudo likelihoods
for assessing convergence, and finally we discuss how the accuracy of the Laplace
approximation can be assessed when random effects enter nonlinearly in the model
function.
The profile likelihood is an inferential tool in its own right, and it can be used
to make likelihood based confidence intervals instead of having to rely on the Wald
approximation. For a scalar parameter θ, the profile likelihood is defined as L(θ) =
maxη L(θ,η), where η are nuisance parameters and θ = (θ,η). Our approach contains
a single loop over the parameter of interest with repeated optimization with respect
to the remaining nuisance parameters. The profile likelihood can be interpolated
by a spline (e.g. spline in R) to reduce the number of values of θ for which the
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likelihood has to be optimized to produce a smooth curve. Figure 3(a) shows the
relative profile likelihood for the variance parameter for the random effects of sampling
occasion in model (4), and Figure 3(b) shows the relative profile likelihood for the
half-year correlation ρ in model (5) with the seasonal effect and the CAR residual
structure. The horizontal lines at 0.1465 and 0.03625 define 95% and 99% confidence
intervals based on the usual χ21-asymptotics of the likelihood ratio statistic. The profile
likelihood confidence bounds can be found by numerically solving for the intersection
of the spline function with these threshold (e.g. using uniroot in R). The figures show
which values of the parameters are supported by the data and which are of negligible
likelihood relative to the MLE. The figures also illustrate the effect of the arguably
arbitrary choice of confidence level.
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Figure 3: Relative profile likelihoods for (a) the variance parameter for the random
effects of sampling occasion in model (4) and (b) the correlation over half a year in
model (5) + (6). The horizontal lines indicate 95% and 99% confidence intervals.
The profile likelihood can be time consuming to compute if the parameter set is
large because of the many optimizations that are required. If interest is in assessing
convergence, the many optimizations can be avoided by making use of the pseudo (or
estimated) likelihood. The pseudo likelihood is given as Le(θ) = L(θ, ηˆ) where ηˆ is
the MLE of η. It ignores the uncertainty in the remaining parameters, and there is
no general way to use it for frequency callibrated inference, but it can be useful for
visually checking that the optimization has converged at the optimum. Figure 4 shows
pseudo log-likelihood plots for all parameters in model (4) around their MLE on the
scale at which the optimization is performed. The plots indicate proper convergence
to an unequivocal optimum. If the pseudo log-likelihood is plotted for a very small
range around the MLEs, the plots can also be used to study the accuracy in the
evaluation of the Laplace log-likelihood as inaccuracies will show up as noise on the
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curve. In this way it is found that the error of the log-likelihood surface is on the order
10−7 to 10−10 for the models we have considered. This is sufficient for the gradient
based estimation of model parameters to be both robust and efficient.
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Figure 4: Pseudo log-likelihood profiles for model (4).
The Laplace approximation is exact for all models estimated in Section 3, be-
cause the random effects enter linearly in the model functions. Sometimes however,
random effects enter nonlinearly and the Laplace likelihood (9) is an approximation
to the marginal likelihood (2), and it is of interest to substantiate how accurate the
approximation is. We may assess the accuracy of the approximation by graphical
means, and to illustrate this, we will use a model that was briefly mentioned in the
introduction
yij =
β1 + b1i
1 + exp[−((tj − β2)/β3 + b2j)] + ǫij (10)
where b2j enter additively on the logit-scale and thus nonlinearly in the model func-
tion. This model has a log-likelihood of -125.39 which is almost identical to that of
model (4), cf. Table 1. Because the two random components in (10) are crossed,
the integral defining the marginal likelihood (2) is 12-dimensional. We know that
the Laplace approximation is exact in the 5 directions corresponding to the linear
random effect, b1i. We can examine how good the Laplace approximation to the
12-dimensional integral is in the directions corresponding to the random effects that
appear nonlinearly in the model function. This is not a rigid assessment of the ac-
curacy of the entire integral, but intuitively we expect the total error to be small,
if the error is negligible in the directions corresponding to the random effects that
appear nonlinearly in the model function. Because the random effects in each ran-
dom component are independent by definition, and because each random effect in
one component only depends on the random effects in the other component indirectly
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through the fixed parameters, the Hessian, D (and H) is very close to orthogonal.
Therefore, the error of the Laplace approximation will not be notably larger in the
directions that we are not examining. The integrand is given by the joint likelihood,
and we may plot this as a function of one of the random effects that enter nonlinearly
in the model function, while holding the fixed effects and the remaining random ef-
fects fixed at their estimates, θˆ and b˜. The approximating Gaussian curve illustrates
the Laplace approximation and is based on b˜ and the appropriate diagonal entry of
D(θˆ, b˜). Figure 5 illustrates the joint likelihood (solid line) and the approximating
Gaussian curve (dashed line) for the random effects b24 (a) and b27 (b). We expect
there to be more information about the random effect b24 than about b27 due to the
structure of the logistic curve (b24 is at a sampling occasion, where the slope of the
logistic curve is large, and b27 is near the asymptotic circumference, where variations
has a smaller influence on the model function, cf. Figure 1(a)). This is reflected in
Figure 5 in two respects: 1) The curve is wider for b27 than for b24, 2) the curve for
b24 is better approximated by the Gaussian curve than the curve for b27.
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Figure 5: Joint likelihood (solid line) at the MLE for two random effects that enter
nonlinearly in the model function and the Gaussian approximation (dashed line).
Using a general integration function (integrate in base package in R), we evaluated
the integrals of the joint likelihoods in Figure 5 with sufficient precision and found
that the relative error of the Laplace approximation in these directions are 0.08% and
0.22%. The error in the directions corresponding to the remaining random effects
that enter non-linearly in the model (10) is of similar size, and we conclude that the
error of the Laplace approximation is negligible from a statistical perspective for this
model.
In model (10), D is an approximation to H due to the nonlinearity of the model
function in the random effects. At the parameter estimates the absolute error in
using D rather than H in the term − log |D/(2π)|/2 in the Laplace approximation
(9) is 0.0058 which is irrelevant from a statistical perspective and lends support to the
previous remark that the second-order term ignored in D is of negligible magnitude.
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5 Comparison to Standard Software
The Laplace approximation gives the exact marginal likelihood for model (3) for
the orange data, because random effects enter linearly in the model function. The
model is an example of a simple NLMM with just one random component and can
be handled by all standard software. The model is used to compare the accuracy
of the R-based estimation scheme to SAS NLMIXED, NONMEM and nlme and the
results are shown in Table 2. Both SAS NLMIXED and NONMEM were used with
the Laplace approximation, and, as can be seen from the table, they both agree with
the implementation presented in this paper to all reported digits (NONMEM uses
an objective function missing a constant term log(2π)
∑
ni (Wang, 2007), which has
been corrected for in the table). Also the parameter and std. err. estimates were
found to be very similar. The last row in Table 2 is nlme using Lindstrom and Bates’
(1990) alternating method, which is not exact for this model. The approximate log-
likelihood at the MLE deviates slightly from the others, which is also the case for the
parameter estimates.
Table 2: Values of the Log-likelihood for model (3) as reported by various software.
l.LA in R -131.5718851
SAS NLMIXED -131.57188
NONMEM -131.5718
nlme in nlme -131.5845
6 Discussion
The presented estimation scheme using the multivariate Laplace approximation offers
a very large flexibility in the specification of NLMMs at the cost of only a rather
limited amount of coding. It provides an option to fit models, assess convergence and
draw inference via profile likelihoods when standard software falls short. Especially
models with crossed random effects are not (at least easily) handled by any currently
available software package such as NONMEM, SAS NLMIXED, or nlme for R/S-
Plus. In this way the approach presented here fills a gap left by standard software
for NLMMs. The analysis of the orange tree data presented here shows that the
flexibility and ability to estimate, compare and draw inference from various models is
of substantial importance to the conclusions of the data analysis. The approximation
error of the Laplace approximation appears to be of only minor importance.
Several other methods for approximating the marginal likelihood of NLMMs than
that of Laplace have been proposed including Gauss Hermite quadrature (GHQ) (e.g.
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Davidian and Gallant, 1992), adaptive Gauss Hermite quadrature (AGQ) (e.g. Lui
and Pierce, 1994; Rabe-Hesketh et al., 2005), simulation methods and linearization
methods. Pinheiro and Bates (1995) compare these methods for models with a single
level of grouping and conclude that Laplace and AGQ are the most appealing if one is
not content with the linearization method of Lindstrom and Bates (1990). In models
with random effects that enter linearly in the model function, the Laplace likelihood
is exact, so there is no need to go to lengths with the more computationally demand-
ing AGQ, but AGQ will improve Laplace in models with nonlinear random effects.
In models with one level of grouping or nested random components, the integration
problems can typically be held in small dimensions, and AGQ can be computationally
feasible, but since the number of evaluations of the joint likelihood increases exponen-
tially with the dimension, the scope of the method is limited. A more sophisticated
approach is to integrate over a sparse grid rather than the full grid as proposed by
Heiss and Winschel (2008). For models with crossed or partially crossed random ef-
fect structures, the dimension of the integral increases linearly with the number of
random effects, so sparse grid integration also quickly reaches its feasible limit. As an
example, consider model (10) with crossed random effects, where one of the random
components enter nonlinearly in the model function. The dimension of the integral
is 12, and AGQ with a modest 5 quadrature points would require 512 = 244,140,625
evaluations of the joint likelihood at each evaluation of the approximation to the
marginal likelihood. The sparse grid methods reduce this number substantially so
that in 10 and 20 dimensions, the number of points is, respectively, 5,281 and 90,561
(Heiss and Winschel, 2008). For the small orange tree data this would be within range
of standard computing power, but if the number of trees is doubled or tripled, this
also becomes too inefficient.
Stochastic methods such as simulated likelihood is to some extent applicable to
models with crossed or partially crossed random effects, but it also suffers from the
curse of dimensionality. As noted by Pinheiro and Bates (1995), the inherent un-
certainty in stochastic approximations makes the likelihood hard to optimize. Millar
(2004) uses simulated likelihood with 50,000 importance samples and exploiting an-
tithetic variables to estimate model (4). He reports a value of the log-likelihood for
model (4) that differ 0.0017 from that of the Laplace likelihood, which is exact for
this model with an absolute error less than 10−7 as discussed in section 4. However,
if the log-likelihood is evaluated at the parameter estimates reported by Millar, the
actual error of Millar’s simulated likelihood is only 0.0002. Although this difference
is irrelevant from an inferential viewpoint, it illustrates the inherent uncertainty in
stochastic methods that can hinder optimization of the likelihood.
The estimation times for our implementations are generally longer compared to
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those of standard software packages, when these are able to estimate the specified
models. The most complex model considered here is model (4) with the CAR structure
and it takes a few minutes to fit. The remaining models converges in a matter of a
few seconds directly to the MLE without any further effort. Larger data sets will
inevitably increase estimation times, but not necessarily the code complexity. In
some cases the optimizations of the computational approach mentioned in section 3.1
might be worth the effort.
In this paper we have illustrated the flexibility of estimation with the multivariate
Laplace approximation in the framework of NLMMs, but this method is applicable for
a much larger class of models. Essentially all mixed models, where the joint likelihood
is easily defined can be accommodated including the important generalized linear
mixed models; univariate as well as multivariate, and also the less common generalized
nonlinear mixed models. When the distribution of the observations is not Gaussian,
the Laplace approximation is naturally less accurate, but by the Bayesian central limit
theorem (Carlin and Louis, 2000), the joint likelihood tends to a normal curve when
the number of observations per random effect increase, so the Laplace approximation
can be expected to be fairly accurate when the information per random effect is not
small. In our experience the Laplace approximation is remarkably accurate for a wide
range of models, but further research is needed to address this topic formally.
Appendix
Table 3: Circumference in millimeters for 5 orange trees reported by Draper and
Smith (1981, p. 524).
Tree Time (days since 31 Dec. 1968)
118S 484S 664A 1004A 1231S 1372A 1582S
1 30 58 87 115 120 142 145
2 33 69 111 156 172 203 203
3 30 51 75 108 115 139 140
4 32 62 112 167 179 209 214
5 30 49 81 125 142 174 177
A, S: Autumn, Spring
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